PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
26079270-0	2015	Surface Modification of Li1.2Ni0.13Mn0.54Co0.13O2 by Hydrazine Vapor as Cathode Material for Lithium-Ion Batteries.	13o2	45-49	transglutaminase 1	Homo sapiens	24-27
26505792-7	2015	Finally, quantitative RT-PCR analysis demonstrated that genes involved in the aggressive phenotypes (TWIST2, EGFR, ACTA2, TGFB1, WNT5B, and APLIN) were down-regulated, whereas epithelial phenotype genes (CDH1, CLDN4, IVL, and TGM1) were up-regulated in SAS cells treated with DZNep.	3-deazaneplanocin	276-281	transglutaminase 1	Homo sapiens	226-230
26416313-0	2015	Effects of composition modulation on the luminescence properties of Eu(3+) doped Li1-xAgxLu(MoO4)2 solid-solution phosphors.	molybdate	92-98	transglutaminase 1	Homo sapiens	81-84
26416313-1	2015	Double molybdate scheelite-type solid-solution phosphors Li1-xAgxLu1-y(MoO4)2:yEu(3+) were synthesized by the solid state reaction method, and their crystal structures and luminescence properties were investigated in detail.	molybdate	7-16	transglutaminase 1	Homo sapiens	57-60
26068405-3	2015	The loss of alpha-helix due to TGase treatment was oxidation-dependent, namely, mild oxidation (0.1-1mM H2O2)>non-oxidation>moderate oxidation (5-20mM H2O2).	Hydrogen Peroxide	104-108	transglutaminase 1	Homo sapiens	31-36
26068405-3	2015	The loss of alpha-helix due to TGase treatment was oxidation-dependent, namely, mild oxidation (0.1-1mM H2O2)>non-oxidation>moderate oxidation (5-20mM H2O2).	Hydrogen Peroxide	157-161	transglutaminase 1	Homo sapiens	31-36
26305102-6	2015	However, the same treatment with astaxanthin significantly abolished the UVB-stimulated expression of TGase 1 protein, which was accompanied by the attenuated phosphorylation of Thr565/Ser376/Ser360MSK1, Ser276NFkappaBp65 and Ser133CREB.	astaxanthine	33-44	transglutaminase 1	Homo sapiens	102-109
26305102-6	2015	However, the same treatment with astaxanthin significantly abolished the UVB-stimulated expression of TGase 1 protein, which was accompanied by the attenuated phosphorylation of Thr565/Ser376/Ser360MSK1, Ser276NFkappaBp65 and Ser133CREB.	ser360msk1	192-202	transglutaminase 1	Homo sapiens	102-109
26305102-6	2015	However, the same treatment with astaxanthin significantly abolished the UVB-stimulated expression of TGase 1 protein, which was accompanied by the attenuated phosphorylation of Thr565/Ser376/Ser360MSK1, Ser276NFkappaBp65 and Ser133CREB.	ser276nfkappabp65	204-221	transglutaminase 1	Homo sapiens	102-109
26305102-6	2015	However, the same treatment with astaxanthin significantly abolished the UVB-stimulated expression of TGase 1 protein, which was accompanied by the attenuated phosphorylation of Thr565/Ser376/Ser360MSK1, Ser276NFkappaBp65 and Ser133CREB.	ser133creb	226-236	transglutaminase 1	Homo sapiens	102-109
26305102-7	2015	The MSK1 inhibitor H89 significantly down-regulated the increased protein expression of TGase 1 in UVB-exposed human keratinocytes, which was accompanied by an abrogating effect on the increased phosphorylation of Ser276NFkappaBp65 and Ser133CREB but not Thr565/Ser376/Ser360MSK1.	ser276nfkappabp65	214-231	transglutaminase 1	Homo sapiens	88-95
26305102-7	2015	The MSK1 inhibitor H89 significantly down-regulated the increased protein expression of TGase 1 in UVB-exposed human keratinocytes, which was accompanied by an abrogating effect on the increased phosphorylation of Ser276NFkappaBp65 and Ser133CREB but not Thr565/Ser376/Ser360MSK1.	ser133creb	236-246	transglutaminase 1	Homo sapiens	88-95
25804288-4	2015	RESULTS: The association between PEs and MD/OCD was moderated by urbanicity (ICR = 2.46, p = 0.005), cannabis use (ICR = 3.76, p = 0.010) and, suggestively, trauma (ICR = 1.91, p = 0.063).	polyether sulfone	33-36	transglutaminase 1	Homo sapiens	77-84
26458153-0	2015	Probing Dynamic Processes in Lithium-Ion Batteries by In Situ NMR Spectroscopy: Application to Li1.08Mn1.92O4 Electrodes.	Lithium	29-36	transglutaminase 1	Homo sapiens	95-98
26510508-2	2015	Here we apply complementary electron microscopy and spectroscopy techniques at multi-length scale on well-formed Li1.2(Ni0.13Mn0.54Co0.13)O2 crystals with two different morphologies as well as two commercially available materials with similar compositions, and unambiguously describe the structural make-up of these samples.	Oxygen	138-140	transglutaminase 1	Homo sapiens	113-116
26068405-4	2015	Moreover, oxidation altered the myosin cross-linking pattern: TGase-initiated S1 cross-linking (which dominated non-oxidized MP) partially shifted to the rod under 0.1-0.5mM H2O2 and extensively to the S2 site with 20mM H2O2.	Hydrogen Peroxide	174-178	transglutaminase 1	Homo sapiens	62-67
26068405-4	2015	Moreover, oxidation altered the myosin cross-linking pattern: TGase-initiated S1 cross-linking (which dominated non-oxidized MP) partially shifted to the rod under 0.1-0.5mM H2O2 and extensively to the S2 site with 20mM H2O2.	Hydrogen Peroxide	220-224	transglutaminase 1	Homo sapiens	62-67
26068405-5	2015	Unraveling of the helical structure and formation of disulfide bonds due to oxidation were implicated in the altered myosin cross-linking pattern during subsequent TGase reactions.	Disulfides	53-62	transglutaminase 1	Homo sapiens	164-169
26079270-0	2015	Surface Modification of Li1.2Ni0.13Mn0.54Co0.13O2 by Hydrazine Vapor as Cathode Material for Lithium-Ion Batteries.	hydrazine	53-62	transglutaminase 1	Homo sapiens	24-27
26079270-0	2015	Surface Modification of Li1.2Ni0.13Mn0.54Co0.13O2 by Hydrazine Vapor as Cathode Material for Lithium-Ion Batteries.	Lithium	93-100	transglutaminase 1	Homo sapiens	24-27
26079270-1	2015	An artificial interface is successfully prepared on the surface of the layered lithium-rich cathode material Li1.2Ni0.13Mn0.54Co0.12O2 via treating it with hydrazine vapor, followed by an annealing process.	Lithium	79-86	transglutaminase 1	Homo sapiens	109-112
26079270-1	2015	An artificial interface is successfully prepared on the surface of the layered lithium-rich cathode material Li1.2Ni0.13Mn0.54Co0.12O2 via treating it with hydrazine vapor, followed by an annealing process.	hydrazine	156-165	transglutaminase 1	Homo sapiens	109-112
26079270-2	2015	The inductively coupled plasma-atomic emission spectrometry (ICP) results indicate that lithium ions are leached out from the surface of Li1.2Ni0.13Mn0.54Co0.12O2 by the hydrazine vapor.	Lithium	88-95	transglutaminase 1	Homo sapiens	137-140
26079270-2	2015	The inductively coupled plasma-atomic emission spectrometry (ICP) results indicate that lithium ions are leached out from the surface of Li1.2Ni0.13Mn0.54Co0.12O2 by the hydrazine vapor.	hydrazine	170-179	transglutaminase 1	Homo sapiens	137-140
26121178-0	2015	Improve First-Cycle Efficiency and Rate Performance of Layered-Layered Li1.2Mn0.6Ni0.2O2 Using Oxygen Stabilizing Dopant.	.2o2	84-88	transglutaminase 1	Homo sapiens	71-74
26121178-0	2015	Improve First-Cycle Efficiency and Rate Performance of Layered-Layered Li1.2Mn0.6Ni0.2O2 Using Oxygen Stabilizing Dopant.	Oxygen	95-101	transglutaminase 1	Homo sapiens	71-74
26121178-2	2015	In this work, we report that barium doping improves the first-cycle efficiency of Li-rich layered-layered Li1.2Mn0.6Ni0.2O2 via suppression of the oxidation of O(2-) ions in the first charging.	Barium	29-35	transglutaminase 1	Homo sapiens	106-109
26121178-4	2015	Meanwhile, because the stabilized oxygen radicals likely facilitate the charge transportation in the layered-layered structure, the barium-doped Li1.2Mn0.6Ni0.2O2 exhibits significant improvement in rate performance.	Reactive Oxygen Species	34-49	transglutaminase 1	Homo sapiens	145-148
26121178-4	2015	Meanwhile, because the stabilized oxygen radicals likely facilitate the charge transportation in the layered-layered structure, the barium-doped Li1.2Mn0.6Ni0.2O2 exhibits significant improvement in rate performance.	Barium	132-138	transglutaminase 1	Homo sapiens	145-148
26121178-4	2015	Meanwhile, because the stabilized oxygen radicals likely facilitate the charge transportation in the layered-layered structure, the barium-doped Li1.2Mn0.6Ni0.2O2 exhibits significant improvement in rate performance.	6ni0.2o2	154-162	transglutaminase 1	Homo sapiens	145-148
26053003-0	2015	Li1.2Mn0.54Ni0.13Co0.13O2-Encapsulated Carbon Nanofiber Network Cathodes with Improved Stability and Rate Capability for Li-Ion Batteries.	Carbon	39-45	transglutaminase 1	Homo sapiens	0-3
25794141-6	2015	TGase-mediated MDC incorporation was strongly reduced by serotonin, underlining the general mechanism of monoaminylation.	Serotonin	57-66	transglutaminase 1	Homo sapiens	0-5
26053003-1	2015	Li1.2Mn0.54Ni0.13Co0.13O2-encapsulated carbon nanofiber network cathode materials were synthesized by a facile electrospinning method.	13o2	21-25	transglutaminase 1	Homo sapiens	0-3
26053003-1	2015	Li1.2Mn0.54Ni0.13Co0.13O2-encapsulated carbon nanofiber network cathode materials were synthesized by a facile electrospinning method.	Carbon	39-45	transglutaminase 1	Homo sapiens	0-3
26053003-3	2015	The nanofiber decorated Li1.2Mn0.54Ni0.13Co0.13O2 electrode demonstrated higher coulombic efficiency of 83.5%, and discharge capacity of 263.7 mAh g(-1) at 1 C as well as higher stability compared to the pristine particle counterpart.	13o2	45-49	transglutaminase 1	Homo sapiens	24-27
25651930-7	2015	In addition, oat oil treatment increased both receptor expression and, consistent with the literature on PPARs, oat oil treatment resulted in a significant upregulation of differentiation genes (involucrin, SPRRs and transglutaminase 1) and ceramide processing genes (beta-glucocerebrosidase, sphingomyelinases 3 and ABCA12).	oat oil	13-20	transglutaminase 1	Homo sapiens	217-235
25846750-1	2015	Using high resolution transmission electron microscopy with image simulation and Fourier analysis, the Li1- x FePO4 (x < 0.01), Li1- x FePO4 (x ~ 0.5), and FePO4 particles, prepared by charging or discharging the 053048 electrochemical cells (thickness: 5 mm, width: 30 mm, height: 48 mm) and dismantled inside an Ar-filled dry box, were investigated.	ferric phosphate	110-115	transglutaminase 1	Homo sapiens	103-106
25651930-7	2015	In addition, oat oil treatment increased both receptor expression and, consistent with the literature on PPARs, oat oil treatment resulted in a significant upregulation of differentiation genes (involucrin, SPRRs and transglutaminase 1) and ceramide processing genes (beta-glucocerebrosidase, sphingomyelinases 3 and ABCA12).	oat oil	112-119	transglutaminase 1	Homo sapiens	217-235
26278733-0	2014	Computational and Experimental Investigation of Ti Substitution in Li1(NixMnxCo1-2x-yTiy)O2 for Lithium Ion Batteries.	Lithium	96-103	transglutaminase 1	Homo sapiens	67-70
25399055-7	2015	Here we present some PCD plant models, focusing on the role of the enzyme responsible for PA conjugation to proteins: transglutaminase (TGase), an enzyme linked with the process of PCD also in some animal models.	Polyamines	90-92	transglutaminase 1	Homo sapiens	118-134
25399055-7	2015	Here we present some PCD plant models, focusing on the role of the enzyme responsible for PA conjugation to proteins: transglutaminase (TGase), an enzyme linked with the process of PCD also in some animal models.	Polyamines	90-92	transglutaminase 1	Homo sapiens	136-141
25053075-0	2015	Transglutaminase-induced crosslinking of gelatin-calcium carbonate composite films.	Calcium Carbonate	49-66	transglutaminase 1	Homo sapiens	0-16
25053075-3	2015	Fluorescence data suggested that the interaction of TGase and gelation-calcium carbonate belonged to a static quenching mechanism, and merely one binding site between TGase and gelatin-calcium carbonate was identified.	Calcium Carbonate	185-202	transglutaminase 1	Homo sapiens	167-172
25053075-4	2015	Moreover, differential scanning calorimetry (DSC), the mechanical properties and the water vapour permeability studies revealed that TGase favoured the strong intramolecular polymerisation of the peptides in gelatin.	Water	85-90	transglutaminase 1	Homo sapiens	133-138
25053075-7	2015	Therefore, TGase successfully facilitated the formation of gelatin-calcium carbonate composite films.	Calcium Carbonate	67-84	transglutaminase 1	Homo sapiens	11-16
25341076-7	2014	In the case of in situ charged bulk crystalline Li2O2, the Li vacancies preferentially form on the interlayer position (Li1), which is supported by first-principle calculations and consistent with their lower energy compared to those located next to oxygen (Li2).	Li2O2	48-53	transglutaminase 1	Homo sapiens	120-123
25265969-2	2014	A discharge voltage of about 2.52 V versus Mg/Mg(2+) corresponding to the redox couples of Fe(3+)/Fe(2+) was predicted for tavorite-Mg0.5FeSO4F, and the experimental diffusion coefficient for the Mg-vacancy in Mg0.5-xFeSO4F is expected to be of the same order of magnitude as that of the Li-vacancy in Li1-xFeSO4F.	ferric sulfate	91-97	transglutaminase 1	Homo sapiens	302-305
25265969-2	2014	A discharge voltage of about 2.52 V versus Mg/Mg(2+) corresponding to the redox couples of Fe(3+)/Fe(2+) was predicted for tavorite-Mg0.5FeSO4F, and the experimental diffusion coefficient for the Mg-vacancy in Mg0.5-xFeSO4F is expected to be of the same order of magnitude as that of the Li-vacancy in Li1-xFeSO4F.	Iron	91-93	transglutaminase 1	Homo sapiens	302-305
25265969-2	2014	A discharge voltage of about 2.52 V versus Mg/Mg(2+) corresponding to the redox couples of Fe(3+)/Fe(2+) was predicted for tavorite-Mg0.5FeSO4F, and the experimental diffusion coefficient for the Mg-vacancy in Mg0.5-xFeSO4F is expected to be of the same order of magnitude as that of the Li-vacancy in Li1-xFeSO4F.	tavorite-	123-132	transglutaminase 1	Homo sapiens	302-305
25265969-2	2014	A discharge voltage of about 2.52 V versus Mg/Mg(2+) corresponding to the redox couples of Fe(3+)/Fe(2+) was predicted for tavorite-Mg0.5FeSO4F, and the experimental diffusion coefficient for the Mg-vacancy in Mg0.5-xFeSO4F is expected to be of the same order of magnitude as that of the Li-vacancy in Li1-xFeSO4F.	Magnesium	43-45	transglutaminase 1	Homo sapiens	302-305
25236224-5	2015	Based on the results of SDS-PAGE, DSC and SEM, it was revealed that the movement of low molecular weight hydrophilic protein was depressed by the cross-linking network structure induced by TGase and SPI during film drying, indicating that adding SPI is essential to improve the thermal stability and water resistance properties of TGase-induced gelatin films.	Sodium Dodecyl Sulfate	24-27	transglutaminase 1	Homo sapiens	189-194
25236224-5	2015	Based on the results of SDS-PAGE, DSC and SEM, it was revealed that the movement of low molecular weight hydrophilic protein was depressed by the cross-linking network structure induced by TGase and SPI during film drying, indicating that adding SPI is essential to improve the thermal stability and water resistance properties of TGase-induced gelatin films.	Water	300-305	transglutaminase 1	Homo sapiens	189-194
25337805-0	2014	Electrochemistry and structure of the cobalt-free Li1+xMO2 (M = Li, Ni, Mn, Fe) composite cathode.	Cobalt	38-44	transglutaminase 1	Homo sapiens	50-58
25337805-0	2014	Electrochemistry and structure of the cobalt-free Li1+xMO2 (M = Li, Ni, Mn, Fe) composite cathode.	Iron	76-78	transglutaminase 1	Homo sapiens	50-58
25337805-1	2014	The development of cathode materials with high capacity and cycle stability is essential to emerging electric-vehicle technologies, however, of serious environmental concern is that materials with these properties developed so far contain the toxic and expensive Co. We report here the Li-rich, Co-free Li1+xMO2 (M = Li, Ni, Mn, Fe) composite cathode material, prepared via a template-free, one-step wet-chemical method followed by conventional annealing in an oxygen atmosphere.	Iron	329-331	transglutaminase 1	Homo sapiens	303-311
25337805-1	2014	The development of cathode materials with high capacity and cycle stability is essential to emerging electric-vehicle technologies, however, of serious environmental concern is that materials with these properties developed so far contain the toxic and expensive Co. We report here the Li-rich, Co-free Li1+xMO2 (M = Li, Ni, Mn, Fe) composite cathode material, prepared via a template-free, one-step wet-chemical method followed by conventional annealing in an oxygen atmosphere.	Oxygen	461-467	transglutaminase 1	Homo sapiens	303-311
26278733-2	2014	Performance enhancement associated with Ti substitution of Co in the cathode material Li1(NixMnxCo1-2x)O2 were investigated using density functional theory calculations, including Hubbard-U corrections.	Cobalt	59-61	transglutaminase 1	Homo sapiens	86-89
26278733-2	2014	Performance enhancement associated with Ti substitution of Co in the cathode material Li1(NixMnxCo1-2x)O2 were investigated using density functional theory calculations, including Hubbard-U corrections.	-2x)o2	99-105	transglutaminase 1	Homo sapiens	86-89
24517223-3	2014	TGase allows the modification of proteins at the level of Gln or Lys residues using as substrate an alkyl-amine or a Gln-mimicking moiety, respectively.	Glutamine	58-61	transglutaminase 1	Homo sapiens	0-5
24977645-2	2014	For better understanding the failure mechanism of battery materials under thermal abuse, the decomposition of a delithiated high energy cathode material, Li1.2-xNi0.15Mn0.55Co0.1O2, in the stainless-steel high pressure capsules was investigated by in situ high energy X-ray diffraction.	stainless	189-198	transglutaminase 1	Homo sapiens	154-157
24679819-0	2014	Facile synthesis of the Li-rich layered oxide Li1.23Ni0.09Co0.12Mn0.56O2 with superior lithium storage performance and new insights into structural transformation of the layered oxide material during charge-discharge cycle: in situ XRD characterization.	Lithium	87-94	transglutaminase 1	Homo sapiens	46-49
24679819-0	2014	Facile synthesis of the Li-rich layered oxide Li1.23Ni0.09Co0.12Mn0.56O2 with superior lithium storage performance and new insights into structural transformation of the layered oxide material during charge-discharge cycle: in situ XRD characterization.	layered oxide	32-45	transglutaminase 1	Homo sapiens	46-49
24679819-1	2014	In this work, the Li-rich oxide Li1.23Ni0.09Co0.12Mn0.56O2 was synthesized through a facile route called aqueous solution-evaporation route that is simple and without waste water.	Water	173-178	transglutaminase 1	Homo sapiens	32-35
24679819-2	2014	The as-prepared Li1.23Ni0.09Co0.12Mn0.56O2 oxide was confirmed to be a layered LiMO2-Li2MnO3 solid solution through ex situ X-ray diffraction (ex situ XRD) and transmission electron microscopy (TEM).	Oxides	43-48	transglutaminase 1	Homo sapiens	16-19
24679819-2	2014	The as-prepared Li1.23Ni0.09Co0.12Mn0.56O2 oxide was confirmed to be a layered LiMO2-Li2MnO3 solid solution through ex situ X-ray diffraction (ex situ XRD) and transmission electron microscopy (TEM).	limo2-li2mno3	79-92	transglutaminase 1	Homo sapiens	16-19
24612062-3	2014	The results indicate disturbed barrier function as demonstrated by increased permeation of testosterone and caffeine particularly in TGM1 knock-down models compared to control models.	Testosterone	91-103	transglutaminase 1	Homo sapiens	133-137
24612062-3	2014	The results indicate disturbed barrier function as demonstrated by increased permeation of testosterone and caffeine particularly in TGM1 knock-down models compared to control models.	Caffeine	108-116	transglutaminase 1	Homo sapiens	133-137
24517223-3	2014	TGase allows the modification of proteins at the level of Gln or Lys residues using as substrate an alkyl-amine or a Gln-mimicking moiety, respectively.	Lysine	65-68	transglutaminase 1	Homo sapiens	0-5
24517223-3	2014	TGase allows the modification of proteins at the level of Gln or Lys residues using as substrate an alkyl-amine or a Gln-mimicking moiety, respectively.	alkyl-amine	100-111	transglutaminase 1	Homo sapiens	0-5
24517223-3	2014	TGase allows the modification of proteins at the level of Gln or Lys residues using as substrate an alkyl-amine or a Gln-mimicking moiety, respectively.	Glutamine	117-120	transglutaminase 1	Homo sapiens	0-5
24517223-6	2014	Surprisingly, incubation of avidin with TGase in the presence of alkylamine containing substrates (dansylcadaverine, 5-hydroxytryptamine) revealed a very low level of derivatization of the Gln126 residue.	alkylamine	65-75	transglutaminase 1	Homo sapiens	40-45
24517223-6	2014	Surprisingly, incubation of avidin with TGase in the presence of alkylamine containing substrates (dansylcadaverine, 5-hydroxytryptamine) revealed a very low level of derivatization of the Gln126 residue.	monodansylcadaverine	99-115	transglutaminase 1	Homo sapiens	40-45
24517223-6	2014	Surprisingly, incubation of avidin with TGase in the presence of alkylamine containing substrates (dansylcadaverine, 5-hydroxytryptamine) revealed a very low level of derivatization of the Gln126 residue.	Serotonin	117-136	transglutaminase 1	Homo sapiens	40-45
24517223-8	2014	On the other hand, incubation of avidin with TGase in the presence of carbobenzoxy-l-glutaminyl-glycine in order to derivatize Lys residue(s) resulted in a clean and high yield production of an avidin derivative, retaining the biotin binding properties and the quaternary structure of the native protein.	carbobenzoxy-l-glutaminyl-glycine	70-103	transglutaminase 1	Homo sapiens	45-50
24517223-8	2014	On the other hand, incubation of avidin with TGase in the presence of carbobenzoxy-l-glutaminyl-glycine in order to derivatize Lys residue(s) resulted in a clean and high yield production of an avidin derivative, retaining the biotin binding properties and the quaternary structure of the native protein.	Lysine	127-130	transglutaminase 1	Homo sapiens	45-50
24517223-8	2014	On the other hand, incubation of avidin with TGase in the presence of carbobenzoxy-l-glutaminyl-glycine in order to derivatize Lys residue(s) resulted in a clean and high yield production of an avidin derivative, retaining the biotin binding properties and the quaternary structure of the native protein.	Biotin	227-233	transglutaminase 1	Homo sapiens	45-50
24517223-10	2014	By using TGase, avidin was also conjugated via a Lys-Gln isopeptide bond to a protein containing a single reactive Gln residue, namely, Gln126 of granulocyte-macrophage colony-stimulating factor.	Glutamine	53-56	transglutaminase 1	Homo sapiens	9-14
23902046-4	2013	First results on the intercalation of a Li1-xCoO2 cathode material demonstrate the potential of the experimental approach for structural studies and underline the importance of studying lithium-ion batteries at work.	Lithium	186-193	transglutaminase 1	Homo sapiens	40-43
24407480-3	2014	The performance of Li1.211Mo0.467Cr0.3O2 shows that lithium diffusion can be facile in disordered materials.	Lithium	52-59	transglutaminase 1	Homo sapiens	19-22
24138287-7	2014	In addition, caffeic acid promotes the expression of genes and proteins related to CE formation such as involucrin and transglutaminase-1.	caffeic acid	13-25	transglutaminase 1	Homo sapiens	119-137
23815352-4	2013	Next, we examined the effects of PVP/fullerenes on the ratio of cells with cornified envelopes and transglutaminase-1 expression by real-time polymerase chain reaction and immunohistochemistry.	Povidone	33-36	transglutaminase 1	Homo sapiens	99-117
23722534-0	2013	Probing the electrode/electrolyte interface in the lithium excess layered oxide Li1.2Ni0.2Mn0.6O2.	Lithium	51-58	transglutaminase 1	Homo sapiens	80-83
23722534-1	2013	A detailed surface investigation of the lithium-excess nickel manganese layered oxide Li1.2Ni0.2Mn0.6O2 structure was carried out using X-ray photoelectron spectroscopy (XPS), total electron yield and transmission X-ray absorption spectroscopy (XAS), and electron energy loss spectroscopy (EELS) during the first two electrochemical cycles.	Lithium	40-47	transglutaminase 1	Homo sapiens	86-89
23722534-1	2013	A detailed surface investigation of the lithium-excess nickel manganese layered oxide Li1.2Ni0.2Mn0.6O2 structure was carried out using X-ray photoelectron spectroscopy (XPS), total electron yield and transmission X-ray absorption spectroscopy (XAS), and electron energy loss spectroscopy (EELS) during the first two electrochemical cycles.	Nickel	55-61	transglutaminase 1	Homo sapiens	86-89
23722534-1	2013	A detailed surface investigation of the lithium-excess nickel manganese layered oxide Li1.2Ni0.2Mn0.6O2 structure was carried out using X-ray photoelectron spectroscopy (XPS), total electron yield and transmission X-ray absorption spectroscopy (XAS), and electron energy loss spectroscopy (EELS) during the first two electrochemical cycles.	manganese layered oxide	62-85	transglutaminase 1	Homo sapiens	86-89
24451036-3	2014	Cells treated with SB showed increased expression of the levels of mRNA and protein of the differentiation markers filaggrin and transglutaminase 1.	Butyric Acid	19-21	transglutaminase 1	Homo sapiens	129-147
24048737-12	2013	Finally, we show that MTI-101 has robust activity as a single agent in the SCID-Hu bone implant and 5TGM1 in vivo model of multiple myeloma.	MTI-101	22-29	transglutaminase 1	Homo sapiens	101-105
23601132-2	2013	A CEST agent, Tm-DO3A-cadaverine, has been designed to detect the catalytic activity of transglutaminase (TGase), which creates a covalent bond between the agent and the side chain of a glutamine amino acid residue.	tm-do3a-cadaverine	14-32	transglutaminase 1	Homo sapiens	88-104
23497871-0	2013	Monitoring the effect of high pressure and transglutaminase treatment of milk on the evolution of flavour compounds during lactic acid fermentation using PTR-ToF-MS.	Lactic Acid	123-134	transglutaminase 1	Homo sapiens	43-59
23601132-2	2013	A CEST agent, Tm-DO3A-cadaverine, has been designed to detect the catalytic activity of transglutaminase (TGase), which creates a covalent bond between the agent and the side chain of a glutamine amino acid residue.	tm-do3a-cadaverine	14-32	transglutaminase 1	Homo sapiens	106-111
23601132-2	2013	A CEST agent, Tm-DO3A-cadaverine, has been designed to detect the catalytic activity of transglutaminase (TGase), which creates a covalent bond between the agent and the side chain of a glutamine amino acid residue.	glutamine amino acid	186-206	transglutaminase 1	Homo sapiens	88-104
23601132-2	2013	A CEST agent, Tm-DO3A-cadaverine, has been designed to detect the catalytic activity of transglutaminase (TGase), which creates a covalent bond between the agent and the side chain of a glutamine amino acid residue.	glutamine amino acid	186-206	transglutaminase 1	Homo sapiens	106-111
23601132-3	2013	CEST appeared at -9.2 ppm after TGase conjugated Tm-DO3A-cadaverine to albumin, which also caused a decrease in CEST from albumin at +4.6 ppm.	tm-do3a-cadaverine	49-67	transglutaminase 1	Homo sapiens	32-37
22801880-4	2012	All of our patients with BSI or SICI carried at least 1 specific missense mutation in TGM1 concerning an arginine at position 307 or 315.	Arginine	105-113	transglutaminase 1	Homo sapiens	86-90
22858378-0	2012	Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation.	Serotonin	44-53	transglutaminase 1	Homo sapiens	0-16
22622417-1	2012	Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of skin barrier diseases due inter alia to mutations in transglutaminase-1 (TGM1), in lipoxygenases (LOXs) of the hepoxilin pathway, and in ichthyin, a putative Mg(2+) transporter encoded by the NIPAL4 gene.	8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid	188-197	transglutaminase 1	Homo sapiens	130-148
22622417-1	2012	Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of skin barrier diseases due inter alia to mutations in transglutaminase-1 (TGM1), in lipoxygenases (LOXs) of the hepoxilin pathway, and in ichthyin, a putative Mg(2+) transporter encoded by the NIPAL4 gene.	8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid	188-197	transglutaminase 1	Homo sapiens	150-154
22622417-7	2012	Altogether, our data indicate that ichthyin and TGM1 are functionally closely related in the lipid processing and that this metabolic pathway can be modified by retinoids.	Retinoids	161-170	transglutaminase 1	Homo sapiens	48-52
23135175-10	2012	CONCLUSIONS: The results showed that Li1(30%La2O3-15%Al2O3-15%SiO2-15%B2O3-5%Li2O) glass infiltrated ZTA ceramic composite had the best capability.	lanthanum oxide	44-49	transglutaminase 1	Homo sapiens	37-40
23135175-10	2012	CONCLUSIONS: The results showed that Li1(30%La2O3-15%Al2O3-15%SiO2-15%B2O3-5%Li2O) glass infiltrated ZTA ceramic composite had the best capability.	Aluminum Oxide	53-58	transglutaminase 1	Homo sapiens	37-40
23135175-10	2012	CONCLUSIONS: The results showed that Li1(30%La2O3-15%Al2O3-15%SiO2-15%B2O3-5%Li2O) glass infiltrated ZTA ceramic composite had the best capability.	Silicon Dioxide	62-66	transglutaminase 1	Homo sapiens	37-40
23135175-10	2012	CONCLUSIONS: The results showed that Li1(30%La2O3-15%Al2O3-15%SiO2-15%B2O3-5%Li2O) glass infiltrated ZTA ceramic composite had the best capability.	boron oxide	70-74	transglutaminase 1	Homo sapiens	37-40
23135175-10	2012	CONCLUSIONS: The results showed that Li1(30%La2O3-15%Al2O3-15%SiO2-15%B2O3-5%Li2O) glass infiltrated ZTA ceramic composite had the best capability.	Dilithium oxide	77-81	transglutaminase 1	Homo sapiens	37-40
23135175-10	2012	CONCLUSIONS: The results showed that Li1(30%La2O3-15%Al2O3-15%SiO2-15%B2O3-5%Li2O) glass infiltrated ZTA ceramic composite had the best capability.	zta	101-104	transglutaminase 1	Homo sapiens	37-40
22858378-0	2012	Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation.	Dopamine	55-63	transglutaminase 1	Homo sapiens	0-16
22858378-0	2012	Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation.	Norepinephrine	68-81	transglutaminase 1	Homo sapiens	0-16
22858378-4	2012	Here we show that the catecholamines dopamine (DA) and noradrenaline (NA) inhibit serotonylation of fibronectin and that DA and NA themselves can be selectively transamidated into fibronectin by TGase.	Dopamine	37-45	transglutaminase 1	Homo sapiens	195-200
22858378-4	2012	Here we show that the catecholamines dopamine (DA) and noradrenaline (NA) inhibit serotonylation of fibronectin and that DA and NA themselves can be selectively transamidated into fibronectin by TGase.	Dopamine	47-49	transglutaminase 1	Homo sapiens	195-200
22858378-4	2012	Here we show that the catecholamines dopamine (DA) and noradrenaline (NA) inhibit serotonylation of fibronectin and that DA and NA themselves can be selectively transamidated into fibronectin by TGase.	Norepinephrine	55-68	transglutaminase 1	Homo sapiens	195-200
22858378-5	2012	All three biogenic monoamines also block TGase-mediated transamidation of another monoamine, monodansylacadaverine, into fibronectin, suggesting a general mechanism of TGase-mediated "monoaminylation".	monoamines	19-29	transglutaminase 1	Homo sapiens	41-46
22858378-5	2012	All three biogenic monoamines also block TGase-mediated transamidation of another monoamine, monodansylacadaverine, into fibronectin, suggesting a general mechanism of TGase-mediated "monoaminylation".	monoamines	19-29	transglutaminase 1	Homo sapiens	168-173
22858378-5	2012	All three biogenic monoamines also block TGase-mediated transamidation of another monoamine, monodansylacadaverine, into fibronectin, suggesting a general mechanism of TGase-mediated "monoaminylation".	monoamine	19-28	transglutaminase 1	Homo sapiens	41-46
22858378-5	2012	All three biogenic monoamines also block TGase-mediated transamidation of another monoamine, monodansylacadaverine, into fibronectin, suggesting a general mechanism of TGase-mediated "monoaminylation".	monoamine	19-28	transglutaminase 1	Homo sapiens	168-173
22858378-5	2012	All three biogenic monoamines also block TGase-mediated transamidation of another monoamine, monodansylacadaverine, into fibronectin, suggesting a general mechanism of TGase-mediated "monoaminylation".	monodansylacadaverine	93-114	transglutaminase 1	Homo sapiens	41-46
22858378-5	2012	All three biogenic monoamines also block TGase-mediated transamidation of another monoamine, monodansylacadaverine, into fibronectin, suggesting a general mechanism of TGase-mediated "monoaminylation".	monodansylacadaverine	93-114	transglutaminase 1	Homo sapiens	168-173
22418868-6	2012	Inhibitors of these UTs block the downstream biological effects of urea, which include increased mRNA and protein levels of (i) transglutaminase-1, involucrin, loricrin, and filaggrin, (ii) epidermal lipid synthetic enzymes, and (iii) cathelicidin/LL-37 and beta-defensin-2.	Urea	67-71	transglutaminase 1	Homo sapiens	128-146
22143573-0	2011	Changes in morphology and activity of transglutaminase following cross-linking and immobilization on a polypropylene microporous membrane.	Polypropylenes	103-116	transglutaminase 1	Homo sapiens	38-54
22143573-1	2011	Transglutaminase (TGase) was cross-linked with glutaraldehyde, and cross-linked crystalline transglutaminase was immobilized on a polypropylene microporous membrane by UV-induced grafting.	Polypropylenes	130-143	transglutaminase 1	Homo sapiens	92-108
21789544-9	2012	We propose a mechanism where neuronal transglutaminase 1 is activated by synaptic activity-dependent influx of calcium ions and thereupon catalyse the formation of an intramolecular cross-link in beta-actin, thereby stabilising the actin cytoskeleton against depolymerising effects.	Calcium	111-118	transglutaminase 1	Homo sapiens	38-56
22060122-3	2011	PG catalyzed incorporation of (15)N-labeled ammonium ions into reactive glutamine amide groups in alpha-lactalbumin similarly to TGase and deamidated the most reactive glutamine amide group once labeled with (15)N. Furthermore, we investigated the effect of ammonium ions on the PG activity by peptide mapping, and more reactive glutamine residues were detected than were detected by the ELT in the presence of ammonium ions.	pg	0-2	transglutaminase 1	Homo sapiens	129-134
22143573-1	2011	Transglutaminase (TGase) was cross-linked with glutaraldehyde, and cross-linked crystalline transglutaminase was immobilized on a polypropylene microporous membrane by UV-induced grafting.	Glutaral	47-61	transglutaminase 1	Homo sapiens	0-16
22065824-4	2011	The structure also exhibits cation disorder with 13.5% Co residing at the lithium (Li1) site.	Lithium	74-81	transglutaminase 1	Homo sapiens	83-86
21940237-3	2011	In cultured normal human keratinocytes, Hydroxydecine( ) induced involucrin, transglutaminase-1 and filaggrin protein production.	10-hydroxy-2-decenoic acid	40-53	transglutaminase 1	Homo sapiens	77-109
21940237-4	2011	In topically Hydroxydecine( )-treated skin equivalents, immunohistochemical analysis revealed an increase in involucrin, transglutaminase-1 and filaggrin staining.	10-hydroxy-2-decenoic acid	13-26	transglutaminase 1	Homo sapiens	121-139
21237254-0	2011	Abnormal expression of MAPK, EGFR, CK17 and TGk in the skin lesions of chloracne patients exposed to dioxins.	Dioxins	101-108	transglutaminase 1	Homo sapiens	44-47
20558776-5	2011	We speculated that 5-HTi activates SMC growth by post-translational transamidation of proteins via transglutaminase (TGase) activity, a process referred to as serotonylation.	5-hti	19-24	transglutaminase 1	Homo sapiens	117-122
20558776-8	2011	Inhibition of TGase with dansylcadaverin blocked this activity, as well as SMC-proliferative and migratory responses to 5-HT.	dansylcadaverin	25-40	transglutaminase 1	Homo sapiens	14-19
21797279-3	2011	Interestingly, the results from our HPLC-based functional TGase assay suggested Lipid IV has a higher affinity for the enzyme than Lipid II.	muramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol	131-139	transglutaminase 1	Homo sapiens	58-63
21300794-6	2011	We have observed that a large population of Abeta monomers contained an 0.984 Da increase in mass at a glutamine residue, indicating that glutamine 15 serves as an indispensable substrate in TGase-mediated deamidation to glutamate 15.	Glutamine	103-112	transglutaminase 1	Homo sapiens	191-196
21300794-6	2011	We have observed that a large population of Abeta monomers contained an 0.984 Da increase in mass at a glutamine residue, indicating that glutamine 15 serves as an indispensable substrate in TGase-mediated deamidation to glutamate 15.	Glutamine	138-147	transglutaminase 1	Homo sapiens	191-196
21300794-6	2011	We have observed that a large population of Abeta monomers contained an 0.984 Da increase in mass at a glutamine residue, indicating that glutamine 15 serves as an indispensable substrate in TGase-mediated deamidation to glutamate 15.	Glutamic Acid	221-230	transglutaminase 1	Homo sapiens	191-196
21237254-3	2011	The aim of the present study was to investigate the role of EGFR, MAPK, CK17, and TGk in the pathogenesis of chloracne related to dioxin exposures.	Dioxins	130-136	transglutaminase 1	Homo sapiens	82-85
21237254-12	2011	CONCLUSIONS: The results demonstrate that in the human skin the activation of mitogen-activated protein kinase pathway and up-regulation of CK17 and TGK may play roles in the pathogenesis of chloracne related to dioxin exposures.	Dioxins	212-218	transglutaminase 1	Homo sapiens	149-152
20865325-1	2011	Transglutaminase (TGase) is a family of enzymes that catalyzes cross-linking reaction between glutamine- and lysine residue of substrate proteins in several mammalian biological events.	Glutamine	94-103	transglutaminase 1	Homo sapiens	0-16
20865325-1	2011	Transglutaminase (TGase) is a family of enzymes that catalyzes cross-linking reaction between glutamine- and lysine residue of substrate proteins in several mammalian biological events.	Glutamine	94-103	transglutaminase 1	Homo sapiens	18-23
20865325-1	2011	Transglutaminase (TGase) is a family of enzymes that catalyzes cross-linking reaction between glutamine- and lysine residue of substrate proteins in several mammalian biological events.	Lysine	109-115	transglutaminase 1	Homo sapiens	0-16
20865325-1	2011	Transglutaminase (TGase) is a family of enzymes that catalyzes cross-linking reaction between glutamine- and lysine residue of substrate proteins in several mammalian biological events.	Lysine	109-115	transglutaminase 1	Homo sapiens	18-23
20717650-7	2011	RESULTS: In cells pretreated with a PLC inhibitor U73122, DOI-stimulated increases in the intracellular Ca(2+) concentration and TGase-modified Rac1 were significantly attenuated as compared to those pretreated with U73343, an inactive analog.	1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione	50-56	transglutaminase 1	Homo sapiens	129-134
20717650-8	2011	The membrane-permeant Ca(2+) chelator, BAPTA-AM strongly reduced TGase-catalyzed Rac1 transamidation upon DOI stimulation.	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester	39-47	transglutaminase 1	Homo sapiens	65-70
20717650-9	2011	Conversely, the Ca(2+) ionophore ionomycin, at a concentration that induced an elevation of cytosolic Ca(2+) to a level comparable to cells treated with DOI, produced an increase in TGase-modified Rac1 without 5-HT(2A) receptor activation.	Ionomycin	33-42	transglutaminase 1	Homo sapiens	182-187
19646949-1	2009	Transglutaminase (TGase) is an enzyme that catalyzes both isopeptide cross-linking and incorporation of primary amines into proteins.	Amines	112-118	transglutaminase 1	Homo sapiens	0-16
21674327-1	2011	Transglutaminase (TGase) is an enzyme that catalyzes the post-translational covalent cross-linking of Gln- and Lys-containing peptides and/or proteins according to its substrate specificity.	Glutamine	102-105	transglutaminase 1	Homo sapiens	0-16
21674327-1	2011	Transglutaminase (TGase) is an enzyme that catalyzes the post-translational covalent cross-linking of Gln- and Lys-containing peptides and/or proteins according to its substrate specificity.	Glutamine	102-105	transglutaminase 1	Homo sapiens	18-23
21674327-1	2011	Transglutaminase (TGase) is an enzyme that catalyzes the post-translational covalent cross-linking of Gln- and Lys-containing peptides and/or proteins according to its substrate specificity.	Lysine	111-114	transglutaminase 1	Homo sapiens	0-16
21674327-1	2011	Transglutaminase (TGase) is an enzyme that catalyzes the post-translational covalent cross-linking of Gln- and Lys-containing peptides and/or proteins according to its substrate specificity.	Lysine	111-114	transglutaminase 1	Homo sapiens	18-23
21674327-2	2011	We have recently designed a variety of Gln-donor fluorescent substrates of microbial transglutaminase (MTG) from Streptomyces mobaraensis and evaluated their potential use in MTG-mediated covalent protein labeling.	Glutamine	39-42	transglutaminase 1	Homo sapiens	85-101
21674327-2	2011	We have recently designed a variety of Gln-donor fluorescent substrates of microbial transglutaminase (MTG) from Streptomyces mobaraensis and evaluated their potential use in MTG-mediated covalent protein labeling.	(Methylthio)acetic acid	103-106	transglutaminase 1	Homo sapiens	85-101
21674327-3	2011	The newly designed substrates are based on the relatively broad substrate recognition of MTG for the substitution of the N-terminal group of a conventional TGase substrate, benzyloxycarbonyl-L-glutaminylglycine (Z-QG).	(Methylthio)acetic acid	89-92	transglutaminase 1	Homo sapiens	156-161
21674327-3	2011	The newly designed substrates are based on the relatively broad substrate recognition of MTG for the substitution of the N-terminal group of a conventional TGase substrate, benzyloxycarbonyl-L-glutaminylglycine (Z-QG).	Z-GLN-GLY-OH	173-210	transglutaminase 1	Homo sapiens	156-161
20441570-1	2010	An extracellular form of the calcium-dependent protein-cross-linking enzyme TGase (transglutaminase) was demonstrated to be involved in the apical growth of Malus domestica pollen tube.	Calcium	29-36	transglutaminase 1	Homo sapiens	76-81
20441570-4	2010	The secreted pollen TGase catalysed the cross-linking of both PAs (polyamines) into proteins (released by the pollen tube) and His6-Xpr-GFP into endogenous or exogenously added substrates.	Polyamines	62-65	transglutaminase 1	Homo sapiens	20-25
20441570-4	2010	The secreted pollen TGase catalysed the cross-linking of both PAs (polyamines) into proteins (released by the pollen tube) and His6-Xpr-GFP into endogenous or exogenously added substrates.	Polyamines	67-77	transglutaminase 1	Homo sapiens	20-25
20485795-1	2010	The development of iminocyclitol-based small molecule libraries against a bacterial TGase is described.	Iminocyclitol	19-32	transglutaminase 1	Homo sapiens	84-89
20546397-4	2010	Both factors potentially impact the availability of reactive lysine/glutaminyl residues required for TGase reactivity.	Lysine	61-67	transglutaminase 1	Homo sapiens	101-106
20546397-4	2010	Both factors potentially impact the availability of reactive lysine/glutaminyl residues required for TGase reactivity.	glutaminyl	68-78	transglutaminase 1	Homo sapiens	101-106
20546397-5	2010	The addition of 10 mM dithiothreitol (DTT) to the substrate mix, CBZ-glutaminyl glycine and hydroxylamine, revealed a 3.6-fold increase in TGase activity, likely due in part to maintenance of the catalytic cysteine residue in a reduced state.	Dithiothreitol	22-36	transglutaminase 1	Homo sapiens	139-144
20546397-5	2010	The addition of 10 mM dithiothreitol (DTT) to the substrate mix, CBZ-glutaminyl glycine and hydroxylamine, revealed a 3.6-fold increase in TGase activity, likely due in part to maintenance of the catalytic cysteine residue in a reduced state.	Dithiothreitol	38-41	transglutaminase 1	Homo sapiens	139-144
20546397-5	2010	The addition of 10 mM dithiothreitol (DTT) to the substrate mix, CBZ-glutaminyl glycine and hydroxylamine, revealed a 3.6-fold increase in TGase activity, likely due in part to maintenance of the catalytic cysteine residue in a reduced state.	cbz-glutaminyl glycine	65-87	transglutaminase 1	Homo sapiens	139-144
20546397-5	2010	The addition of 10 mM dithiothreitol (DTT) to the substrate mix, CBZ-glutaminyl glycine and hydroxylamine, revealed a 3.6-fold increase in TGase activity, likely due in part to maintenance of the catalytic cysteine residue in a reduced state.	Hydroxylamine	92-105	transglutaminase 1	Homo sapiens	139-144
20546397-5	2010	The addition of 10 mM dithiothreitol (DTT) to the substrate mix, CBZ-glutaminyl glycine and hydroxylamine, revealed a 3.6-fold increase in TGase activity, likely due in part to maintenance of the catalytic cysteine residue in a reduced state.	Cysteine	206-214	transglutaminase 1	Homo sapiens	139-144
20546397-8	2010	Carbohydrate-staining revealed formation of glyco-polymers due to covalent linkages between glucosamine and mWPC proteins after TGase processing.	Carbohydrates	0-12	transglutaminase 1	Homo sapiens	128-133
20546397-8	2010	Carbohydrate-staining revealed formation of glyco-polymers due to covalent linkages between glucosamine and mWPC proteins after TGase processing.	glyco-polymers	44-58	transglutaminase 1	Homo sapiens	128-133
20546397-8	2010	Carbohydrate-staining revealed formation of glyco-polymers due to covalent linkages between glucosamine and mWPC proteins after TGase processing.	Glucosamine	92-103	transglutaminase 1	Homo sapiens	128-133
20546397-12	2010	PRACTICAL APPLICATION: Taken together, these results suggest that unique TGase-mWPC and/or TGase-mWPC-glucosamine ingredients may be designed to provide novel, value-added, polymeric/glyco-polymeric protein products that afford added benefit for the milk industry.	Glucosamine	102-113	transglutaminase 1	Homo sapiens	91-96
21528696-2	2010	The coagulation cascade triggered by LPS or beta-1,3-D-glucans (BDG) results in the formation of coagulin fibrils that are subsequently stabilized by transglutaminase (TGase)-dependent cross-linking.	(1----3)-beta-d-glucan	44-62	transglutaminase 1	Homo sapiens	150-166
21528696-2	2010	The coagulation cascade triggered by LPS or beta-1,3-D-glucans (BDG) results in the formation of coagulin fibrils that are subsequently stabilized by transglutaminase (TGase)-dependent cross-linking.	(1----3)-beta-d-glucan	44-62	transglutaminase 1	Homo sapiens	168-173
21528696-2	2010	The coagulation cascade triggered by LPS or beta-1,3-D-glucans (BDG) results in the formation of coagulin fibrils that are subsequently stabilized by transglutaminase (TGase)-dependent cross-linking.	(1----3)-beta-d-glucan	64-67	transglutaminase 1	Homo sapiens	150-166
21528696-2	2010	The coagulation cascade triggered by LPS or beta-1,3-D-glucans (BDG) results in the formation of coagulin fibrils that are subsequently stabilized by transglutaminase (TGase)-dependent cross-linking.	(1----3)-beta-d-glucan	64-67	transglutaminase 1	Homo sapiens	168-173
21081267-7	2011	Additionally, in the presence of SB203580 Ca(2+) induced expression of pro-filaggrin and loricrin was inhibited at the protein level and expression of filaggrin, keratin 10, and transglutaminase 1 at the mRNA level.	SB 203580	33-41	transglutaminase 1	Homo sapiens	178-196
20663161-10	2010	The recombinant tgK protein (tgK) was expressed and purified by immobilized metal affinity chromatography (IMAC).	Metals	76-81	transglutaminase 1	Homo sapiens	16-19
20663161-10	2010	The recombinant tgK protein (tgK) was expressed and purified by immobilized metal affinity chromatography (IMAC).	Metals	76-81	transglutaminase 1	Homo sapiens	29-32
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	Calcium	134-141	transglutaminase 1	Homo sapiens	7-23
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	Calcium	134-141	transglutaminase 1	Homo sapiens	83-88
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	gamma-carboxamide	205-222	transglutaminase 1	Homo sapiens	7-23
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	gamma-carboxamide	205-222	transglutaminase 1	Homo sapiens	83-88
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	Glutamine	247-256	transglutaminase 1	Homo sapiens	7-23
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	Glutamine	247-256	transglutaminase 1	Homo sapiens	83-88
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	Amines	286-292	transglutaminase 1	Homo sapiens	7-23
20112034-1	2010	Tissue transglutaminase (TG2) is a multifunctional member of the transglutaminase (TGase) family (E.C.2.3.2.13), which catalyzes in a calcium-dependent reaction the formation of covalent bonds between the gamma-carboxamide groups of peptide-bound glutamine residues and various primary amines.	Amines	286-292	transglutaminase 1	Homo sapiens	83-88
20167857-4	2010	However, cadaverine, the most widely used substrate for TGase activity assay, is not isozyme specific.	Cadaverine	9-19	transglutaminase 1	Homo sapiens	56-61
20167857-7	2010	Ca(2+)-dependent labeling of FITC-pepK5 was clearly seen in the upper spinous and granular layers of normal human skin where it precisely overlapped with TGase1 immunostaining.	Fluorescein-5-isothiocyanate	29-33	transglutaminase 1	Homo sapiens	154-160
20167857-8	2010	Both specificity and sensitivity of FITC-pepK5 labeling for TGase1 activity were higher than those of FITC-cadaverine labeling.	Fluorescein-5-isothiocyanate	36-40	transglutaminase 1	Homo sapiens	60-66
20167857-10	2010	FITC-pepK5 labeling was negative in LI patients carrying TGM1 truncation mutations and partially abolished in the other LI patients harboring missense mutations.	Fluorescein-5-isothiocyanate	0-4	transglutaminase 1	Homo sapiens	57-61
20027206-9	2009	Moreover, we show that the MAG-specific TGase is restricted to the anopheline lineage, where it functions to promote sperm storage rather than as a mechanical barrier to re-insemination.	mag	27-30	transglutaminase 1	Homo sapiens	40-45
19646949-1	2009	Transglutaminase (TGase) is an enzyme that catalyzes both isopeptide cross-linking and incorporation of primary amines into proteins.	Amines	112-118	transglutaminase 1	Homo sapiens	18-23
18696179-5	2009	Indeed, at low guanidine concentrations tissue TG-ase exists in a non-native state which is still affected by the ligands as in the native form.	Guanidine	15-24	transglutaminase 1	Homo sapiens	47-53
18948357-5	2009	Arginine residues in TGase-1 were mutated in 39% (22/57) of patients overall and 54% (20/37) of those with missense mutations.	Arginine	0-8	transglutaminase 1	Homo sapiens	21-28
19241467-10	2009	Thirty-one percent (36 of 115) of all mutations and 41% (29 of 71) of missense mutations occurred in arginine residues in TGase-1.	Arginine	101-109	transglutaminase 1	Homo sapiens	122-129
19241467-12	2009	We constructed a model of human TGase-1 and showed that all mutated arginines that reside in the two beta-barrel domains and two (R142 and R143) in the beta-sandwich are located at domain interfaces.	Arginine	68-77	transglutaminase 1	Homo sapiens	32-39
19241467-14	2009	The high frequency of mutated arginine codons in TGM1 may be due to the deamination of 5" methylated CpG dinucleotides.	Arginine	30-38	transglutaminase 1	Homo sapiens	49-53
19241467-14	2009	The high frequency of mutated arginine codons in TGM1 may be due to the deamination of 5" methylated CpG dinucleotides.	cytidylyl-3'-5'-guanosine	101-118	transglutaminase 1	Homo sapiens	49-53
19127169-8	2009	RESULTS: Carboxymethyl-lysine-collagen increased Tgase activity in tenocytes 2.3- to 5.6-fold over unmodified collagen controls in both normal and high glucose media, without altering enzyme protein levels.	N(6)-carboxymethyllysine	9-29	transglutaminase 1	Homo sapiens	49-54
19127169-8	2009	RESULTS: Carboxymethyl-lysine-collagen increased Tgase activity in tenocytes 2.3- to 5.6-fold over unmodified collagen controls in both normal and high glucose media, without altering enzyme protein levels.	Glucose	152-159	transglutaminase 1	Homo sapiens	49-54
19127169-11	2009	CONCLUSIONS: Carboxymethyl-lysine-collagen increased Tgase activity in tenocytes, likely posttranslationally.	N(6)-carboxymethyllysine	13-33	transglutaminase 1	Homo sapiens	53-58
19186937-0	2009	Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.	Polyethylene Glycols	26-29	transglutaminase 1	Homo sapiens	0-16
19186937-4	2009	Here, a fast and reliable method is proposed to characterize proteins conjugated at the level of glutamine (Gln) residues using microbial transglutaminase (TGase).	Glutamine	97-106	transglutaminase 1	Homo sapiens	138-154
19186937-4	2009	Here, a fast and reliable method is proposed to characterize proteins conjugated at the level of glutamine (Gln) residues using microbial transglutaminase (TGase).	Glutamine	97-106	transglutaminase 1	Homo sapiens	156-161
19186937-4	2009	Here, a fast and reliable method is proposed to characterize proteins conjugated at the level of glutamine (Gln) residues using microbial transglutaminase (TGase).	Glutamine	108-111	transglutaminase 1	Homo sapiens	138-154
19186937-4	2009	Here, a fast and reliable method is proposed to characterize proteins conjugated at the level of glutamine (Gln) residues using microbial transglutaminase (TGase).	Glutamine	108-111	transglutaminase 1	Homo sapiens	156-161
18948357-12	2009	The high frequency of mutated arginine codons in TGM1 may be due to the deamination of CpG dinucleotides.	Arginine	30-38	transglutaminase 1	Homo sapiens	49-53
18948357-12	2009	The high frequency of mutated arginine codons in TGM1 may be due to the deamination of CpG dinucleotides.	cytidylyl-3'-5'-guanosine	87-104	transglutaminase 1	Homo sapiens	49-53
19197536-5	2009	We then studied the biomarkers before and after 4 weeks of treatment with liarozole (75 or 150 mg/day), which produced a better therapeutic response in patients with Ichthyin (n=3) than in those with TGM1 (n=6) mutations.	liarozole	74-83	transglutaminase 1	Homo sapiens	200-204
19049964-4	2009	Treatment with monodansylcadarevine (MDC), a selective TGase inhibitor or down-regulation of TGase-1 with small interfering RNA (siRNA) decreased RPTC proliferation.	monodansylcadarevine	15-35	transglutaminase 1	Homo sapiens	55-60
18400843-10	2008	Serotonin itself is bound to Rac1 by TGase following 5-HT(2A) receptor stimulation as demonstrated by coimmunoprecipitation experiments and a dose-dependent decrease of serotonin-associated Rac1 by cystamine.	Serotonin	169-178	transglutaminase 1	Homo sapiens	37-42
19006370-4	2008	The structure, configurational stability, and stereodynamics in solution of alpha-lithiated oxazolinyloxirane Li-1 have been also synergically investigated by means of in situ IR and NMR spectroscopy.	oxazolinyloxirane	92-109	transglutaminase 1	Homo sapiens	110-114
19006370-5	2008	IR spectroscopic studies showed that lithiation of 1 is complete at -98 degrees C within 1 min and is accompanied by a decrease of the CN wavenumber by only 60 cm(-1), so supporting the idea that the structure of Li-1 may be more similar to that of an "organolithium" rather than an "azaenolate".	organolithium	253-266	transglutaminase 1	Homo sapiens	213-217
19006370-5	2008	IR spectroscopic studies showed that lithiation of 1 is complete at -98 degrees C within 1 min and is accompanied by a decrease of the CN wavenumber by only 60 cm(-1), so supporting the idea that the structure of Li-1 may be more similar to that of an "organolithium" rather than an "azaenolate".	azaenolate	284-294	transglutaminase 1	Homo sapiens	213-217
19006370-6	2008	In addition to this, multinuclear magnetic resonance studies suggested that at least in a range of concentration of 0.08-0.3 M, Li-1 mainly exists in THF as a monomeric eta(3)-aza-allyl coordinated species rapidly equilibrating, on the NMR time scale, with a complex mixture of diastereomeric oxazoline-bridged dimeric species variously intraaggregated.	tetrahydrofuran	150-153	transglutaminase 1	Homo sapiens	128-132
19006370-6	2008	In addition to this, multinuclear magnetic resonance studies suggested that at least in a range of concentration of 0.08-0.3 M, Li-1 mainly exists in THF as a monomeric eta(3)-aza-allyl coordinated species rapidly equilibrating, on the NMR time scale, with a complex mixture of diastereomeric oxazoline-bridged dimeric species variously intraaggregated.	(3)-aza	172-179	transglutaminase 1	Homo sapiens	128-132
19006370-6	2008	In addition to this, multinuclear magnetic resonance studies suggested that at least in a range of concentration of 0.08-0.3 M, Li-1 mainly exists in THF as a monomeric eta(3)-aza-allyl coordinated species rapidly equilibrating, on the NMR time scale, with a complex mixture of diastereomeric oxazoline-bridged dimeric species variously intraaggregated.	Oxazoline	293-302	transglutaminase 1	Homo sapiens	128-132
18312388-3	2008	We now report that extracts prepared from silica mud and two different microalgae species derived from the Blue Lagoon are capable of inducing involucrin, loricrin, transglutaminase-1 and filaggrin gene expression in primary human epidermal keratinocytes.	Silicon Dioxide	42-48	transglutaminase 1	Homo sapiens	165-197
18400843-10	2008	Serotonin itself is bound to Rac1 by TGase following 5-HT(2A) receptor stimulation as demonstrated by coimmunoprecipitation experiments and a dose-dependent decrease of serotonin-associated Rac1 by cystamine.	Cystamine	198-207	transglutaminase 1	Homo sapiens	37-42
18400843-11	2008	These data support the hypothesis that Rac1 activity is transiently increased due to TGase-catalyzed transamidation of serotonin to Rac1 via stimulation of 5-HT(2A) receptors.	Serotonin	119-128	transglutaminase 1	Homo sapiens	85-90
17326681-1	2007	Application of shear and cross-linking enzyme transglutaminase (Tgase) induced fibrous hierarchical structures in dense (30% w/w) calcium caseinate (Ca-caseinate) dispersions.	Calcium	130-137	transglutaminase 1	Homo sapiens	64-69
18400843-1	2008	Transglutaminase (TGase)-induced activation of small G proteins via 5-hydroxytryptamine (HT)(2A) receptor signaling leads to platelet aggregation (Cell 115:851-862, 2003).	Serotonin	68-87	transglutaminase 1	Homo sapiens	0-16
18400843-1	2008	Transglutaminase (TGase)-induced activation of small G proteins via 5-hydroxytryptamine (HT)(2A) receptor signaling leads to platelet aggregation (Cell 115:851-862, 2003).	Serotonin	68-87	transglutaminase 1	Homo sapiens	18-23
18400843-2	2008	We hypothesize that stimulation of 5-HT(2A) receptors in neurons activates TGase, resulting in transamidation of serotonin to a small G protein, Rac1, thereby constitutively activating Rac1.	Serotonin	113-122	transglutaminase 1	Homo sapiens	75-80
18400843-3	2008	Using immunoprecipitation and immunoblotting, we show that, in rat cortical cell line A1A1v, serotonin increases TGase-catalyzed transamidation of Rac1.	Serotonin	93-102	transglutaminase 1	Homo sapiens	113-118
18400843-5	2008	Treatment with a 5-HT(2A/2C) receptor agonist 2,5-dimethoxy-4-iodoamphetamine, but not the 5-HT(1A) receptor agonist 5-hydroxy-2-dipropylamino tetralin, increases transamidation of Rac1 by TGase.	4-iodo-2,5-dimethoxyphenylisopropylamine	46-77	transglutaminase 1	Homo sapiens	189-194
18400843-9	2008	Inhibition of TGase by cystamine or small interfering RNA reduces TGase modification of Rac1, and cystamine also prevents Rac1 activation.	Cystamine	23-32	transglutaminase 1	Homo sapiens	14-19
18400843-9	2008	Inhibition of TGase by cystamine or small interfering RNA reduces TGase modification of Rac1, and cystamine also prevents Rac1 activation.	Cystamine	23-32	transglutaminase 1	Homo sapiens	66-71
18400843-10	2008	Serotonin itself is bound to Rac1 by TGase following 5-HT(2A) receptor stimulation as demonstrated by coimmunoprecipitation experiments and a dose-dependent decrease of serotonin-associated Rac1 by cystamine.	Serotonin	0-9	transglutaminase 1	Homo sapiens	37-42
18052077-5	2007	A number of point mutants of human TGase-2 defective for binding GTP, as well as a mutant that shows impaired GTP-hydrolytic activity, were generated.	Guanosine Triphosphate	65-68	transglutaminase 1	Homo sapiens	35-40
18052077-6	2007	Similar to what we had found for TGase-S, there was a time-dependent decrease in the expression of the GTP-binding-defective TGase-2 mutants in different cell lines, whereas the expression of wild-type TGase-2 and the GTP hydrolysis-defective mutant was sustained.	Guanosine Triphosphate	103-106	transglutaminase 1	Homo sapiens	33-38
18422943-9	2008	Our findings support the hypotheses that (i) gamma-glutamylpolyamines are reflective of TGase activity in human brain, (ii) polyamination is an important post-translational modification of brain proteins, and (iii) TGase-catalyzed modification of proteins is increased in HD brain.	gamma-glutamylpolyamines	45-69	transglutaminase 1	Homo sapiens	88-93
18422943-9	2008	Our findings support the hypotheses that (i) gamma-glutamylpolyamines are reflective of TGase activity in human brain, (ii) polyamination is an important post-translational modification of brain proteins, and (iii) TGase-catalyzed modification of proteins is increased in HD brain.	gamma-glutamylpolyamines	45-69	transglutaminase 1	Homo sapiens	215-220
18007579-0	2008	Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo.	Sodium Dodecyl Sulfate	27-48	transglutaminase 1	Homo sapiens	96-114
17988081-3	2008	For proof of concept, different IgG1s (commercial bovine IgG1, and L1CAM targeting chCE7 and chCE7 aglycosylated) were enzymatically functionalization with different fluorescent TGase substrates based on the CY3 analogue Dy547.	cy3	208-211	transglutaminase 1	Homo sapiens	178-183
17988081-6	2008	Three new TGase substrates were synthesized for this study including Lys-substrate 1 useful for BTGase and TG2 and two Gln-substrates tailor-made for BTGase (substrate 2) and TG2 (substrate 3).	Glutamine	119-122	transglutaminase 1	Homo sapiens	10-15
18052077-6	2007	Similar to what we had found for TGase-S, there was a time-dependent decrease in the expression of the GTP-binding-defective TGase-2 mutants in different cell lines, whereas the expression of wild-type TGase-2 and the GTP hydrolysis-defective mutant was sustained.	Guanosine Triphosphate	218-221	transglutaminase 1	Homo sapiens	33-38
17609251-8	2007	The altered affinity for GTP allowed tTG(V1,2) to exhibit enhanced TGase activity when there is a transient increase in Ca(+2) levels.	Guanosine Triphosphate	25-28	transglutaminase 1	Homo sapiens	67-72
17713965-4	2007	The new method facilitated a combinatorial study of transglutaminase (TGase) enzyme substrate peptides, revealing new details of the effect of amino acid composition on TGase substrates.	Peptides	94-102	transglutaminase 1	Homo sapiens	52-68
17713965-4	2007	The new method facilitated a combinatorial study of transglutaminase (TGase) enzyme substrate peptides, revealing new details of the effect of amino acid composition on TGase substrates.	Peptides	94-102	transglutaminase 1	Homo sapiens	70-75
17713965-4	2007	The new method facilitated a combinatorial study of transglutaminase (TGase) enzyme substrate peptides, revealing new details of the effect of amino acid composition on TGase substrates.	Peptides	94-102	transglutaminase 1	Homo sapiens	169-174
17713965-10	2007	Two-stage screening identified 267 glutamine peptides as TGase-reactive, of which 21 were further analyzed by solution-phase enzyme kinetics.	glutamine peptides	35-53	transglutaminase 1	Homo sapiens	57-62
18251895-4	2007	In vivo synthesis of polyamine glutamyl derivatives (glutamyl PAs), catalyzed by TGase activity, was evaluated after supplying labeled putrescine (Pu, a physiological substrate of TGase) to leaves.	polyamine glutamyl derivatives	21-51	transglutaminase 1	Homo sapiens	81-86
18251895-4	2007	In vivo synthesis of polyamine glutamyl derivatives (glutamyl PAs), catalyzed by TGase activity, was evaluated after supplying labeled putrescine (Pu, a physiological substrate of TGase) to leaves.	polyamine glutamyl derivatives	21-51	transglutaminase 1	Homo sapiens	180-185
18251895-4	2007	In vivo synthesis of polyamine glutamyl derivatives (glutamyl PAs), catalyzed by TGase activity, was evaluated after supplying labeled putrescine (Pu, a physiological substrate of TGase) to leaves.	glutamyl pas	53-65	transglutaminase 1	Homo sapiens	81-86
18251895-4	2007	In vivo synthesis of polyamine glutamyl derivatives (glutamyl PAs), catalyzed by TGase activity, was evaluated after supplying labeled putrescine (Pu, a physiological substrate of TGase) to leaves.	glutamyl pas	53-65	transglutaminase 1	Homo sapiens	180-185
18251895-4	2007	In vivo synthesis of polyamine glutamyl derivatives (glutamyl PAs), catalyzed by TGase activity, was evaluated after supplying labeled putrescine (Pu, a physiological substrate of TGase) to leaves.	Putrescine	135-145	transglutaminase 1	Homo sapiens	81-86
18251895-4	2007	In vivo synthesis of polyamine glutamyl derivatives (glutamyl PAs), catalyzed by TGase activity, was evaluated after supplying labeled putrescine (Pu, a physiological substrate of TGase) to leaves.	Putrescine	147-149	transglutaminase 1	Homo sapiens	81-86
18251895-8	2007	A biotin-labeled cadaverine incorporation assay showed that TGase activity occurred in S1 (containing soluble proteins), S2 (proteins released by both cell walls and membranes) and S3 (membrane intrinsic proteins) fractions.	Biotin	2-8	transglutaminase 1	Homo sapiens	60-65
18251895-8	2007	A biotin-labeled cadaverine incorporation assay showed that TGase activity occurred in S1 (containing soluble proteins), S2 (proteins released by both cell walls and membranes) and S3 (membrane intrinsic proteins) fractions.	Cadaverine	17-27	transglutaminase 1	Homo sapiens	60-65
17240993-1	2007	Tissue transglutaminase (TGase) is a Ca2+-dependent enzyme that catalyzes cross-linking of intracellular proteins through a mechanism that involves isopeptide bond formation between Gln and Lys residues and is allosterically regulated by GTP.	Glutamine	182-185	transglutaminase 1	Homo sapiens	25-30
17468528-3	2007	STS deficiency in X-linked ichthyosis leads to cholesterol sulfate accumulation, which induces transglutaminase-1 dysfunction.	cholesteryl sulfate	47-66	transglutaminase 1	Homo sapiens	95-113
17240993-1	2007	Tissue transglutaminase (TGase) is a Ca2+-dependent enzyme that catalyzes cross-linking of intracellular proteins through a mechanism that involves isopeptide bond formation between Gln and Lys residues and is allosterically regulated by GTP.	Lysine	190-193	transglutaminase 1	Homo sapiens	25-30
17240993-1	2007	Tissue transglutaminase (TGase) is a Ca2+-dependent enzyme that catalyzes cross-linking of intracellular proteins through a mechanism that involves isopeptide bond formation between Gln and Lys residues and is allosterically regulated by GTP.	Guanosine Triphosphate	238-241	transglutaminase 1	Homo sapiens	25-30
17008102-3	2006	Biol.2005, 12, 469-475] to confer affinity for the TGase active site and bear electrophilic groups such as alpha,beta-unsaturated amide, chloroacetamide or maleimide; their general structure being Cbz-Phe-spacer-electrophile.	carbobenzoxyphenylalanine	197-204	transglutaminase 1	Homo sapiens	51-56
17024410-2	2007	Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum.	Amides	52-57	transglutaminase 1	Homo sapiens	13-31
17024410-2	2007	Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum.	Amides	52-57	transglutaminase 1	Homo sapiens	33-40
17024410-2	2007	Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum.	Glutamine	79-88	transglutaminase 1	Homo sapiens	13-31
17024410-2	2007	Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum.	Glutamine	79-88	transglutaminase 1	Homo sapiens	33-40
17024410-2	2007	Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum.	Lysine	93-99	transglutaminase 1	Homo sapiens	13-31
17024410-2	2007	Keratinocyte transglutaminase 1 (TGase 1) catalyzes amide crosslinking between glutamine and lysine residues on precursor proteins forming the impermeable layers of the epidermal cell envelopes (CE), the highly insoluble membranous structures of the stratum corneum.	Lysine	93-99	transglutaminase 1	Homo sapiens	33-40
17008102-3	2006	Biol.2005, 12, 469-475] to confer affinity for the TGase active site and bear electrophilic groups such as alpha,beta-unsaturated amide, chloroacetamide or maleimide; their general structure being Cbz-Phe-spacer-electrophile.	alpha,beta-unsaturated amide	107-135	transglutaminase 1	Homo sapiens	51-56
17361747-3	2006	This result means that the crystal lattice constant of the layer Li1-x, Hx NbO3 is little larger than that of the LiNbO3 crystal substrate, resulting in a stress.	lithium niobate	114-120	transglutaminase 1	Homo sapiens	65-68
17008102-3	2006	Biol.2005, 12, 469-475] to confer affinity for the TGase active site and bear electrophilic groups such as alpha,beta-unsaturated amide, chloroacetamide or maleimide; their general structure being Cbz-Phe-spacer-electrophile.	chloroacetamide	137-152	transglutaminase 1	Homo sapiens	51-56
17008102-3	2006	Biol.2005, 12, 469-475] to confer affinity for the TGase active site and bear electrophilic groups such as alpha,beta-unsaturated amide, chloroacetamide or maleimide; their general structure being Cbz-Phe-spacer-electrophile.	maleimide	156-165	transglutaminase 1	Homo sapiens	51-56
17116873-5	2006	The apoptotic activity of TGase-S is not dependent on its transamidation activity because the mutation of a cysteine residue that is essential for catalyzing this reaction does not compromise the ability of TGase-S to induce cell death.	Cysteine	108-116	transglutaminase 1	Homo sapiens	26-31
16172037-4	2005	This reaction requires transglutaminase (TGase), which is a calcium-dependent enzyme catalyzing an intermolecular isopeptide bond formation between proteins.	Calcium	60-67	transglutaminase 1	Homo sapiens	23-39
16985168-9	2006	The AhR ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin also up-regulated keratinocyte TGM1 mRNA in a concentration- and time-dependent manner.	Polychlorinated Dibenzodioxins	15-50	transglutaminase 1	Homo sapiens	82-86
16985168-11	2006	These findings implicate AhR-dependent up-regulation of TGM1 mRNA in differentiating keratinocytes as one mechanism contributing toward chloracne in humans exposed to toxic levels of dioxin.	Dioxins	183-189	transglutaminase 1	Homo sapiens	56-60
16620812-2	2006	We demonstrate herein that TGase is functionally active in Leishmania parasites by using labeled polyamine that becomes conjugated into protein substrates.	Polyamines	97-106	transglutaminase 1	Homo sapiens	27-32
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	monodansylcadaverine	153-173	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	monodansylcadaverine	153-173	transglutaminase 1	Homo sapiens	140-145
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	monodansylcadaverine	175-178	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	Cystamine	181-190	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	Cystamine	192-194	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	Iodoacetamide	201-214	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	Iodoacetamide	216-221	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	didansylcadaverine	233-251	transglutaminase 1	Homo sapiens	30-35
16620812-7	2006	The potential contribution of TGase-catalyzed reactions in promastigote proliferation was supported by findings that standard inhibitors of TGase [e.g., monodansylcadaverine (MDC), cystamine (CS), and iodoacetamide (IodoA)], but not didansylcadaverine (DDC), a close analogue of MDC, had a profound dose-dependent inhibition on parasite growth.	didansylcadaverine	253-256	transglutaminase 1	Homo sapiens	30-35
16888160-1	2006	In the present study, we have utilized the transglutaminase (TGase) enzyme to modify the primary structure of VIP with diaminopropane (DAP) at the level of the Gln16.	2,4-diaminophenol	119-133	transglutaminase 1	Homo sapiens	43-59
16888160-1	2006	In the present study, we have utilized the transglutaminase (TGase) enzyme to modify the primary structure of VIP with diaminopropane (DAP) at the level of the Gln16.	2,4-diaminophenol	119-133	transglutaminase 1	Homo sapiens	61-66
16888160-1	2006	In the present study, we have utilized the transglutaminase (TGase) enzyme to modify the primary structure of VIP with diaminopropane (DAP) at the level of the Gln16.	2,4-diaminophenol	135-138	transglutaminase 1	Homo sapiens	43-59
16888160-1	2006	In the present study, we have utilized the transglutaminase (TGase) enzyme to modify the primary structure of VIP with diaminopropane (DAP) at the level of the Gln16.	2,4-diaminophenol	135-138	transglutaminase 1	Homo sapiens	61-66
16791723-3	2006	To further investigate the possibility to utilize the modified protein for tissue engineering application, TGase crosslinked gelatine was incorporated in a gellan matrix, a polysaccharide, to enhance the stability in aqueous media.	Polysaccharides	173-187	transglutaminase 1	Homo sapiens	107-112
16530159-0	2006	Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes.	Vitamin E	63-72	transglutaminase 1	Homo sapiens	24-42
16530159-6	2006	Vitamin E treatment also led to increased expression of a known PPARgamma target gene involved in terminal keratinocytes differentiation, the transglutaminase-1.	Vitamin E	0-9	transglutaminase 1	Homo sapiens	142-160
16445883-6	2006	Sedimentation velocities of protein-coated particles in TGase-containing water-glycerol solutions were tracked with different levels of creatine.	Water	73-78	transglutaminase 1	Homo sapiens	56-61
16721663-3	2006	We show that beta-amyloid-induced cell death was reduced in RA-differentiated SH-SY5Y cells treated with the TGase inhibitor monodansyl cadaverine.	monodansylcadaverine	125-146	transglutaminase 1	Homo sapiens	109-114
16721663-5	2006	These effects were specific for beta-amyloid-treated cells, as TGase reversed the neurotoxic effects caused by hydrogen peroxide treatment.	Hydrogen Peroxide	111-128	transglutaminase 1	Homo sapiens	63-68
16368535-2	2006	A previous study showed that transglutaminase (TGase) 2 catalyzes the incorporation of polyamines into HPV 18 E7 protein, and thereby diminishes its ability to bind Rb.	Polyamines	87-97	transglutaminase 1	Homo sapiens	47-52
16368535-2	2006	A previous study showed that transglutaminase (TGase) 2 catalyzes the incorporation of polyamines into HPV 18 E7 protein, and thereby diminishes its ability to bind Rb.	Rubidium	165-167	transglutaminase 1	Homo sapiens	47-52
16368535-6	2006	In addition, the treatment of either spermidine or spermine in cultured cell system reduced the ability of E7 to inactivate Rb with a TGase activity-dependent manner.	Spermidine	37-47	transglutaminase 1	Homo sapiens	134-139
16368535-6	2006	In addition, the treatment of either spermidine or spermine in cultured cell system reduced the ability of E7 to inactivate Rb with a TGase activity-dependent manner.	Spermine	51-59	transglutaminase 1	Homo sapiens	134-139
16368535-6	2006	In addition, the treatment of either spermidine or spermine in cultured cell system reduced the ability of E7 to inactivate Rb with a TGase activity-dependent manner.	Rubidium	124-126	transglutaminase 1	Homo sapiens	134-139
16452617-2	2006	Using alternating-laser excitation and chymotrypsin inhibitor 2 as a model, we show that chemical labeling of a unique cysteine, followed by enzymatic modification of a reactive glutamine in an N-terminally appended substrate sequence recognition tag for transglutaminase (TGase) affords stoichiometrically D-/A-labeled protein suitable for single-molecule FRET experiments.	Cysteine	119-127	transglutaminase 1	Homo sapiens	255-271
16452617-2	2006	Using alternating-laser excitation and chymotrypsin inhibitor 2 as a model, we show that chemical labeling of a unique cysteine, followed by enzymatic modification of a reactive glutamine in an N-terminally appended substrate sequence recognition tag for transglutaminase (TGase) affords stoichiometrically D-/A-labeled protein suitable for single-molecule FRET experiments.	Cysteine	119-127	transglutaminase 1	Homo sapiens	273-278
16452617-2	2006	Using alternating-laser excitation and chymotrypsin inhibitor 2 as a model, we show that chemical labeling of a unique cysteine, followed by enzymatic modification of a reactive glutamine in an N-terminally appended substrate sequence recognition tag for transglutaminase (TGase) affords stoichiometrically D-/A-labeled protein suitable for single-molecule FRET experiments.	Glutamine	178-187	transglutaminase 1	Homo sapiens	255-271
16452617-2	2006	Using alternating-laser excitation and chymotrypsin inhibitor 2 as a model, we show that chemical labeling of a unique cysteine, followed by enzymatic modification of a reactive glutamine in an N-terminally appended substrate sequence recognition tag for transglutaminase (TGase) affords stoichiometrically D-/A-labeled protein suitable for single-molecule FRET experiments.	Glutamine	178-187	transglutaminase 1	Homo sapiens	273-278
16332100-6	2005	By comparison to our earlier results on the Li1-xNi0.5Mn0.5O2 system, we attribute the active participation of oxygen in the redox process in Li1-xCo1/3Ni1/3Mn1/3O2 to be related to the presence of Co in this system.	Oxygen	111-117	transglutaminase 1	Homo sapiens	44-47
16332100-6	2005	By comparison to our earlier results on the Li1-xNi0.5Mn0.5O2 system, we attribute the active participation of oxygen in the redox process in Li1-xCo1/3Ni1/3Mn1/3O2 to be related to the presence of Co in this system.	Oxygen	111-117	transglutaminase 1	Homo sapiens	142-145
16172037-4	2005	This reaction requires transglutaminase (TGase), which is a calcium-dependent enzyme catalyzing an intermolecular isopeptide bond formation between proteins.	Calcium	60-67	transglutaminase 1	Homo sapiens	41-46
16038494-0	2005	Excitation energy dependence for the Li 1s X-ray photoelectron spectra of LiMn2O4.	lithium manganese oxide	74-81	transglutaminase 1	Homo sapiens	37-41
15675041-1	2004	The treatment of cystamine, a transglutaminase(TGase) inhibitor, has beneficial effects in several diseases including CAG-expansion disorders and cataract.	Cystamine	17-26	transglutaminase 1	Homo sapiens	47-52
15908778-10	2005	TGase was induced between 3-5-fold the control level and its inhibition partially reversed the antiproliferative effect of atRA.	Tretinoin	123-127	transglutaminase 1	Homo sapiens	0-5
15745743-1	2005	Tissue transglutaminase (TGase) is a Ca(2+)-dependent enzyme that catalyzes cross-linking of intracellular proteins through a mechanism that involves isopeptide bond formation between Gln and Lys residues.	Glutamine	184-187	transglutaminase 1	Homo sapiens	25-30
15745743-1	2005	Tissue transglutaminase (TGase) is a Ca(2+)-dependent enzyme that catalyzes cross-linking of intracellular proteins through a mechanism that involves isopeptide bond formation between Gln and Lys residues.	Lysine	192-195	transglutaminase 1	Homo sapiens	25-30
15745743-2	2005	In addition to its transamidation activity, TGase can bind guanosine 5"-triphosphate (GTP) and does so in a manner that is antagonized by calcium.	Guanosine Triphosphate	59-84	transglutaminase 1	Homo sapiens	44-49
15745743-2	2005	In addition to its transamidation activity, TGase can bind guanosine 5"-triphosphate (GTP) and does so in a manner that is antagonized by calcium.	Guanosine Triphosphate	86-89	transglutaminase 1	Homo sapiens	44-49
15745743-2	2005	In addition to its transamidation activity, TGase can bind guanosine 5"-triphosphate (GTP) and does so in a manner that is antagonized by calcium.	Calcium	138-145	transglutaminase 1	Homo sapiens	44-49
15684497-3	2005	In two subpopulations, the inverse correlation between DNA synthesis and epsilon-(gamma-glutamyl) lysine (Gln-Lys) cross-linking catalyzed by TGase was demonstrated at 1 d after partial hepatectomy.	epsilon-(gamma-glutamyl)-lysine	73-104	transglutaminase 1	Homo sapiens	142-147
15684497-3	2005	In two subpopulations, the inverse correlation between DNA synthesis and epsilon-(gamma-glutamyl) lysine (Gln-Lys) cross-linking catalyzed by TGase was demonstrated at 1 d after partial hepatectomy.	Gln-Lys	106-113	transglutaminase 1	Homo sapiens	142-147
16012394-9	2005	Interactions of the TG-ase product-glutamate with antigens of the major histocompatibility complex type II (MHC II, or HLA DQ) cause autoimmunological reaction by CD4+ T lymphocytes.	Glutamic Acid	35-44	transglutaminase 1	Homo sapiens	20-26
15675041-3	2004	Cystamine is a more potent inhibitor for TGase than cysteamine with different kinetics pattern in a non-reducing condition.	Cystamine	0-9	transglutaminase 1	Homo sapiens	41-46
15675041-5	2004	How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.	Cystamine	10-19	transglutaminase 1	Homo sapiens	44-49
15675041-5	2004	How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.	Cystamine	10-19	transglutaminase 1	Homo sapiens	185-190
15675041-5	2004	How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.	Cystamine	151-160	transglutaminase 1	Homo sapiens	44-49
15675041-5	2004	How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.	Cystamine	151-160	transglutaminase 1	Homo sapiens	185-190
15272014-1	2004	Tissue transglutaminase (TGase) exhibits both a GTP binding/hydrolytic capability and an enzymatic transamidation activity.	Guanosine Triphosphate	48-51	transglutaminase 1	Homo sapiens	25-30
15581620-1	2004	The aim of this study was to evaluate the involvement of oxidative stress in glutamate-evoked transglutaminase (TGase) upregulation in astrocyte cultures (14 DIV).	Glutamic Acid	77-86	transglutaminase 1	Homo sapiens	112-117
15581620-4	2004	The pre-incubation with glutathione ethyl ester or cysteamine recovered oxidative status and was effective in significantly reducing glutamate-increased tissue TGase.	S-ethyl glutathione	24-47	transglutaminase 1	Homo sapiens	160-165
15581620-4	2004	The pre-incubation with glutathione ethyl ester or cysteamine recovered oxidative status and was effective in significantly reducing glutamate-increased tissue TGase.	Cysteamine	51-61	transglutaminase 1	Homo sapiens	160-165
15581620-4	2004	The pre-incubation with glutathione ethyl ester or cysteamine recovered oxidative status and was effective in significantly reducing glutamate-increased tissue TGase.	Glutamic Acid	133-142	transglutaminase 1	Homo sapiens	160-165
15581620-5	2004	These data suggest that tissue TGase upregulation may be part of a biochemical response to oxidative stress induced by a prolonged exposure of astrocyte cultures to glutamate.	Glutamic Acid	165-174	transglutaminase 1	Homo sapiens	31-36
15272014-3	2004	Retinoic acid (RA) consistently induces TGase expression and activation, and it was shown recently that RA-induced TGase expression was inhibited in NIH3T3 mouse fibroblasts co-stimulated with epidermal growth factor (EGF).	Tretinoin	0-13	transglutaminase 1	Homo sapiens	40-45
15272014-3	2004	Retinoic acid (RA) consistently induces TGase expression and activation, and it was shown recently that RA-induced TGase expression was inhibited in NIH3T3 mouse fibroblasts co-stimulated with epidermal growth factor (EGF).	Tretinoin	0-13	transglutaminase 1	Homo sapiens	115-120
15272014-3	2004	Retinoic acid (RA) consistently induces TGase expression and activation, and it was shown recently that RA-induced TGase expression was inhibited in NIH3T3 mouse fibroblasts co-stimulated with epidermal growth factor (EGF).	Tretinoin	15-17	transglutaminase 1	Homo sapiens	40-45
15272014-3	2004	Retinoic acid (RA) consistently induces TGase expression and activation, and it was shown recently that RA-induced TGase expression was inhibited in NIH3T3 mouse fibroblasts co-stimulated with epidermal growth factor (EGF).	Tretinoin	15-17	transglutaminase 1	Homo sapiens	115-120
15272014-3	2004	Retinoic acid (RA) consistently induces TGase expression and activation, and it was shown recently that RA-induced TGase expression was inhibited in NIH3T3 mouse fibroblasts co-stimulated with epidermal growth factor (EGF).	Tretinoin	104-106	transglutaminase 1	Homo sapiens	40-45
15272014-3	2004	Retinoic acid (RA) consistently induces TGase expression and activation, and it was shown recently that RA-induced TGase expression was inhibited in NIH3T3 mouse fibroblasts co-stimulated with epidermal growth factor (EGF).	Tretinoin	104-106	transglutaminase 1	Homo sapiens	115-120
15272014-4	2004	Here we investigate whether EGF also antagonized RA-induced TGase expression in breast cancer cells.	Tretinoin	49-51	transglutaminase 1	Homo sapiens	60-65
15272014-9	2004	Exposure of cells to a TGase inhibitor or expression of a dominant-negative form of TGase potently inhibited EGF-mediated protection from doxorubicin-induced apoptosis.	Doxorubicin	138-149	transglutaminase 1	Homo sapiens	23-28
15272014-9	2004	Exposure of cells to a TGase inhibitor or expression of a dominant-negative form of TGase potently inhibited EGF-mediated protection from doxorubicin-induced apoptosis.	Doxorubicin	138-149	transglutaminase 1	Homo sapiens	84-89
15290349-4	2004	Moreover, in situ measurement of TGase activity shows that endogenous TGase 5 is active upon treatment with phorbol acetate, and the enzyme co-localises with vimentin intermediate filaments.	phorbol acetate	108-123	transglutaminase 1	Homo sapiens	33-38
15245430-2	2004	Here we demonstrate that treatment of cultured human keratinocytes with ciglitazone, a PPAR-gamma activator, increases involucrin and transglutaminase 1 mRNA levels.	ciglitazone	72-83	transglutaminase 1	Homo sapiens	134-152
15353354-6	2004	Tgase-specific isopeptide (epsilon-(gamma-glutamyl) lysine) bonds were measured in cartilage extracts by HPLC.	epsilon-(gamma-glutamyl)-lysine	27-58	transglutaminase 1	Homo sapiens	0-5
15161308-2	2004	In diethyl ether Li-1 and LiCH(2)CN form a mixed dimeric (1:1) complex, while Li-2 and LiCH(2)CN form a mixed trimeric (2:1) complex.	Ether	3-16	transglutaminase 1	Homo sapiens	17-21
15270890-6	2004	To characterize the biological effects further and to evaluate the efficacy of topical paricalcitol treatment in psoriasis, we have analysed immunohistochemically the expression of one of the markers for epidermal differentiation (transglutaminase K) in paricalcitol-treated skin as compared with placebo treatment.	paricalcitol	87-99	transglutaminase 1	Homo sapiens	231-249
15270890-6	2004	To characterize the biological effects further and to evaluate the efficacy of topical paricalcitol treatment in psoriasis, we have analysed immunohistochemically the expression of one of the markers for epidermal differentiation (transglutaminase K) in paricalcitol-treated skin as compared with placebo treatment.	paricalcitol	254-266	transglutaminase 1	Homo sapiens	231-249
15270890-12	2004	The immunoreactivity of transglutaminase K changed after 12 weeks of paricalcitol treatment almost completely to the pattern characteristic for nonlesional psoriatic skin.	paricalcitol	69-81	transglutaminase 1	Homo sapiens	24-42
15161308-7	2004	In tetrahydrofuran only N-metalated mixed LiCH(2)CN dimers were observed for both Li-1 and Li-2 with the less shielded (13)C NMR shifts of delta -2.5 and -2.2 for the alpha-carbon of LiCH(2)CN of the complexes.	tetrahydrofuran	3-18	transglutaminase 1	Homo sapiens	82-86
15161308-7	2004	In tetrahydrofuran only N-metalated mixed LiCH(2)CN dimers were observed for both Li-1 and Li-2 with the less shielded (13)C NMR shifts of delta -2.5 and -2.2 for the alpha-carbon of LiCH(2)CN of the complexes.	Nitrogen	24-25	transglutaminase 1	Homo sapiens	82-86
15161308-7	2004	In tetrahydrofuran only N-metalated mixed LiCH(2)CN dimers were observed for both Li-1 and Li-2 with the less shielded (13)C NMR shifts of delta -2.5 and -2.2 for the alpha-carbon of LiCH(2)CN of the complexes.	Carbon	173-179	transglutaminase 1	Homo sapiens	82-86
15102081-6	2004	Accelerated barrier recovery was explicable by amplified lamellar body secretion, while partial normalization of the CE in the outer SC correlated with persistence of abundant calcium in the extracellular spaces (positioned to activate transglutaminase-1).	Calcium	176-183	transglutaminase 1	Homo sapiens	236-254
15170505-3	2004	The resulting homopolymers are further stabilized when the plasma transglutaminase (TGase) intermolecularly cross-links epsilon-(gamma-glutamyl)lysine bonds.	Lysine	143-150	transglutaminase 1	Homo sapiens	66-82
15170505-3	2004	The resulting homopolymers are further stabilized when the plasma transglutaminase (TGase) intermolecularly cross-links epsilon-(gamma-glutamyl)lysine bonds.	Lysine	143-150	transglutaminase 1	Homo sapiens	84-89
15078184-5	2004	Moreover, recent studies show that cystamine, an in vitro TGase inhibitor, prolongs the lives of HD-transgenic mice.	Cystamine	35-44	transglutaminase 1	Homo sapiens	58-63
15057874-11	2004	Other Ki-ras-dependent, but DFMO-independent, genes included transglutaminase (TGase) and kallikrein 6 (KLK6).	Eflornithine	28-32	transglutaminase 1	Homo sapiens	61-77
15057874-11	2004	Other Ki-ras-dependent, but DFMO-independent, genes included transglutaminase (TGase) and kallikrein 6 (KLK6).	Eflornithine	28-32	transglutaminase 1	Homo sapiens	79-84
14744016-4	2003	The GTP binding activity of Galphah was markedly inhibited by Ca2+ whereas the TGase activity was strongly stimulated, suggesting that Ca2+ acts as a regulator, switching Galphah from a GTPase to a TGase.	Guanosine Triphosphate	4-7	transglutaminase 1	Homo sapiens	198-203
14995116-9	2004	For example, using 10 units of soluble TGase/g resulted in extensive cross-linking of alpha-lactalbumin and beta-lactoglobulin in WPI, as evidenced by SDS-PAGE and Western blotting results.	Sodium Dodecyl Sulfate	151-154	transglutaminase 1	Homo sapiens	39-44
15010546-6	2004	Our binding model of CBz-Gln-Gly on tissue TGase has allowed us to propose the following steps in the acylation of tissue TGase.	cbz-gln-gly	21-32	transglutaminase 1	Homo sapiens	43-48
15010546-6	2004	Our binding model of CBz-Gln-Gly on tissue TGase has allowed us to propose the following steps in the acylation of tissue TGase.	cbz-gln-gly	21-32	transglutaminase 1	Homo sapiens	122-127
14744016-4	2003	The GTP binding activity of Galphah was markedly inhibited by Ca2+ whereas the TGase activity was strongly stimulated, suggesting that Ca2+ acts as a regulator, switching Galphah from a GTPase to a TGase.	galphah	28-35	transglutaminase 1	Homo sapiens	198-203
14744016-4	2003	The GTP binding activity of Galphah was markedly inhibited by Ca2+ whereas the TGase activity was strongly stimulated, suggesting that Ca2+ acts as a regulator, switching Galphah from a GTPase to a TGase.	galphah	171-178	transglutaminase 1	Homo sapiens	79-84
18494907-9	2003	Labelled cadaverine as an exogenous substrate for transglutaminase (TGase) could be incorporated into CEs during maturation.	Cadaverine	9-19	transglutaminase 1	Homo sapiens	50-66
14744016-4	2003	The GTP binding activity of Galphah was markedly inhibited by Ca2+ whereas the TGase activity was strongly stimulated, suggesting that Ca2+ acts as a regulator, switching Galphah from a GTPase to a TGase.	galphah	171-178	transglutaminase 1	Homo sapiens	198-203
14624577-1	2003	Short peptide substrates with high specificity toward transglutaminase (TGase) enzyme were designed, characterized, and coupled to a biocompatible polymer, allowing for rapid enzymatic cross-linking of peptide-polymer conjugates into hydrogels.	Polymers	147-154	transglutaminase 1	Homo sapiens	54-70
14624577-1	2003	Short peptide substrates with high specificity toward transglutaminase (TGase) enzyme were designed, characterized, and coupled to a biocompatible polymer, allowing for rapid enzymatic cross-linking of peptide-polymer conjugates into hydrogels.	Polymers	147-154	transglutaminase 1	Homo sapiens	72-77
14624577-4	2003	Several acyl donor and acyl acceptor peptides with high specificities toward TGase were identified, including a few containing the unusual amino acid l-3,4-dihydroxylphenylalanine (DOPA), which is found in the adhesive proteins secreted by marine and freshwater mussels.	l-3,4-dihydroxylphenylalanine	150-179	transglutaminase 1	Homo sapiens	77-82
18494907-9	2003	Labelled cadaverine as an exogenous substrate for transglutaminase (TGase) could be incorporated into CEs during maturation.	Cadaverine	9-19	transglutaminase 1	Homo sapiens	68-73
18494907-9	2003	Labelled cadaverine as an exogenous substrate for transglutaminase (TGase) could be incorporated into CEs during maturation.	Cerium	102-105	transglutaminase 1	Homo sapiens	50-66
18494907-9	2003	Labelled cadaverine as an exogenous substrate for transglutaminase (TGase) could be incorporated into CEs during maturation.	Cerium	102-105	transglutaminase 1	Homo sapiens	68-73
18494907-11	2003	These results obviously demonstrate that maturation of CEs was mediated by TGase activity in the SC, and that immature CEs found in the outermost face SC have potential to mature by cross-linking of endogenous CE precursors present in the SC.	Cerium	55-58	transglutaminase 1	Homo sapiens	75-80
12899634-1	2003	Tissue transglutaminase (TGase) catalyzes transfer of gamma-acyl moieties of Gln residues in peptides or protein substrates to either water or amine nucleophiles through an acyl-enzyme intermediate formed from initial acyl-transfer to an active site Cys residue.	Glutamine	77-80	transglutaminase 1	Homo sapiens	25-30
12899634-1	2003	Tissue transglutaminase (TGase) catalyzes transfer of gamma-acyl moieties of Gln residues in peptides or protein substrates to either water or amine nucleophiles through an acyl-enzyme intermediate formed from initial acyl-transfer to an active site Cys residue.	Water	134-139	transglutaminase 1	Homo sapiens	25-30
12899634-1	2003	Tissue transglutaminase (TGase) catalyzes transfer of gamma-acyl moieties of Gln residues in peptides or protein substrates to either water or amine nucleophiles through an acyl-enzyme intermediate formed from initial acyl-transfer to an active site Cys residue.	Amines	143-148	transglutaminase 1	Homo sapiens	25-30
12899634-1	2003	Tissue transglutaminase (TGase) catalyzes transfer of gamma-acyl moieties of Gln residues in peptides or protein substrates to either water or amine nucleophiles through an acyl-enzyme intermediate formed from initial acyl-transfer to an active site Cys residue.	Cysteine	250-253	transglutaminase 1	Homo sapiens	25-30
12866625-1	2003	The potential application of the o-phthaldialdehyde (OPA) reagent for quantification of the type and extent of the reaction(s) catalysed by transglutaminase (TGase) during incubation with sodium caseinate (NaCN) was investigated.	o-Phthalaldehyde	33-51	transglutaminase 1	Homo sapiens	140-156
12823447-5	2003	B.C1 monoclonal antibody failed to detect TGase 1 in the patient"s skin sample, and TGase activity measured by monodansyl cadaverine-incorporation showed the reduced TGase activity at the distribution of TGase 1 in the epidermis.	monodansylcadaverine	111-132	transglutaminase 1	Homo sapiens	84-89
12823447-5	2003	B.C1 monoclonal antibody failed to detect TGase 1 in the patient"s skin sample, and TGase activity measured by monodansyl cadaverine-incorporation showed the reduced TGase activity at the distribution of TGase 1 in the epidermis.	monodansylcadaverine	111-132	transglutaminase 1	Homo sapiens	204-211
12866625-0	2003	Characterisation and quantification of the reaction(s) catalysed by transglutaminase using the o-phthaldialdehyde reagent.	o-Phthalaldehyde	95-113	transglutaminase 1	Homo sapiens	68-84
14529493-0	2003	Inhibitory and promotive effects of polyamines on transglutaminase-induced protein polymerization.	Polyamines	36-46	transglutaminase 1	Homo sapiens	50-66
14529493-2	2003	We examined the effects of polyamines on TGase activity.	Polyamines	27-37	transglutaminase 1	Homo sapiens	41-46
14529493-5	2003	These results suggested polyamines played two distinct roles as inhibitor and promoter for TGase-catalyzed protein polymerization.	Polyamines	24-34	transglutaminase 1	Homo sapiens	91-96
12866625-1	2003	The potential application of the o-phthaldialdehyde (OPA) reagent for quantification of the type and extent of the reaction(s) catalysed by transglutaminase (TGase) during incubation with sodium caseinate (NaCN) was investigated.	o-Phthalaldehyde	33-51	transglutaminase 1	Homo sapiens	158-163
12866625-1	2003	The potential application of the o-phthaldialdehyde (OPA) reagent for quantification of the type and extent of the reaction(s) catalysed by transglutaminase (TGase) during incubation with sodium caseinate (NaCN) was investigated.	Sodium Cyanide	206-210	transglutaminase 1	Homo sapiens	140-156
12866625-1	2003	The potential application of the o-phthaldialdehyde (OPA) reagent for quantification of the type and extent of the reaction(s) catalysed by transglutaminase (TGase) during incubation with sodium caseinate (NaCN) was investigated.	Sodium Cyanide	206-210	transglutaminase 1	Homo sapiens	158-163
12866625-2	2003	Initial studies were performed to ensure that NH3, a by-product of TGase activity, could be determined with the OPA reagent in trichloroacetic acid (TCA) supernatants of NaCN solutions.	Ammonia	46-49	transglutaminase 1	Homo sapiens	67-72
12866625-2	2003	Initial studies were performed to ensure that NH3, a by-product of TGase activity, could be determined with the OPA reagent in trichloroacetic acid (TCA) supernatants of NaCN solutions.	Trichloroacetic Acid	127-147	transglutaminase 1	Homo sapiens	67-72
12866625-2	2003	Initial studies were performed to ensure that NH3, a by-product of TGase activity, could be determined with the OPA reagent in trichloroacetic acid (TCA) supernatants of NaCN solutions.	Trichloroacetic Acid	149-152	transglutaminase 1	Homo sapiens	67-72
12866625-2	2003	Initial studies were performed to ensure that NH3, a by-product of TGase activity, could be determined with the OPA reagent in trichloroacetic acid (TCA) supernatants of NaCN solutions.	Sodium Cyanide	170-174	transglutaminase 1	Homo sapiens	67-72
12866625-5	2003	The release of NH3 and the decrease in epsilon-amino groups on incubating NaCN with TGase was subsequently quantified using the OPA reagent.	Sodium Cyanide	74-78	transglutaminase 1	Homo sapiens	84-89
12866625-6	2003	Incubation of NaCN (4% w/v) with TGase at 23 degrees C resulted in progressive increases and decreases, respectively, in NH3 and -amino group concentration with increased incubation time.	Sodium Cyanide	14-18	transglutaminase 1	Homo sapiens	33-38
12866625-7	2003	These changes were dependent on TGase:NaCN.	Sodium Cyanide	38-42	transglutaminase 1	Homo sapiens	32-37
12866625-8	2003	It was estimated that approximately 20% of the available Lys residues in NaCN were involved in TGase-catalysed cross-links.	Lysine	57-60	transglutaminase 1	Homo sapiens	95-100
12866625-8	2003	It was estimated that approximately 20% of the available Lys residues in NaCN were involved in TGase-catalysed cross-links.	Sodium Cyanide	73-77	transglutaminase 1	Homo sapiens	95-100
12652652-1	2003	Calcium induces both involucrin and transglutaminase-K in normal keratinocytes (NHK) but not in squamous carcinoma cell lines (SCC).	Calcium	0-7	transglutaminase 1	Homo sapiens	36-54
11980702-1	2002	Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear.	Glutamine	102-112	transglutaminase 1	Homo sapiens	0-16
12615360-8	2003	The expression of involucrin and transglutaminase 1 were induced by 1,25(OH)2D3 and its analogues in mRNA and protein levels.	Calcitriol	68-79	transglutaminase 1	Homo sapiens	33-51
12401808-3	2003	Here we report that RA-induced neuronal differentiation of SH-SY5Y cells is coupled with increased expression/activation of TGase and in vivo transamidation and activation of RhoA.	Tretinoin	20-22	transglutaminase 1	Homo sapiens	124-129
16233392-7	2003	Two types of synthetic Arg-Gly-Asp (RGD) peptides, RGDLLQ and RGDLLG were also added to the gelatin solution where RGDLLQ is a substrate of TGase by virtue of a glutamine (Q) residue with an epsilon-amino group and RGDLLG is not.	Peptides	41-49	transglutaminase 1	Homo sapiens	140-145
16233392-7	2003	Two types of synthetic Arg-Gly-Asp (RGD) peptides, RGDLLQ and RGDLLG were also added to the gelatin solution where RGDLLQ is a substrate of TGase by virtue of a glutamine (Q) residue with an epsilon-amino group and RGDLLG is not.	Glutamine	161-170	transglutaminase 1	Homo sapiens	140-145
12135484-2	2002	Transglutaminase (TGase) catalyses the post-translational modification of proteins by transamidation of available glutamine residues.	Glutamine	114-123	transglutaminase 1	Homo sapiens	0-16
12135484-2	2002	Transglutaminase (TGase) catalyses the post-translational modification of proteins by transamidation of available glutamine residues.	Glutamine	114-123	transglutaminase 1	Homo sapiens	18-23
12962330-2	2003	Histones are substrates for transglutaminase (TGase), and polymerized histone and polyamine binding histone have been suggested to play important roles in nucleus.	Polyamines	82-91	transglutaminase 1	Homo sapiens	28-44
12962330-2	2003	Histones are substrates for transglutaminase (TGase), and polymerized histone and polyamine binding histone have been suggested to play important roles in nucleus.	Polyamines	82-91	transglutaminase 1	Homo sapiens	46-51
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Polyamines	80-90	transglutaminase 1	Homo sapiens	56-61
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Putrescine	99-109	transglutaminase 1	Homo sapiens	56-61
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Putrescine	111-114	transglutaminase 1	Homo sapiens	56-61
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Spermidine	117-127	transglutaminase 1	Homo sapiens	56-61
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Spermidine	129-132	transglutaminase 1	Homo sapiens	56-61
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Spermine	139-147	transglutaminase 1	Homo sapiens	56-61
12962330-3	2003	We examined whether histone polymerization catalyzed by TGase was influenced by polyamines such as putrescine (PUT), spermidine (SPD), and spermine (SPM).	Spermine	149-152	transglutaminase 1	Homo sapiens	56-61
12401808-5	2003	Using C-3 exoenzyme (RhoA inhibitor) or monodansylcadaverine (TGase inhibitor), we show that transamidated RhoA regulates cytoskeletal rearrangement and activation of ERK1/2 and p38gamma MAP kinases.	monodansylcadaverine	40-60	transglutaminase 1	Homo sapiens	62-67
12401808-8	2003	The results of our studies suggest a novel mechanism of RA signaling, which involves activation of TGase and transamidation of RhoA.	Tretinoin	56-58	transglutaminase 1	Homo sapiens	99-104
12401808-9	2003	RA-induced activation of TGase is proposed to induce multiple signaling pathways that regulate neuronal differentiation.	Tretinoin	0-2	transglutaminase 1	Homo sapiens	25-30
12388601-4	2002	Treatment in R6/2 transgenic HD mice, using the transglutaminase inhibitor cystamine, significantly extended survival, improved body weight and motor performance, and delayed the neuropathological sequela.	Cystamine	75-84	transglutaminase 1	Homo sapiens	48-64
12388601-8	2002	Cystamine treatment normalized transglutaminase and GGEL levels in R6/2 mice.	Cystamine	0-9	transglutaminase 1	Homo sapiens	31-47
12207487-3	2002	Combinations of hydrolysis and incubation with TGase generated products displaying novel physicochemical and nitrogen solubility properties.	Nitrogen	109-117	transglutaminase 1	Homo sapiens	47-52
12369414-4	2002	Dissociation of TGase-treated casein micelles by urea or sodium citrate or removal of colloidal calcium phosphate by acidification and dialysis was reduced, presumably due to the formation of cross-links between the caseins.	Urea	49-53	transglutaminase 1	Homo sapiens	16-21
12369414-4	2002	Dissociation of TGase-treated casein micelles by urea or sodium citrate or removal of colloidal calcium phosphate by acidification and dialysis was reduced, presumably due to the formation of cross-links between the caseins.	Sodium Citrate	57-71	transglutaminase 1	Homo sapiens	16-21
12369414-4	2002	Dissociation of TGase-treated casein micelles by urea or sodium citrate or removal of colloidal calcium phosphate by acidification and dialysis was reduced, presumably due to the formation of cross-links between the caseins.	calcium phosphate	96-113	transglutaminase 1	Homo sapiens	16-21
12052711-3	2002	The incorporation site of the TGase-catalyzed modification is limited to the substrate Gln residues for TGases.	Glutamine	87-90	transglutaminase 1	Homo sapiens	30-35
11980702-1	2002	Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear.	Glutamine	102-112	transglutaminase 1	Homo sapiens	18-23
11980702-1	2002	Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear.	Lysine	117-124	transglutaminase 1	Homo sapiens	0-16
11980702-1	2002	Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear.	Lysine	117-124	transglutaminase 1	Homo sapiens	18-23
11980702-1	2002	Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear.	Calcium	130-137	transglutaminase 1	Homo sapiens	0-16
11980702-1	2002	Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear.	Calcium	130-137	transglutaminase 1	Homo sapiens	18-23
11741784-0	2002	Synthesis of dipeptide-bound epoxides and alpha,beta-unsaturated amides as potential irreversible transglutaminase inhibitors.	Dipeptides	13-22	transglutaminase 1	Homo sapiens	98-114
11741784-0	2002	Synthesis of dipeptide-bound epoxides and alpha,beta-unsaturated amides as potential irreversible transglutaminase inhibitors.	Epoxy Compounds	29-37	transglutaminase 1	Homo sapiens	98-114
11741784-0	2002	Synthesis of dipeptide-bound epoxides and alpha,beta-unsaturated amides as potential irreversible transglutaminase inhibitors.	alpha,beta-unsaturated amides	42-71	transglutaminase 1	Homo sapiens	98-114
11853093-13	2002	To investigate the in situ regulation of the TGase activity of tTG, a TGase activity assay was done with a dose response of GTP, measuring incorporation of fluorescein cadaverine.	Fluorescein Cadaverine	156-178	transglutaminase 1	Homo sapiens	70-75
11853093-8	2002	Previous in vitro studies have demonstrated that the Mg-GTP complex inhibits the TGase activity of tTG [T.S.	magnesium GTP	53-59	transglutaminase 1	Homo sapiens	81-86
11853093-14	2002	TGase activity was inhibited by GTP in a similar manner as in vitro.	Guanosine Triphosphate	32-35	transglutaminase 1	Homo sapiens	0-5
11853093-13	2002	To investigate the in situ regulation of the TGase activity of tTG, a TGase activity assay was done with a dose response of GTP, measuring incorporation of fluorescein cadaverine.	Guanosine Triphosphate	124-127	transglutaminase 1	Homo sapiens	45-50
11853093-13	2002	To investigate the in situ regulation of the TGase activity of tTG, a TGase activity assay was done with a dose response of GTP, measuring incorporation of fluorescein cadaverine.	Guanosine Triphosphate	124-127	transglutaminase 1	Homo sapiens	70-75
11853093-13	2002	To investigate the in situ regulation of the TGase activity of tTG, a TGase activity assay was done with a dose response of GTP, measuring incorporation of fluorescein cadaverine.	Fluorescein Cadaverine	156-178	transglutaminase 1	Homo sapiens	45-50
11590211-6	2001	Pretreatment of human keratinocytes with pepstatin, a protease inhibitor, blocked the increase in soluble TGase activity induced by treatment with SPC.	pepstatin	41-50	transglutaminase 1	Homo sapiens	106-111
11697888-0	2001	Transglutaminase activity is involved in polyamine-induced programmed cell death.	Polyamines	41-50	transglutaminase 1	Homo sapiens	0-16
11697888-6	2001	Cells exposed to spermidine showed a marked increase of intracellular transglutaminase (TGase) activity ( approximately 30-fold over control).	Spermidine	17-27	transglutaminase 1	Homo sapiens	70-86
11697888-6	2001	Cells exposed to spermidine showed a marked increase of intracellular transglutaminase (TGase) activity ( approximately 30-fold over control).	Spermidine	17-27	transglutaminase 1	Homo sapiens	88-93
11697888-7	2001	Inhibitors of polyamine oxidation or inhibitors of TGase activity prevented polyamine-induced apoptosis.	Polyamines	76-85	transglutaminase 1	Homo sapiens	51-56
11697888-8	2001	Moreover, tissue TGase overexpression significantly increased cell sensitivity to polyamine, suggesting that this effect is likely related to enhanced intracellular TGase activity.	Polyamines	82-91	transglutaminase 1	Homo sapiens	17-22
11697888-8	2001	Moreover, tissue TGase overexpression significantly increased cell sensitivity to polyamine, suggesting that this effect is likely related to enhanced intracellular TGase activity.	Polyamines	82-91	transglutaminase 1	Homo sapiens	165-170
11697888-9	2001	These data indicate that polyamines may modulate cell viability through a novel TGase-dependent process.	Polyamines	25-35	transglutaminase 1	Homo sapiens	80-85
11738473-4	2002	The most ubiquitously expressed member of the TGase family, known as tissue TGase (tTG) or TG2, which, in addition to catalyzing the production of epsilon-lysine to gamma-glutaminyl isodipeptide bonds, serves a dual function as the G-protein Galpha(h) and is both expressed and active in PNS and CNS.	epsilon-lysine	147-161	transglutaminase 1	Homo sapiens	46-51
11590211-6	2001	Pretreatment of human keratinocytes with pepstatin, a protease inhibitor, blocked the increase in soluble TGase activity induced by treatment with SPC.	sphingosine phosphorylcholine	147-150	transglutaminase 1	Homo sapiens	106-111
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	dimethyl-4-phenylenediamine	145-178	transglutaminase 1	Homo sapiens	102-118
11438548-5	2001	Furthermore, it was determined that expression of exogenous TGase in cells exhibited enhanced GTP binding and transamidation activities and mimicked the survival advantage imparted by RA.	Guanosine Triphosphate	94-97	transglutaminase 1	Homo sapiens	60-65
11438548-5	2001	Furthermore, it was determined that expression of exogenous TGase in cells exhibited enhanced GTP binding and transamidation activities and mimicked the survival advantage imparted by RA.	Tretinoin	184-186	transglutaminase 1	Homo sapiens	60-65
11438548-6	2001	We tested whether the ability of this dual function enzyme to limit HPR-mediated apoptosis was a result of the ability of TGase to bind GTP and/or catalyze transamidation and found that GTP binding was sufficient for the protective effect.	Guanosine Triphosphate	136-139	transglutaminase 1	Homo sapiens	122-127
11438548-6	2001	We tested whether the ability of this dual function enzyme to limit HPR-mediated apoptosis was a result of the ability of TGase to bind GTP and/or catalyze transamidation and found that GTP binding was sufficient for the protective effect.	Guanosine Triphosphate	186-189	transglutaminase 1	Homo sapiens	122-127
11325259-1	2001	A novel methodology for the enzymatic preparation from suitably derivatized oligosaccharides of N-linked neoglycopeptides using the microbial glutaminyl-peptide gamma-glutamyl transferase, transglutaminase (TGase), is described.	Oligosaccharides	76-92	transglutaminase 1	Homo sapiens	189-205
11325259-1	2001	A novel methodology for the enzymatic preparation from suitably derivatized oligosaccharides of N-linked neoglycopeptides using the microbial glutaminyl-peptide gamma-glutamyl transferase, transglutaminase (TGase), is described.	Oligosaccharides	76-92	transglutaminase 1	Homo sapiens	207-212
11325259-1	2001	A novel methodology for the enzymatic preparation from suitably derivatized oligosaccharides of N-linked neoglycopeptides using the microbial glutaminyl-peptide gamma-glutamyl transferase, transglutaminase (TGase), is described.	n-linked neoglycopeptides	96-121	transglutaminase 1	Homo sapiens	189-205
11325259-1	2001	A novel methodology for the enzymatic preparation from suitably derivatized oligosaccharides of N-linked neoglycopeptides using the microbial glutaminyl-peptide gamma-glutamyl transferase, transglutaminase (TGase), is described.	n-linked neoglycopeptides	96-121	transglutaminase 1	Homo sapiens	207-212
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	n-allyl glycosides	0-18	transglutaminase 1	Homo sapiens	160-176
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	Oligosaccharides	30-46	transglutaminase 1	Homo sapiens	160-176
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	Cysteamine	81-91	transglutaminase 1	Homo sapiens	160-176
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	Sulfides	118-127	transglutaminase 1	Homo sapiens	160-176
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	gamma-carboxamide	208-225	transglutaminase 1	Homo sapiens	160-176
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	Dipeptides	239-248	transglutaminase 1	Homo sapiens	160-176
11325259-2	2001	N-Allyl glycosides of various oligosaccharides were photochemically coupled with cysteamine to yield amino-terminated thioether spacers, which were accepted by transglutaminase to transamidate the side-chain gamma-carboxamide group in the dipeptide Z-Gln-Gly.	Z-Gln-Gly	249-258	transglutaminase 1	Homo sapiens	160-176
11029458-8	2001	p38 MAP kinase inhibitors, SB202190 and SB203580, abolished the induction of differentiation markers, transglutaminase-1, loricrin, and involucrin.	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	27-35	transglutaminase 1	Homo sapiens	102-120
11029458-8	2001	p38 MAP kinase inhibitors, SB202190 and SB203580, abolished the induction of differentiation markers, transglutaminase-1, loricrin, and involucrin.	SB 203580	40-48	transglutaminase 1	Homo sapiens	102-120
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	monodansylcadaverine	125-145	transglutaminase 1	Homo sapiens	234-239
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	monodansylcadaverine	125-145	transglutaminase 1	Homo sapiens	440-445
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	monodansylcadaverine	147-150	transglutaminase 1	Homo sapiens	234-239
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	monodansylcadaverine	147-150	transglutaminase 1	Homo sapiens	440-445
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	Tretinoin	253-255	transglutaminase 1	Homo sapiens	234-239
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	Tretinoin	305-307	transglutaminase 1	Homo sapiens	234-239
11438548-4	2001	In attempting to discover the underlying biochemical activities that might account for these cellular effects, we found that monodansylcadaverine (MDC), which binds to the enzyme (transamidase) active site of tissue transglutaminase (TGase), eliminated RA protection against cell death and in fact caused RA to become an apoptotic factor, suggesting that the ability of RA to protect against apoptosis is linked to the expression of active TGase.	Tretinoin	305-307	transglutaminase 1	Homo sapiens	234-239
11435435-6	2001	Overexpression of HOXA7 attenuated the transglutaminase 1 induction by phorbol ester, demonstrating that HOXA7 expression is inversely related to keratinocyte differentiation, and to transglutaminase 1 expression.	Phorbol Esters	71-84	transglutaminase 1	Homo sapiens	39-57
11435435-6	2001	Overexpression of HOXA7 attenuated the transglutaminase 1 induction by phorbol ester, demonstrating that HOXA7 expression is inversely related to keratinocyte differentiation, and to transglutaminase 1 expression.	Phorbol Esters	71-84	transglutaminase 1	Homo sapiens	183-201
11350930-0	2001	Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2.	Tretinoin	31-44	transglutaminase 1	Homo sapiens	8-27
11350930-1	2001	Transamidation is a post-translational modification of proteins mediated by tissue transglutaminase II (TGase), a GTP-binding protein, participating in signal transduction pathways as a non-conventional G-protein.	Guanosine Triphosphate	114-117	transglutaminase 1	Homo sapiens	83-102
11350930-1	2001	Transamidation is a post-translational modification of proteins mediated by tissue transglutaminase II (TGase), a GTP-binding protein, participating in signal transduction pathways as a non-conventional G-protein.	Guanosine Triphosphate	114-117	transglutaminase 1	Homo sapiens	104-109
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	Tretinoin	0-13	transglutaminase 1	Homo sapiens	100-105
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	Tretinoin	0-13	transglutaminase 1	Homo sapiens	125-130
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	Tretinoin	0-13	transglutaminase 1	Homo sapiens	272-277
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	Tretinoin	15-17	transglutaminase 1	Homo sapiens	100-105
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	Tretinoin	15-17	transglutaminase 1	Homo sapiens	125-130
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	Tretinoin	15-17	transglutaminase 1	Homo sapiens	272-277
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	monodansylcadaverine	198-218	transglutaminase 1	Homo sapiens	100-105
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	monodansylcadaverine	198-218	transglutaminase 1	Homo sapiens	125-130
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	monodansylcadaverine	198-218	transglutaminase 1	Homo sapiens	272-277
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	monodansylcadaverine	220-223	transglutaminase 1	Homo sapiens	100-105
11350930-2	2001	Retinoic acid (RA), which is known to have a role in cell differentiation, is a potent activator of TGASE: The activation of TGase results in increased transamidation of RhoA, which is inhibited by monodansylcadaverine (MDC; an inhibitor of transglutaminase activity) and TGaseM (a TGase mutant lacking transglutaminase activity).	monodansylcadaverine	220-223	transglutaminase 1	Homo sapiens	125-130
11348458-8	2001	All selective PPAR ligands marginally induced transglutaminase-1 expression with the PPARdelta-selective ligand L165041 being the most potent.	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid	112-119	transglutaminase 1	Homo sapiens	46-64
11305905-9	2001	In the presence of Ca(2+), up to 15 cysteines were found to be nitrosylated and this modification resulted in an inhibition of TGase activity.	Cysteine	36-45	transglutaminase 1	Homo sapiens	127-132
11749178-2	2001	Fluorescent probes were used to detect that the membrane protein BR may act as a glutamine donor as well as a lysine donor for TGase.	Lysine	110-116	transglutaminase 1	Homo sapiens	127-132
11013236-4	2001	Since TGase-mediated protein aggregation is implicated in polyglutamine ((CAG)(n)/Q(n) expansion) disorder apoptosis, and expanded Q(n) repeats are excellent TGase substrates, a role for TGase in AD is possible.	polyglutamine	58-71	transglutaminase 1	Homo sapiens	6-11
11013236-4	2001	Since TGase-mediated protein aggregation is implicated in polyglutamine ((CAG)(n)/Q(n) expansion) disorder apoptosis, and expanded Q(n) repeats are excellent TGase substrates, a role for TGase in AD is possible.	GUANOSINE 5'-TRIPHOSPHATE P3-[1-(2-NITROPHENYL)ETHYL ESTER]	74-77	transglutaminase 1	Homo sapiens	6-11
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	dimethyl-4-phenylenediamine	145-178	transglutaminase 1	Homo sapiens	120-125
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	dimethyl-4-phenylenediamine	180-185	transglutaminase 1	Homo sapiens	102-118
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	dimethyl-4-phenylenediamine	180-185	transglutaminase 1	Homo sapiens	120-125
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	gamma-glutamyl	192-206	transglutaminase 1	Homo sapiens	102-118
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	gamma-glutamyl	192-206	transglutaminase 1	Homo sapiens	120-125
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	carbobenzyloxy-l-glutamylglycine	230-262	transglutaminase 1	Homo sapiens	102-118
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	carbobenzyloxy-l-glutamylglycine	230-262	transglutaminase 1	Homo sapiens	120-125
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	Z-Gln-Gly	264-273	transglutaminase 1	Homo sapiens	102-118
10998259-1	2000	Herein we report the development of a direct and continuous spectrophotometric method for determining transglutaminase (TGase) activity by using N,N-dimethyl-1,4-phenylenediamine (DMPDA) as a gamma-glutamyl acceptor substrate and carbobenzyloxy-l-glutamylglycine (Z-Gln-Gly) as a typical peptide gamma-glutamyl donor substrate.	Z-Gln-Gly	264-273	transglutaminase 1	Homo sapiens	120-125
10998259-2	2000	The transamidation activity of TGase can thus be followed by monitoring the increase of absorbance of the resulting anilide product at 278 nm.	Anilides	116-123	transglutaminase 1	Homo sapiens	31-36
10898571-1	2000	To expand the applications of poly(ethylene glycol) (PEG)-protein conjugates for clinical use, we have developed a novel method for dual and site-specific incorporations of PEG derivatives into proteins using a substrate peptide (AQQIVM, named TG2) and transglutaminase (TGase).	Polyethylene Glycols	30-51	transglutaminase 1	Homo sapiens	253-269
11129585-3	2000	Recombinant TGase 1 was susceptible to limited proteolysis by both mu- and m-calpains, the calcium-dependent intracellular cysteine proteases.	Calcium	91-98	transglutaminase 1	Homo sapiens	12-19
11129585-5	2000	Furthermore, the effects of GTP, nitric oxide, and sphingosylphosphocholine, known as regulatory factors for tissue-type isozyme (TGase 2), on the enzymatic activity of TGase 1 were investigated.	Guanosine Triphosphate	28-31	transglutaminase 1	Homo sapiens	169-176
11129585-5	2000	Furthermore, the effects of GTP, nitric oxide, and sphingosylphosphocholine, known as regulatory factors for tissue-type isozyme (TGase 2), on the enzymatic activity of TGase 1 were investigated.	Nitric Oxide	33-45	transglutaminase 1	Homo sapiens	169-176
11129585-5	2000	Furthermore, the effects of GTP, nitric oxide, and sphingosylphosphocholine, known as regulatory factors for tissue-type isozyme (TGase 2), on the enzymatic activity of TGase 1 were investigated.	sphingosine phosphorylcholine	51-75	transglutaminase 1	Homo sapiens	169-176
10898571-1	2000	To expand the applications of poly(ethylene glycol) (PEG)-protein conjugates for clinical use, we have developed a novel method for dual and site-specific incorporations of PEG derivatives into proteins using a substrate peptide (AQQIVM, named TG2) and transglutaminase (TGase).	Polyethylene Glycols	30-51	transglutaminase 1	Homo sapiens	271-276
10898571-2	2000	In our previous studies, TG2 was shown to be a special peptide with two adjacent Gln substrates for guinea pig liver transglutaminase (G-TGase).	Glutamine	81-84	transglutaminase 1	Homo sapiens	137-142
10898571-4	2000	For the G-TGase-catalyzed reaction, rTG2-IL-2 was dually and site-specifically modified with alkylamine derivatives of PEG (PEG10, average M(r) 10 kDa) at both the Gln2 and Gln3 residues in the appended tag.	alkylamine	93-103	transglutaminase 1	Homo sapiens	10-15
10898571-4	2000	For the G-TGase-catalyzed reaction, rTG2-IL-2 was dually and site-specifically modified with alkylamine derivatives of PEG (PEG10, average M(r) 10 kDa) at both the Gln2 and Gln3 residues in the appended tag.	Polyethylene Glycols	119-122	transglutaminase 1	Homo sapiens	10-15
10898571-8	2000	Thus, TGase-catalyzed PEG-incorporation would improve the therapeutic utility of PEG-protein conjugates.	Polyethylene Glycols	22-25	transglutaminase 1	Homo sapiens	6-11
10898571-8	2000	Thus, TGase-catalyzed PEG-incorporation would improve the therapeutic utility of PEG-protein conjugates.	Polyethylene Glycols	81-84	transglutaminase 1	Homo sapiens	6-11
10747935-0	2000	GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.	Guanosine Triphosphate	0-3	transglutaminase 1	Homo sapiens	32-48
10747935-0	2000	GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.	Guanosine Triphosphate	91-94	transglutaminase 1	Homo sapiens	32-48
10747935-2	2000	It has receptor signaling activity that requires GTP binding and Ca(2+)-activated transglutaminase (TGase) activity that is inhibited by GTP binding.	Guanosine Triphosphate	137-140	transglutaminase 1	Homo sapiens	82-98
10747935-2	2000	It has receptor signaling activity that requires GTP binding and Ca(2+)-activated transglutaminase (TGase) activity that is inhibited by GTP binding.	Guanosine Triphosphate	137-140	transglutaminase 1	Homo sapiens	100-105
10747935-10	2000	Mutagenesis of residues N-terminal to Gly(170) impaired both GTP binding and TGase activity.	Glycine	38-41	transglutaminase 1	Homo sapiens	77-82
10747935-11	2000	From computer modeling of G(h), it is evident that the GTP-binding region identified here is distinct from, but interacts with, the TGase active site.	Guanosine Triphosphate	55-58	transglutaminase 1	Homo sapiens	132-137
10747935-12	2000	Together with structural considerations of G(h) versus other GTP-binding proteins, these findings indicate that G(h) has a unique GTP-binding pocket and provide for the first time a mechanism for GTP-mediated regulation of the TGase activity of G(h).	Guanosine Triphosphate	61-64	transglutaminase 1	Homo sapiens	227-232
10747935-12	2000	Together with structural considerations of G(h) versus other GTP-binding proteins, these findings indicate that G(h) has a unique GTP-binding pocket and provide for the first time a mechanism for GTP-mediated regulation of the TGase activity of G(h).	Guanosine Triphosphate	130-133	transglutaminase 1	Homo sapiens	227-232
10747935-12	2000	Together with structural considerations of G(h) versus other GTP-binding proteins, these findings indicate that G(h) has a unique GTP-binding pocket and provide for the first time a mechanism for GTP-mediated regulation of the TGase activity of G(h).	Guanosine Triphosphate	130-133	transglutaminase 1	Homo sapiens	227-232
10692116-4	2000	mRNA and protein levels of involucrin and transglutaminase 1, markers of differentiation, increased 2- to 3-fold in normal human keratinocytes incubated in the presence of 25- or 22R-hydroxycholesterol in low calcium.	Hydroxycholesterols	183-201	transglutaminase 1	Homo sapiens	42-60
10871075-0	2000	Lamellar ichthyosis: response to etretinate with transglutaminase 1 recovery.	Etretinate	33-43	transglutaminase 1	Homo sapiens	49-67
10692116-4	2000	mRNA and protein levels of involucrin and transglutaminase 1, markers of differentiation, increased 2- to 3-fold in normal human keratinocytes incubated in the presence of 25- or 22R-hydroxycholesterol in low calcium.	Calcium	209-216	transglutaminase 1	Homo sapiens	42-60
10692116-9	2000	22R-hydroxycholesterol increased transglutaminase 1 and involucrin promoter activity 2- to 3-fold.	22-hydroxycholesterol	0-22	transglutaminase 1	Homo sapiens	33-51
10644724-0	2000	Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine.	Cholesterol	0-11	transglutaminase 1	Homo sapiens	79-97
10644724-0	2000	Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine.	3-sulfate	12-21	transglutaminase 1	Homo sapiens	79-97
10644724-0	2000	Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine.	Esters	145-151	transglutaminase 1	Homo sapiens	79-97
10644724-0	2000	Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine.	Glutamine	173-182	transglutaminase 1	Homo sapiens	79-97
10644724-4	2000	TGase 1 is a key component of barrier formation in keratinocytes: it participates in the cross-linking of cell envelope (CE) structural proteins, and also forms the lipid bound envelope by esterification of long chain omega-hydroxyceramides onto CE proteins.	omega-hydroxyceramides	218-240	transglutaminase 1	Homo sapiens	0-7
10644724-6	2000	Sequencing of tryptic peptides from TGase 1-reacted involucrin showed a large increase in deamidation of substrate glutamines.	Peptides	22-30	transglutaminase 1	Homo sapiens	36-43
10644724-6	2000	Sequencing of tryptic peptides from TGase 1-reacted involucrin showed a large increase in deamidation of substrate glutamines.	Glutamine	115-125	transglutaminase 1	Homo sapiens	36-43
10644724-7	2000	We hypothesize that supraphysiological levels of CSO(4) in keratinocyte membranes distort the structure of TGase 1 and facilitate the access of water into its active site causing hydrolysis of substrate glutamine residues.	CSO	49-52	transglutaminase 1	Homo sapiens	107-114
10479291-9	1999	All three heteroarotinoids induced production of TGase, a marker of retinoid activity in human erythroleukemic cells.	heteroarotinoids	10-26	transglutaminase 1	Homo sapiens	49-54
10479291-9	1999	All three heteroarotinoids induced production of TGase, a marker of retinoid activity in human erythroleukemic cells.	Retinoids	68-76	transglutaminase 1	Homo sapiens	49-54
10479291-10	1999	Esters 2 and 3 were the more potent TGase activators than 1, in agreement with the stronger activation of the RAR receptors by 2 and 3.	Esters	0-6	transglutaminase 1	Homo sapiens	36-41
10411887-0	1999	A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation.	long-chain omega-hydroxyceramides	55-88	transglutaminase 1	Homo sapiens	21-39
10411887-0	1999	A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation.	Esters	106-111	transglutaminase 1	Homo sapiens	21-39
10411887-2	1999	Here we show that the membrane-bound form of the TGase 1 enzyme can also form ester bonds between specific glutaminyl residues of human involucrin and a synthetic analog of epidermal specific omega-hydroxyceramides.	Esters	78-83	transglutaminase 1	Homo sapiens	49-56
10411887-2	1999	Here we show that the membrane-bound form of the TGase 1 enzyme can also form ester bonds between specific glutaminyl residues of human involucrin and a synthetic analog of epidermal specific omega-hydroxyceramides.	omega-hydroxyceramides	192-214	transglutaminase 1	Homo sapiens	49-56
10411887-6	1999	When recombinant human TGase 1 and involucrin were reacted on the surface of synthetic lipid vesicles containing lipid Z, lipid Z was attached to involucrin and formed saponifiable protein-lipid adducts.	lipid Z	113-120	transglutaminase 1	Homo sapiens	23-30
9856823-0	1998	Cholesterol sulfate activates transcription of transglutaminase 1 gene in normal human keratinocytes.	cholesteryl sulfate	0-19	transglutaminase 1	Homo sapiens	47-65
10377424-4	1999	More TGase-catalyzed aggregates formed when the polyglutamine domain of htt exceeded the pathologic threshold of polyQ36.	polyglutamine	48-61	transglutaminase 1	Homo sapiens	5-10
10377424-4	1999	More TGase-catalyzed aggregates formed when the polyglutamine domain of htt exceeded the pathologic threshold of polyQ36.	polyq36	113-120	transglutaminase 1	Homo sapiens	5-10
9920792-5	1999	A tight correlation between the induction of tissue TGase, the inhibition of cell growth, and apoptosis was evident in all eight RA-sensitive cell lines.	Tretinoin	129-131	transglutaminase 1	Homo sapiens	52-57
9989277-13	1999	Consistent with increased substrate-driven retinoic acid synthesis in SCC, the expression of transglutaminase 1 was suppressed to a greater extent in the SCCs than in NHK, when cells were exposed to equivalent medium concentrations of retinol.	Tretinoin	43-56	transglutaminase 1	Homo sapiens	93-111
9989277-13	1999	Consistent with increased substrate-driven retinoic acid synthesis in SCC, the expression of transglutaminase 1 was suppressed to a greater extent in the SCCs than in NHK, when cells were exposed to equivalent medium concentrations of retinol.	Vitamin A	235-242	transglutaminase 1	Homo sapiens	93-111
9865910-1	1998	The expression of cholesterol sulfate (CS) is known to increase during squamous differentiation of keratinocytes and to activate the epsilon, eta, and zeta forms of protein kinase C as a signal transduction molecule for the subsequent expression of transglutaminase-1 (TG-1) and cytokeratins.	cholesteryl sulfate	18-37	transglutaminase 1	Homo sapiens	249-267
9865910-1	1998	The expression of cholesterol sulfate (CS) is known to increase during squamous differentiation of keratinocytes and to activate the epsilon, eta, and zeta forms of protein kinase C as a signal transduction molecule for the subsequent expression of transglutaminase-1 (TG-1) and cytokeratins.	cholesteryl sulfate	18-37	transglutaminase 1	Homo sapiens	269-273
9865910-1	1998	The expression of cholesterol sulfate (CS) is known to increase during squamous differentiation of keratinocytes and to activate the epsilon, eta, and zeta forms of protein kinase C as a signal transduction molecule for the subsequent expression of transglutaminase-1 (TG-1) and cytokeratins.	cholesteryl sulfate	39-41	transglutaminase 1	Homo sapiens	249-267
9865910-1	1998	The expression of cholesterol sulfate (CS) is known to increase during squamous differentiation of keratinocytes and to activate the epsilon, eta, and zeta forms of protein kinase C as a signal transduction molecule for the subsequent expression of transglutaminase-1 (TG-1) and cytokeratins.	cholesteryl sulfate	39-41	transglutaminase 1	Homo sapiens	269-273
9865910-5	1998	These findings indicate that CS is coexpressed with TG-1 and cytokeratin in the well-differentiated types of squamous cell cancers as a tumor marker.	cholesteryl sulfate	29-31	transglutaminase 1	Homo sapiens	52-56
10408336-6	1999	When amines were absent in the assay mixture as an external amino donor, lysine residue occurring in the peptide was an effective amino donor site for TGase.	Amines	5-11	transglutaminase 1	Homo sapiens	151-156
10408336-6	1999	When amines were absent in the assay mixture as an external amino donor, lysine residue occurring in the peptide was an effective amino donor site for TGase.	Lysine	73-79	transglutaminase 1	Homo sapiens	151-156
10196183-7	1999	In reactions of involucrin with TGase 1 enzyme in solution, 80 of its 150 glutamines serve as donor residues.	Glutamine	74-84	transglutaminase 1	Homo sapiens	32-39
10599347-4	1999	The chemical structure of the antimalarials is very similar to dansylputrescine, a potent transglutaminase (TGase) inhibitor.	dansylputrescine	63-79	transglutaminase 1	Homo sapiens	90-106
10599347-4	1999	The chemical structure of the antimalarials is very similar to dansylputrescine, a potent transglutaminase (TGase) inhibitor.	dansylputrescine	63-79	transglutaminase 1	Homo sapiens	108-113
10599347-8	1999	HCQS showed a concentration-dependent inhibition of TGase activity.	hcqs	0-4	transglutaminase 1	Homo sapiens	52-57
10599347-9	1999	We suggest that HCQS caused an initial break in the barrier function of the epidermis by inhibiting TGase activity; this was followed by a physiologic response of the epidermis aimed at barrier restoration.	hcqs	16-20	transglutaminase 1	Homo sapiens	100-105
9832162-6	1998	The distribution of amine donors correlated closely with that of Arg residues, suggesting a link between neighboring positive charge and the TGase selectivity for donor sites in the protein substrate.	Amines	20-25	transglutaminase 1	Homo sapiens	141-146
9832162-6	1998	The distribution of amine donors correlated closely with that of Arg residues, suggesting a link between neighboring positive charge and the TGase selectivity for donor sites in the protein substrate.	Arginine	65-68	transglutaminase 1	Homo sapiens	141-146
9856823-2	1998	Cholesterol sulfate is formed during keratinization and activates the eta isoform of protein kinase C. Transglutaminase 1 is a key enzyme for formation of the cornified envelope in terminally differentiated keratinocytes.	cholesteryl sulfate	0-19	transglutaminase 1	Homo sapiens	103-121
9856823-3	1998	In this study, we demonstrated that cholesterol sulfate acts as a transcriptional activator of the transglutaminase 1 gene in normal human keratinocytes.	cholesteryl sulfate	36-55	transglutaminase 1	Homo sapiens	99-117
9856823-5	1998	Treatment of normal human keratinocytes with cholesterol sulfate induced activity of transglutaminase 1 in a dose- and time-dependent manner.	cholesteryl sulfate	45-64	transglutaminase 1	Homo sapiens	85-103
9856823-6	1998	Activation of transcription of transglutaminase 1 by cholesterol sulfate was demonstrated by northern blotting analysis, whereas that by cholesterol was not.	cholesteryl sulfate	53-72	transglutaminase 1	Homo sapiens	31-49
9856823-6	1998	Activation of transcription of transglutaminase 1 by cholesterol sulfate was demonstrated by northern blotting analysis, whereas that by cholesterol was not.	Cholesterol	53-64	transglutaminase 1	Homo sapiens	31-49
9856823-7	1998	In order to identify a cholesterol sulfate responsive region in the transglutaminase 1 gene, plasmids were constructed containing a luciferase reporter gene ligated to deletion fragments of the 5" upstream region of the tranglutaminase 1 gene and were transfected into normal human keratinocytes.	cholesteryl sulfate	23-42	transglutaminase 1	Homo sapiens	68-86
9856823-9	1998	Our results indicate that the responsive element(s) for cholesterol sulfate and phorbol ester is located upstream of the human transglutaminase 1 gene at a position(s) between -819 and -549, whereas the responsive element for Ca2+ is located at a position between -79 and -49.	cholesteryl sulfate	56-75	transglutaminase 1	Homo sapiens	127-145
9856823-9	1998	Our results indicate that the responsive element(s) for cholesterol sulfate and phorbol ester is located upstream of the human transglutaminase 1 gene at a position(s) between -819 and -549, whereas the responsive element for Ca2+ is located at a position between -79 and -49.	Phorbol Esters	80-93	transglutaminase 1	Homo sapiens	127-145
9710604-7	1998	A dominant-negative eta isoform counteracted the induction of transglutaminase 1 by differentiation inducers such as a phorbol ester, 1alpha,25-dihydroxyvitamin D3, and a high concentration of Ca2+.	Phorbol Esters	119-132	transglutaminase 1	Homo sapiens	62-80
9860283-4	1998	Since conventional enzyme assays and mutational analyses are tedious, we developed a novel assay for the rapid screening of transglutaminase 1 activity using covalent incorporation of biotinylated substrate peptides into skin cryostat sections.	Peptides	207-215	transglutaminase 1	Homo sapiens	124-142
9722562-6	1998	With TGase 1, only one glutamine on the head domain and one lysine on the tail domain were used for limited interchain cross-linking.	Glutamine	23-32	transglutaminase 1	Homo sapiens	5-12
9710604-7	1998	A dominant-negative eta isoform counteracted the induction of transglutaminase 1 by differentiation inducers such as a phorbol ester, 1alpha,25-dihydroxyvitamin D3, and a high concentration of Ca2+.	1alpha	134-140	transglutaminase 1	Homo sapiens	62-80
9679326-0	1998	Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity.	Sphingosine	61-72	transglutaminase 1	Homo sapiens	37-53
9710604-7	1998	A dominant-negative eta isoform counteracted the induction of transglutaminase 1 by differentiation inducers such as a phorbol ester, 1alpha,25-dihydroxyvitamin D3, and a high concentration of Ca2+.	25-dihydroxyvitamin d3	141-163	transglutaminase 1	Homo sapiens	62-80
9679326-5	1998	The DNA hydrolytic activity associated with tissue TGase was dependent on Mg2+ in contrast to the Ca2+ requirement for the classical cross-linking activity of TGase, and was inhibited by Zn2+.	magnesium ion	74-78	transglutaminase 1	Homo sapiens	51-56
9679326-5	1998	The DNA hydrolytic activity associated with tissue TGase was dependent on Mg2+ in contrast to the Ca2+ requirement for the classical cross-linking activity of TGase, and was inhibited by Zn2+.	Zinc	187-191	transglutaminase 1	Homo sapiens	51-56
9679326-5	1998	The DNA hydrolytic activity associated with tissue TGase was dependent on Mg2+ in contrast to the Ca2+ requirement for the classical cross-linking activity of TGase, and was inhibited by Zn2+.	Zinc	187-191	transglutaminase 1	Homo sapiens	159-164
9361026-1	1997	Transglutaminase 1 (TGase 1) is a tissue-specific enzyme which is expressed in the keratinized stratified squamous epithelia and which catalyzes straightepsilon-(gamma-glutamyl) lysine cross-links of proteins to form the cell envelope at the periphery of cornified cells.	(gamma-glutamyl) lysine	161-184	transglutaminase 1	Homo sapiens	0-18
9430726-2	1998	Tissue transglutaminase (tTG) catalyzes a Ca(2+)-dependent transglutaminase (TGase) activity that stabilizes tissues and a GTP hydrolysis activity that regulates cell receptor signaling.	Guanosine Triphosphate	123-126	transglutaminase 1	Homo sapiens	7-23
9430726-7	1998	Furthermore, the TGase activity of tTG was inhibited by Mg-GTP, Mg-GDP, and Mg-GMP, with IC50 values of 9, 9, and 400 microM, respectively, whereas the Mg-adenine nucleotides were ineffective.	magnesium GTP	56-62	transglutaminase 1	Homo sapiens	17-22
9430726-7	1998	Furthermore, the TGase activity of tTG was inhibited by Mg-GTP, Mg-GDP, and Mg-GMP, with IC50 values of 9, 9, and 400 microM, respectively, whereas the Mg-adenine nucleotides were ineffective.	Mg-GDP	64-70	transglutaminase 1	Homo sapiens	17-22
9430726-7	1998	Furthermore, the TGase activity of tTG was inhibited by Mg-GTP, Mg-GDP, and Mg-GMP, with IC50 values of 9, 9, and 400 microM, respectively, whereas the Mg-adenine nucleotides were ineffective.	Mg-GMP	76-82	transglutaminase 1	Homo sapiens	17-22
9430726-7	1998	Furthermore, the TGase activity of tTG was inhibited by Mg-GTP, Mg-GDP, and Mg-GMP, with IC50 values of 9, 9, and 400 microM, respectively, whereas the Mg-adenine nucleotides were ineffective.	mg-adenine nucleotides	152-174	transglutaminase 1	Homo sapiens	17-22
9430726-11	1998	Furthermore, binding of Mg-GTP causes a conformational change and the inhibition of TGase activity, whereas Mg-ATP is ineffective.	magnesium GTP	24-30	transglutaminase 1	Homo sapiens	84-89
9412722-6	1997	A pH of 7.5 and a concentration of 2 mM calcium chloride were determined to be optimal for ascertaining the SePl TGase activity in a filter paper assay.	Calcium Chloride	40-56	transglutaminase 1	Homo sapiens	113-118
9412722-7	1997	Immunoprecipitation using polyclonal antibody prepared with a semipurified TGase preparation, concurrently comparing increasing serum dilution and enzyme activity, revealed a predominant protein band on SDS-PAGE of 83 kDa.	Sodium Dodecyl Sulfate	203-206	transglutaminase 1	Homo sapiens	75-80
9506447-5	1998	Thus, we have established a rapid TGK assay in situ on frozen skin sections using incorporation of dansyl-cadaverin to assess transglutaminase (TG) activity in combination with immunohistochemistry for TGK protein.	dansyl-cadaverin	99-115	transglutaminase 1	Homo sapiens	34-37
9397150-6	1998	1,25(OH)2D3 exerted a biphasic effect on transglutaminase (TGase) and involucrin (INV) mRNA levels, with maximal stimulation at 10(-9) M. RA inhibited TGase and INV mRNA levels and antagonized the stimulation by 1,25(OH)2D3.	Calcitriol	0-11	transglutaminase 1	Homo sapiens	41-57
9397150-6	1998	1,25(OH)2D3 exerted a biphasic effect on transglutaminase (TGase) and involucrin (INV) mRNA levels, with maximal stimulation at 10(-9) M. RA inhibited TGase and INV mRNA levels and antagonized the stimulation by 1,25(OH)2D3.	Calcitriol	0-11	transglutaminase 1	Homo sapiens	59-64
9397150-6	1998	1,25(OH)2D3 exerted a biphasic effect on transglutaminase (TGase) and involucrin (INV) mRNA levels, with maximal stimulation at 10(-9) M. RA inhibited TGase and INV mRNA levels and antagonized the stimulation by 1,25(OH)2D3.	Calcitriol	0-11	transglutaminase 1	Homo sapiens	151-156
9397150-7	1998	A similar pattern was observed for TGase protein, but, RA, which, by itself, reduced INV, markedly enhanced the ability of 1,25(OH)2D3 to raise INV levels, possibly by inhibiting 1,25(OH)2D3-stimulated TGase activity and cross-linking of soluble INV into the insoluble cornified envelope (CE).	Tretinoin	55-57	transglutaminase 1	Homo sapiens	202-207
9397150-7	1998	A similar pattern was observed for TGase protein, but, RA, which, by itself, reduced INV, markedly enhanced the ability of 1,25(OH)2D3 to raise INV levels, possibly by inhibiting 1,25(OH)2D3-stimulated TGase activity and cross-linking of soluble INV into the insoluble cornified envelope (CE).	Calcitriol	123-134	transglutaminase 1	Homo sapiens	202-207
9397150-7	1998	A similar pattern was observed for TGase protein, but, RA, which, by itself, reduced INV, markedly enhanced the ability of 1,25(OH)2D3 to raise INV levels, possibly by inhibiting 1,25(OH)2D3-stimulated TGase activity and cross-linking of soluble INV into the insoluble cornified envelope (CE).	Calcitriol	179-190	transglutaminase 1	Homo sapiens	35-40
9397150-7	1998	A similar pattern was observed for TGase protein, but, RA, which, by itself, reduced INV, markedly enhanced the ability of 1,25(OH)2D3 to raise INV levels, possibly by inhibiting 1,25(OH)2D3-stimulated TGase activity and cross-linking of soluble INV into the insoluble cornified envelope (CE).	Calcitriol	179-190	transglutaminase 1	Homo sapiens	202-207
9361026-1	1997	Transglutaminase 1 (TGase 1) is a tissue-specific enzyme which is expressed in the keratinized stratified squamous epithelia and which catalyzes straightepsilon-(gamma-glutamyl) lysine cross-links of proteins to form the cell envelope at the periphery of cornified cells.	(gamma-glutamyl) lysine	161-184	transglutaminase 1	Homo sapiens	20-27
9361026-2	1997	A transient expression assay using a luciferase reporter gene linked to the 2.5 kb 5" upstream region of the human TGase 1 gene (TGM1) showed phorbol ester-responsive promoter activity in cultured normal human keratinocytes.	Phorbol Esters	142-155	transglutaminase 1	Homo sapiens	115-122
9361026-2	1997	A transient expression assay using a luciferase reporter gene linked to the 2.5 kb 5" upstream region of the human TGase 1 gene (TGM1) showed phorbol ester-responsive promoter activity in cultured normal human keratinocytes.	Phorbol Esters	142-155	transglutaminase 1	Homo sapiens	129-133
9361026-6	1997	Furthermore, topical application of a phorbol ester to adult tail skin enhanced expression of the transgene as well as TGase 1 mRNA in the epidermis.	Phorbol Esters	38-51	transglutaminase 1	Homo sapiens	119-126
9089643-1	1997	Transglutaminase (TGase) activities were measured in rat tissues 1-7 days after intraperitoneal injection of saline or lipopolysaccharide (LPS) and in the cells and media from pre-confluent human fibroblasts cultured for two days in the presence or absence of LPS.	Sodium Chloride	109-115	transglutaminase 1	Homo sapiens	18-23
9352417-10	1997	HCQS showed a concentration-dependent inhibition of TGase activity.	Hydroxychloroquine	0-4	transglutaminase 1	Homo sapiens	52-57
9352417-11	1997	CONCLUSIONS: We suggest that HCQS causes an initial break in the barrier function of the epidermis by inhibiting TGase activity; this is followed by a physiologic response of the epidermis aimed at barrier restoration.	Hydroxychloroquine	29-33	transglutaminase 1	Homo sapiens	113-118
9144392-1	1997	Transglutaminase (TGase) is a calcium-dependent enzyme which catalyzes the iso-peptide cross-link between peptide-bound glutamine and lysine in vivo.	Calcium	30-37	transglutaminase 1	Homo sapiens	0-16
9144392-1	1997	Transglutaminase (TGase) is a calcium-dependent enzyme which catalyzes the iso-peptide cross-link between peptide-bound glutamine and lysine in vivo.	Calcium	30-37	transglutaminase 1	Homo sapiens	18-23
9144392-1	1997	Transglutaminase (TGase) is a calcium-dependent enzyme which catalyzes the iso-peptide cross-link between peptide-bound glutamine and lysine in vivo.	Glutamine	120-129	transglutaminase 1	Homo sapiens	0-16
9144392-1	1997	Transglutaminase (TGase) is a calcium-dependent enzyme which catalyzes the iso-peptide cross-link between peptide-bound glutamine and lysine in vivo.	Glutamine	120-129	transglutaminase 1	Homo sapiens	18-23
9144392-1	1997	Transglutaminase (TGase) is a calcium-dependent enzyme which catalyzes the iso-peptide cross-link between peptide-bound glutamine and lysine in vivo.	Lysine	134-140	transglutaminase 1	Homo sapiens	0-16
9144392-1	1997	Transglutaminase (TGase) is a calcium-dependent enzyme which catalyzes the iso-peptide cross-link between peptide-bound glutamine and lysine in vivo.	Lysine	134-140	transglutaminase 1	Homo sapiens	18-23
9144392-6	1997	When we treated keratinocyte with these TGase inhibitors under calcium-induced differentiation, the formation of a cornified cell envelope (CE) was decreased to the same level of CE under proliferating conditions without cytotoxic effect.	Calcium	63-70	transglutaminase 1	Homo sapiens	40-45
9196026-4	1997	While the expression of the TGM1 gene is markedly affected by the calcium concentration of the medium, all trans retinoic acid, vitamin D3, and TPA treatment, the expression of the RABGGTA gene was unaffected by these reagents.	Calcium	66-73	transglutaminase 1	Homo sapiens	28-32
9196026-4	1997	While the expression of the TGM1 gene is markedly affected by the calcium concentration of the medium, all trans retinoic acid, vitamin D3, and TPA treatment, the expression of the RABGGTA gene was unaffected by these reagents.	Cholecalciferol	128-138	transglutaminase 1	Homo sapiens	28-32
9196026-4	1997	While the expression of the TGM1 gene is markedly affected by the calcium concentration of the medium, all trans retinoic acid, vitamin D3, and TPA treatment, the expression of the RABGGTA gene was unaffected by these reagents.	Tetradecanoylphorbol Acetate	144-147	transglutaminase 1	Homo sapiens	28-32
9037390-2	1997	TGase derived from guinea pig liver was activated by calcium to catalyze the in vitro cross-linking of the largest soluble recombinant tau isoform (htau40) into insoluble complexes as determined by electrophoresis following incubation in 4 M urea and SDS.	Calcium	53-60	transglutaminase 1	Homo sapiens	0-5
9037390-2	1997	TGase derived from guinea pig liver was activated by calcium to catalyze the in vitro cross-linking of the largest soluble recombinant tau isoform (htau40) into insoluble complexes as determined by electrophoresis following incubation in 4 M urea and SDS.	Urea	242-246	transglutaminase 1	Homo sapiens	0-5
9037390-2	1997	TGase derived from guinea pig liver was activated by calcium to catalyze the in vitro cross-linking of the largest soluble recombinant tau isoform (htau40) into insoluble complexes as determined by electrophoresis following incubation in 4 M urea and SDS.	Sodium Dodecyl Sulfate	251-254	transglutaminase 1	Homo sapiens	0-5
9037390-3	1997	The TGase-catalyzed formation of these insoluble complexes occurred within 15 min to 24 h and the decreased migration of the insoluble material correlated with increased calcium concentrations ranging from 2 mM to 50 mM when analyzed electrophoretically.	Calcium	170-177	transglutaminase 1	Homo sapiens	4-9
8634442-2	1996	In the present study, we show that t-RA treatment dramatically induced type II transglutaminase (type II TGase) expression in cells carrying the t(15;17) translocation and expressing the PML-RARalpha product such as the APL-derived NB4 cell line and fresh leukemic cells from APL patients.	Tretinoin	35-39	transglutaminase 1	Homo sapiens	105-110
8824274-3	1996	We show here that the equilibrium partitioning of TGase 1 between the cytosol and membranes is controlled by variable modification by myristate and palmitate.	myristate and palmitate	134-157	transglutaminase 1	Homo sapiens	50-57
8855943-3	1996	The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3).	Glutamine	71-80	transglutaminase 1	Homo sapiens	114-119
8855943-3	1996	The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3).	Amines	154-160	transglutaminase 1	Homo sapiens	114-119
8855943-3	1996	The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3).	monodansylcadaverine	162-182	transglutaminase 1	Homo sapiens	114-119
8855943-3	1996	The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3).	monodansylcadaverine	184-187	transglutaminase 1	Homo sapiens	114-119
8855943-3	1996	The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3).	Polyethylene Glycols	221-239	transglutaminase 1	Homo sapiens	114-119
8855943-3	1996	The expressed chimeric protein (rTG1-IL-2) is chemically modified at a glutamine site in the appended sequence by TGase-catalyzed transamination with two amines, monodansylcadaverine (MDC), or a constructed derivative of poly (oxyethylene) (POE3).	poe3	241-245	transglutaminase 1	Homo sapiens	114-119
8772694-5	1996	METHODS AND RESULTS: Immunological and biochemical studies with nonfailling and failing human heart tissues revealed that the GTP-binding and TGase activities of human heart TGase II (hhG alpha n) are downregulated in both ischemic and dilated cardiomyopathic human heart.	Guanosine Triphosphate	126-129	transglutaminase 1	Homo sapiens	174-179
8634442-8	1996	In NB4 cells, using novel receptor-selective ligands such as 9-cis-RA, TTNPB, AM580, and SR11217, we found that RAR- and RARalpha-selective retinoids were able to induce growth arrest, granulocytic differentiation, and type II TGase, whereas the RXR-selective retinoid SR11217 was inactive.	Retinoids	140-149	transglutaminase 1	Homo sapiens	227-232
8634442-8	1996	In NB4 cells, using novel receptor-selective ligands such as 9-cis-RA, TTNPB, AM580, and SR11217, we found that RAR- and RARalpha-selective retinoids were able to induce growth arrest, granulocytic differentiation, and type II TGase, whereas the RXR-selective retinoid SR11217 was inactive.	Retinoids	140-148	transglutaminase 1	Homo sapiens	227-232
8634442-9	1996	Moreover, an RAR alpha-antagonist completely inhibited the expression of type II TGase and CD18 induced by these selective retinoids in NB4 cells.	Retinoids	123-132	transglutaminase 1	Homo sapiens	81-86
8634442-12	1996	On the basis of these results we hypothesize a specific involvement of a signaling pathway involving PML-RAR alpha for the induction of growth arrest, granulocytic differentiation, and type II TGase by retinoids in APL cells.	Retinoids	202-211	transglutaminase 1	Homo sapiens	193-198
7914183-0	1994	High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells.	Doxorubicin	46-57	transglutaminase 1	Homo sapiens	15-31
8592067-0	1996	Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes.	Calcium	123-130	transglutaminase 1	Homo sapiens	99-115
8592067-1	1996	We analyzed the effects of three different calcium concentrations on the RNA and functional protein levels of transglutaminase (TGase) and involucrin (INV) over time in culture.	Calcium	43-50	transglutaminase 1	Homo sapiens	110-126
8592067-1	1996	We analyzed the effects of three different calcium concentrations on the RNA and functional protein levels of transglutaminase (TGase) and involucrin (INV) over time in culture.	Calcium	43-50	transglutaminase 1	Homo sapiens	128-133
8592067-3	1996	The highest calcium concentration (1.2 mM) induced the greatest levels of INV and TGase message, INV protein, and rates of CE formation, but not maximal levels of TGase protein.	Calcium	12-19	transglutaminase 1	Homo sapiens	82-87
8592067-4	1996	By examining cytosol and membrane fractions of keratinocytes, we found that after synthesis, TGase protein shifts, under the influence of calcium (both 0.1 mM and 1.2 mM), from the cytosol into the membrane in postconfluent cells.	Calcium	138-145	transglutaminase 1	Homo sapiens	93-98
8592067-5	1996	However, only 1.2 mM calcium induced significant amounts of TGase activity.	Calcium	21-28	transglutaminase 1	Homo sapiens	60-65
8592067-6	1996	These data indicate that elevated calcium (1.2 mM) achieves the expected induction in keratinocyte differentiation by regulation of not only INV and TGase message levels, but also the translation and activation of TGase protein.	Calcium	34-41	transglutaminase 1	Homo sapiens	149-154
8592067-6	1996	These data indicate that elevated calcium (1.2 mM) achieves the expected induction in keratinocyte differentiation by regulation of not only INV and TGase message levels, but also the translation and activation of TGase protein.	Calcium	34-41	transglutaminase 1	Homo sapiens	214-219
8592067-7	1996	Our data suggest that this calcium-induced activation of TGase protein occurs while the protein is anchored in the membrane.	Calcium	27-34	transglutaminase 1	Homo sapiens	57-62
8720146-1	1995	Transglutaminase (TGase) catalyzes an acyl-transfer reaction between peptidyl glutamine residues and primary amines including the epsilon-amino group of lysine residues in protein.	Glutamine	78-87	transglutaminase 1	Homo sapiens	18-23
8720146-1	1995	Transglutaminase (TGase) catalyzes an acyl-transfer reaction between peptidyl glutamine residues and primary amines including the epsilon-amino group of lysine residues in protein.	Amines	109-115	transglutaminase 1	Homo sapiens	18-23
8720146-1	1995	Transglutaminase (TGase) catalyzes an acyl-transfer reaction between peptidyl glutamine residues and primary amines including the epsilon-amino group of lysine residues in protein.	Lysine	153-159	transglutaminase 1	Homo sapiens	18-23
8720146-6	1995	The brain TGase activity was Ca(2+)-dependent (EC50 approximately 0.28 mM), and its Km values for putrescine and N,N-dimethylcasein were 0.26 and 0.065 mM, respectively.	Putrescine	98-108	transglutaminase 1	Homo sapiens	10-15
8720146-7	1995	GTP inhibited the brain enzyme activity 100-fold more potently than ATP did, and the enzyme was photolabeled with [alpha-32P]8-azido-GTP, suggesting that the brain TGase is a member of the GTP-binding protein family.	Guanosine Triphosphate	0-3	transglutaminase 1	Homo sapiens	164-169
8720146-7	1995	GTP inhibited the brain enzyme activity 100-fold more potently than ATP did, and the enzyme was photolabeled with [alpha-32P]8-azido-GTP, suggesting that the brain TGase is a member of the GTP-binding protein family.	Adenosine Triphosphate	68-71	transglutaminase 1	Homo sapiens	164-169
8720146-7	1995	GTP inhibited the brain enzyme activity 100-fold more potently than ATP did, and the enzyme was photolabeled with [alpha-32P]8-azido-GTP, suggesting that the brain TGase is a member of the GTP-binding protein family.	[alpha-32p]8-azido-gtp	114-136	transglutaminase 1	Homo sapiens	164-169
8720146-7	1995	GTP inhibited the brain enzyme activity 100-fold more potently than ATP did, and the enzyme was photolabeled with [alpha-32P]8-azido-GTP, suggesting that the brain TGase is a member of the GTP-binding protein family.	Guanosine Triphosphate	133-136	transglutaminase 1	Homo sapiens	164-169
8720146-8	1995	Monoiodo-acetate and cystamine potently inhibited the enzyme activity, suggesting that cysteine residue(s) are essential for brain TGase.	Iodoacetic Acid	0-16	transglutaminase 1	Homo sapiens	131-136
8720146-8	1995	Monoiodo-acetate and cystamine potently inhibited the enzyme activity, suggesting that cysteine residue(s) are essential for brain TGase.	Cystamine	21-30	transglutaminase 1	Homo sapiens	131-136
8720146-8	1995	Monoiodo-acetate and cystamine potently inhibited the enzyme activity, suggesting that cysteine residue(s) are essential for brain TGase.	Cysteine	87-95	transglutaminase 1	Homo sapiens	131-136
7592852-6	1995	The TGase 3 reaction favored certain lysines and glutamines by forming mostly intrachain cross-links, whereas TGase 1 formed mostly large oligomeric complexes by interchain cross-links involving different lysines and glutamines.	Lysine	205-212	transglutaminase 1	Homo sapiens	110-117
7592852-6	1995	The TGase 3 reaction favored certain lysines and glutamines by forming mostly intrachain cross-links, whereas TGase 1 formed mostly large oligomeric complexes by interchain cross-links involving different lysines and glutamines.	Glutamine	217-227	transglutaminase 1	Homo sapiens	110-117
7564522-1	1995	We studied tissue transglutaminase (TGase) expression in human myelomonocytic leukemia cells treated by combinations of all-trans retinoic acid (RA) and 1,25 dihydroxyvitamin D3 (VD).	Tretinoin	145-147	transglutaminase 1	Homo sapiens	36-41
7564522-1	1995	We studied tissue transglutaminase (TGase) expression in human myelomonocytic leukemia cells treated by combinations of all-trans retinoic acid (RA) and 1,25 dihydroxyvitamin D3 (VD).	Calcitriol	153-177	transglutaminase 1	Homo sapiens	36-41
8603579-2	1996	By sequential complementary DNA subtractive hybridization, one of the messenger RNAs (mRNA) induced by progesterone in human endometrial stromal cells decidualized in vitro was identified as that of a tissue transglutaminase type II (TGase).	Progesterone	103-115	transglutaminase 1	Homo sapiens	201-239
8603579-4	1996	Both the TGase inhibitor monodansylcadaverine and oligodeoxynucleotide complementary to the TGase mRNA inhibited the decidualization, as assessed by PRL production and morphological transformation.	monodansylcadaverine	25-45	transglutaminase 1	Homo sapiens	9-14
8603579-4	1996	Both the TGase inhibitor monodansylcadaverine and oligodeoxynucleotide complementary to the TGase mRNA inhibited the decidualization, as assessed by PRL production and morphological transformation.	Oligodeoxyribonucleotides	50-70	transglutaminase 1	Homo sapiens	92-97
8603579-5	1996	Expression of TGase mRNA in human decidua and endometria exposed to high levels of progesterone in vivo was demonstrated by Northern blotting and in situ hybridization.	Progesterone	83-95	transglutaminase 1	Homo sapiens	14-19
8944344-4	1996	OBJECTIVE: To explain the molecular mechanism of enalapril-induced acantholysis a potential link between transglutaminase (TGase) activity and the effects of this drug was investigated.	Enalapril	49-58	transglutaminase 1	Homo sapiens	105-121
8944344-4	1996	OBJECTIVE: To explain the molecular mechanism of enalapril-induced acantholysis a potential link between transglutaminase (TGase) activity and the effects of this drug was investigated.	Enalapril	49-58	transglutaminase 1	Homo sapiens	123-128
8944344-5	1996	METHODS: TGase activity in extracts from human breast skin cultured in the presence of thiopronine, captopril and enalapril were evaluated in vitro.	Tiopronin	87-98	transglutaminase 1	Homo sapiens	9-14
8944344-5	1996	METHODS: TGase activity in extracts from human breast skin cultured in the presence of thiopronine, captopril and enalapril were evaluated in vitro.	Captopril	100-109	transglutaminase 1	Homo sapiens	9-14
8944344-5	1996	METHODS: TGase activity in extracts from human breast skin cultured in the presence of thiopronine, captopril and enalapril were evaluated in vitro.	Enalapril	114-123	transglutaminase 1	Homo sapiens	9-14
8944344-7	1996	RESULTS: Enalapril, the most powerful acantholytic drug in vitro, was found to inhibit both the purified enzyme and the TGase activity in the extracts from cultured human breast skin explants.	Enalapril	9-18	transglutaminase 1	Homo sapiens	120-125
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	gamma-carboxamide	152-169	transglutaminase 1	Homo sapiens	15-31
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	gamma-carboxamide	152-169	transglutaminase 1	Homo sapiens	33-38
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	gamma-carboxamide	152-169	transglutaminase 1	Homo sapiens	59-64
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	Glutamine	193-202	transglutaminase 1	Homo sapiens	15-31
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	Glutamine	193-202	transglutaminase 1	Homo sapiens	33-38
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	Glutamine	193-202	transglutaminase 1	Homo sapiens	59-64
7914183-2	1994	The degree of therapeutic efficacy or toxicity of drugs may be related to their ability to serve as a substrate for TGase and their covalent linkage to glutamine residues of regulatory proteins through the catalytic action of this enzyme.	Glutamine	152-161	transglutaminase 1	Homo sapiens	116-121
7914183-3	1994	Here, doxorubicin (adriamycin)-resistant human breast carcinoma MCF-7ADR cells exhibited 40- to 6C-fold higher TGase activity than control drug-sensitive MCF-7WT cells.	Doxorubicin	6-17	transglutaminase 1	Homo sapiens	111-116
7914183-3	1994	Here, doxorubicin (adriamycin)-resistant human breast carcinoma MCF-7ADR cells exhibited 40- to 6C-fold higher TGase activity than control drug-sensitive MCF-7WT cells.	Doxorubicin	19-29	transglutaminase 1	Homo sapiens	111-116
7914183-4	1994	The same was observed in vivo: a small proportion of tumor cells became positive for TGase after administration of adriamycin-based chemotherapy to patients with breast carcinoma.	Doxorubicin	115-125	transglutaminase 1	Homo sapiens	85-90
7914183-5	1994	Similarly, continuous culture of MCF-7WT cells in the presence of adriamycin led to the appearance of the drug-resistant phenotype that was in turn associated with increased expression of TGase.	Doxorubicin	66-76	transglutaminase 1	Homo sapiens	188-193
7914183-6	1994	This increase in TGase was specific for adriamycin resistance.	Doxorubicin	40-50	transglutaminase 1	Homo sapiens	17-22
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	Amines	138-144	transglutaminase 1	Homo sapiens	15-31
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	Amines	138-144	transglutaminase 1	Homo sapiens	33-38
7914183-1	1994	Tissue type II transglutaminase (TGase) is a member of the TGase family that catalyzes Ca(2+)-dependent covalent cross-linking of several amines to the gamma-carboxamide group of protein-bound glutamine residues.	Amines	138-144	transglutaminase 1	Homo sapiens	59-64
7919657-5	1994	Mouse P4.2 is on average 73% identical with human erythrocyte P4.2, although regional variations exist, with greatest conservation in the regions of the molecule that contain the TGase active site, the TGase calcium-binding site, and a band 3 binding site.	Calcium	208-215	transglutaminase 1	Homo sapiens	202-207
8099784-0	1993	Calcium pretreatment induces the decrease in epidermal growth factor binding through the activation of transglutaminase in isolated liver membrane.	Calcium	0-7	transglutaminase 1	Homo sapiens	103-119
8104036-3	1993	Treatment of the enzyme with iodoacetamide, a cysteine-directed reagent, caused a 94% loss of TGase activity within 8 min, but no significant loss of GTPase activity.	Iodoacetamide	29-42	transglutaminase 1	Homo sapiens	94-99
8104036-3	1993	Treatment of the enzyme with iodoacetamide, a cysteine-directed reagent, caused a 94% loss of TGase activity within 8 min, but no significant loss of GTPase activity.	Cysteine	46-54	transglutaminase 1	Homo sapiens	94-99
8099784-6	1993	The Ca2+ effect was prevented by monodansylcadaverine or iodoacetamide, transglutaminase (TGase) inhibitors.	Iodoacetamide	57-70	transglutaminase 1	Homo sapiens	90-95
1356818-0	1992	Regulation of transglutaminase 1 gene expression by 12-O-tetradecanoylphorbol-13-acetate, dexamethasone, and retinoic acid in cultured human keratinocytes.	Tetradecanoylphorbol Acetate	52-88	transglutaminase 1	Homo sapiens	14-32
7678985-1	1993	We examined the expression of the transglutaminase 1 (TGase 1) gene in frozen sections of normal and psoriatic epidermis by means of non-radioactive in situ hybridization with digoxigenin-labelled cRNA probes.	Digoxigenin	176-187	transglutaminase 1	Homo sapiens	34-52
7678985-1	1993	We examined the expression of the transglutaminase 1 (TGase 1) gene in frozen sections of normal and psoriatic epidermis by means of non-radioactive in situ hybridization with digoxigenin-labelled cRNA probes.	Digoxigenin	176-187	transglutaminase 1	Homo sapiens	54-61
1356818-0	1992	Regulation of transglutaminase 1 gene expression by 12-O-tetradecanoylphorbol-13-acetate, dexamethasone, and retinoic acid in cultured human keratinocytes.	Dexamethasone	90-103	transglutaminase 1	Homo sapiens	14-32
1356818-0	1992	Regulation of transglutaminase 1 gene expression by 12-O-tetradecanoylphorbol-13-acetate, dexamethasone, and retinoic acid in cultured human keratinocytes.	Tretinoin	109-122	transglutaminase 1	Homo sapiens	14-32
1356818-1	1992	Transglutaminase 1 (TG1) is an enzyme that is expressed at the late stage of terminal differentiation of keratinocytes and catalyzes the epsilon-(gamma-glutamyl)lysine cross-linking reaction to form a highly insoluble cell envelope.	epsilon-(gamma-glutamyl)-lysine	137-167	transglutaminase 1	Homo sapiens	0-18
1356818-1	1992	Transglutaminase 1 (TG1) is an enzyme that is expressed at the late stage of terminal differentiation of keratinocytes and catalyzes the epsilon-(gamma-glutamyl)lysine cross-linking reaction to form a highly insoluble cell envelope.	epsilon-(gamma-glutamyl)-lysine	137-167	transglutaminase 1	Homo sapiens	20-23
1356818-3	1992	Treatment of NHEK with TPA, up to 10 nM, markedly increased the levels of TG1 mRNA in a dose-dependent manner.	Tetradecanoylphorbol Acetate	23-26	transglutaminase 1	Homo sapiens	74-77
1356818-6	1992	The induction of TG1 mRNA expression by TPA was inhibited by 1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine (H-7) and staurosporine.	Tetradecanoylphorbol Acetate	40-43	transglutaminase 1	Homo sapiens	17-20
1356818-6	1992	The induction of TG1 mRNA expression by TPA was inhibited by 1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine (H-7) and staurosporine.	1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine	61-108	transglutaminase 1	Homo sapiens	17-20
1356818-6	1992	The induction of TG1 mRNA expression by TPA was inhibited by 1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine (H-7) and staurosporine.	1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine	110-113	transglutaminase 1	Homo sapiens	17-20
1356818-6	1992	The induction of TG1 mRNA expression by TPA was inhibited by 1-(5-isoquinolinylsulfonyl)-2-methyl-piperazine (H-7) and staurosporine.	Staurosporine	119-132	transglutaminase 1	Homo sapiens	17-20
1356818-7	1992	Dexamethasone at a concentration of 1 microM also increased the TG1 mRNA levels, but the maximum induction was observed (3-fold above the basal level) after 72 h of incubation.	Dexamethasone	0-13	transglutaminase 1	Homo sapiens	64-67
1356818-9	1992	Moreover, 1 microM of retinoic acid completely inhibited the induction of TG1 mRNA by both TPA and dexamethasone.	Tretinoin	22-35	transglutaminase 1	Homo sapiens	74-77
1356818-9	1992	Moreover, 1 microM of retinoic acid completely inhibited the induction of TG1 mRNA by both TPA and dexamethasone.	Tetradecanoylphorbol Acetate	91-94	transglutaminase 1	Homo sapiens	74-77
1356818-9	1992	Moreover, 1 microM of retinoic acid completely inhibited the induction of TG1 mRNA by both TPA and dexamethasone.	Dexamethasone	99-112	transglutaminase 1	Homo sapiens	74-77
1355099-0	1992	Short-term retinoic acid treatment increases in vivo, but decreases in vitro, epidermal transglutaminase-K enzyme activity and immunoreactivity.	Tretinoin	11-24	transglutaminase 1	Homo sapiens	88-106
1506417-5	1992	However, combined withdrawal of lI-1 and IFN-alpha/beta causes in 2 of 4 TC-lines significant reduction of TC-death.	Technetium	73-75	transglutaminase 1	Homo sapiens	32-36
1506417-5	1992	However, combined withdrawal of lI-1 and IFN-alpha/beta causes in 2 of 4 TC-lines significant reduction of TC-death.	Technetium	107-109	transglutaminase 1	Homo sapiens	32-36
1506417-6	1992	Combined removal of TNF, IFN-alpha/beta, lI-1, and lI-6 leads to complete prevention of SU-mediated growth inhibitory and lytic effects, suggesting that besides these cytokines other signals are not involved significantly.	su	88-90	transglutaminase 1	Homo sapiens	41-45
1355099-3	1992	We have investigated whether the hyperproliferative state induced by short-term application of topical retinoic acid is similarly characterized by an increase in transglutaminase-K enzyme activity and immunoreactivity.	Tretinoin	103-116	transglutaminase 1	Homo sapiens	162-180
1355099-4	1992	Retinoic acid (0.1% cream) or vehicle were applied to human skin and occluded for 4 d. Skin biopsies were obtained for measurement of transglutaminase-K and transglutaminase-C activity and immunoreactivity.	Tretinoin	0-13	transglutaminase 1	Homo sapiens	134-152
1355099-6	1992	Transglutaminase-K activity was increased 2.8 times in retinoic acid compared to vehicle-treated skin (p less than 0.005, n = 12) whereas there was no significant difference in transglutaminase-C activity.	Tretinoin	55-68	transglutaminase 1	Homo sapiens	0-18
1355099-8	1992	In vehicle-treated skin, transglutaminase-K immunoreactivity was limited to a narrow, substratum corneal band, but was considerably expanded in a diffuse suprabasal pattern in retinoic acid-treated epidermis.	Tretinoin	176-189	transglutaminase 1	Homo sapiens	25-43
1355099-9	1992	In contrast, transglutaminase-K immunostaining was decreased and its enzymatic activity reduced sixfold in retinoic acid-treated keratinocytes (p less than 0.01, n = 4).	Tretinoin	107-120	transglutaminase 1	Homo sapiens	13-31
1355099-10	1992	These results demonstrate that retinoic acid treatment in vivo, in contrast to in vitro, leads to not only increased transglutaminase-K protein expression but also increased enzymatic activity in the absence of detectable increases in mRNA levels.	Tretinoin	31-44	transglutaminase 1	Homo sapiens	117-135
1730114-3	1992	A rat IgG2a MoAb that recognizes EMA, ICR2, was labeled with Indium-111 (100 megabecquerel per milligram [MBq/mg]MoAb) using the bicyclic anhydride of the chelating agent diethylene triamine pentacetic acid (ccDTPA) and was administered intravenously to 22 patients known to have or thought to have colorectal cancer.	Indium-111	61-71	transglutaminase 1	Homo sapiens	38-42
1353732-2	1992	When phosphorylated cystatin alpha (P-cystatin alpha) was incubated with epidermal transglutaminase (TGase) and Ca2+ ions, polymerized protein was produced by formation of epsilon-(gamma-glutamyl)lysine cross-linking peptide bonds between lysine residues of cystatin alpha and glutamine residues of suitable protein(s) in the enzyme preparation.	epsilon-(gamma-glutamyl)-lysine	172-202	transglutaminase 1	Homo sapiens	101-106
1353732-2	1992	When phosphorylated cystatin alpha (P-cystatin alpha) was incubated with epidermal transglutaminase (TGase) and Ca2+ ions, polymerized protein was produced by formation of epsilon-(gamma-glutamyl)lysine cross-linking peptide bonds between lysine residues of cystatin alpha and glutamine residues of suitable protein(s) in the enzyme preparation.	Lysine	196-202	transglutaminase 1	Homo sapiens	101-106
1353732-2	1992	When phosphorylated cystatin alpha (P-cystatin alpha) was incubated with epidermal transglutaminase (TGase) and Ca2+ ions, polymerized protein was produced by formation of epsilon-(gamma-glutamyl)lysine cross-linking peptide bonds between lysine residues of cystatin alpha and glutamine residues of suitable protein(s) in the enzyme preparation.	Glutamine	277-286	transglutaminase 1	Homo sapiens	101-106
1352294-5	1992	The effect was maximal at physiological (micromolar) concentrations of the endogenous TGase regulators calcium and GTP.	Calcium	103-110	transglutaminase 1	Homo sapiens	86-91
1352294-5	1992	The effect was maximal at physiological (micromolar) concentrations of the endogenous TGase regulators calcium and GTP.	Guanosine Triphosphate	115-118	transglutaminase 1	Homo sapiens	86-91
1351505-3	1992	The cDNA clones were sequenced and unequivocally identified as TGase K by comparison to the N-terminal amino acid sequences of two cyanogen bromide fragments from the purified enzyme.	Cyanogen Bromide	131-147	transglutaminase 1	Homo sapiens	63-70
1348508-7	1992	Use of human-rodent cell hybrid panels and chromosomal in situ hybridization with biotin-labeled probes revealed that the human TGM1 gene maps to chromosome position 14q11.2-13.	Biotin	82-88	transglutaminase 1	Homo sapiens	128-132
1676683-3	1991	Partially-purified TGase from human brain was inhibited by ATP in a manner similar to that observed with the rat liver enzyme.	Adenosine Triphosphate	59-62	transglutaminase 1	Homo sapiens	19-24
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Guanosine Triphosphate	103-128	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Guanosine Triphosphate	130-133	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Guanosine Diphosphate	136-160	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Guanosine Diphosphate	162-165	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Adenosine Triphosphate	171-193	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Adenosine Triphosphate	195-198	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Calcium	274-281	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Magnesium	283-292	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Strontium	294-303	transglutaminase 1	Homo sapiens	92-97
1683874-4	1991	Binding occurred equally well at 4 degrees C or 37 degrees C. Prior incubation of exogenous TGase with guanosine 5"-triphosphate (GTP), guanosine 5"-diphosphate (GDP), or adenosine triphosphate (ATP) had little effect on the amount bound to matrix, but prior treatment with calcium, magnesium, strontium, or manganese ions enhanced binding 2- to 3-fold.	Manganese	308-317	transglutaminase 1	Homo sapiens	92-97
1683874-6	1991	Immunofluorescent techniques showed that binding of exogenous TGase to ECM was prevented by prior mixing with fibronectin or collagen, but not with several other ECM components, including laminin, elastin, chondroitin sulfate, heparan sulfate, and hyaluronic acid.	Chondroitin Sulfates	206-225	transglutaminase 1	Homo sapiens	62-67
1683874-6	1991	Immunofluorescent techniques showed that binding of exogenous TGase to ECM was prevented by prior mixing with fibronectin or collagen, but not with several other ECM components, including laminin, elastin, chondroitin sulfate, heparan sulfate, and hyaluronic acid.	Heparitin Sulfate	227-242	transglutaminase 1	Homo sapiens	62-67
1683874-6	1991	Immunofluorescent techniques showed that binding of exogenous TGase to ECM was prevented by prior mixing with fibronectin or collagen, but not with several other ECM components, including laminin, elastin, chondroitin sulfate, heparan sulfate, and hyaluronic acid.	Hyaluronic Acid	248-263	transglutaminase 1	Homo sapiens	62-67
1683874-7	1991	ECM-bound TGase was released by 2 M potassium thiocyanate (KSCN) treatment but was not released by treatment with a variety of amino acids, salts, reducing agents, glycerol, or other chaotropic agents.	potassium thiocyanate	36-57	transglutaminase 1	Homo sapiens	10-15
1683874-7	1991	ECM-bound TGase was released by 2 M potassium thiocyanate (KSCN) treatment but was not released by treatment with a variety of amino acids, salts, reducing agents, glycerol, or other chaotropic agents.	potassium thiocyanate	59-63	transglutaminase 1	Homo sapiens	10-15
1683874-7	1991	ECM-bound TGase was released by 2 M potassium thiocyanate (KSCN) treatment but was not released by treatment with a variety of amino acids, salts, reducing agents, glycerol, or other chaotropic agents.	Glycerol	164-172	transglutaminase 1	Homo sapiens	10-15
1676683-9	1991	Since ATP levels in cells are of mM order, these results suggest that TGase activity is controlled by ATP in vivo.	Adenosine Triphosphate	6-9	transglutaminase 1	Homo sapiens	70-75
1676683-9	1991	Since ATP levels in cells are of mM order, these results suggest that TGase activity is controlled by ATP in vivo.	Adenosine Triphosphate	102-105	transglutaminase 1	Homo sapiens	70-75
1676683-6	1991	CTP has a TGase-inhibitory potency equivalent to that of ATP, whereas GTP and UTP possess about 50% of the inhibitory activity of ATP.	Cytidine Triphosphate	0-3	transglutaminase 1	Homo sapiens	10-15
1676683-7	1991	ADP inhibits TGase activity to the same extent as ATP, but AMP causes much less inhibition, and there is no inhibition by adenosine or adenine.	Adenosine Diphosphate	0-3	transglutaminase 1	Homo sapiens	13-18
1686607-3	1991	This report discusses membrane-associated erythrocyte TGase activity which can crosslink substrates at micromolar calcium concentrations in the presence of calmodulin (CaM).	Calcium	114-121	transglutaminase 1	Homo sapiens	54-59
1670769-6	1991	Using the active site oligonucleotide as a probe, we have isolated and sequenced cDNA clones encoding the transglutaminase K enzyme.	Oligonucleotides	22-37	transglutaminase 1	Homo sapiens	106-124
1686607-5	1991	The EGTA eluate from the affinity chromatography displays TGase activity at ten times that of the initial hemolysate.	Egtazic Acid	4-8	transglutaminase 1	Homo sapiens	58-63
2070229-2	1991	This technique was evaluated in 16 patients with colorectal tumours (14 cancers, one adenoma, one lipoma) with the 111In-labelled monoclonal antibody (MAb) ICR2 which recognizes the tumour-associated epithelial membrane antigen (EMA).	Indium-111	115-120	transglutaminase 1	Homo sapiens	156-160
1686607-7	1991	TGase crosslinking of fibronectin, fibrinogen, and membrane cytoskeletal substrates was associated with substrate degradation and could be inhibited competitively by putrescine.	Putrescine	166-176	transglutaminase 1	Homo sapiens	0-5
1686607-4	1991	This TGase activity coisolates with a 1 M NaCl extraction of cytoskeletal components and is purified by CaM affinity chromatography.	Sodium Chloride	42-46	transglutaminase 1	Homo sapiens	5-10
2389549-6	1990	52, 331-341) to resemble the ICRs 1 and 2 (A and B boxes) of tRNA genes, with the complementary sequences at the 3" termini of the (-) strands resembling the ICR2 motif of methionine initiator tRNA genes (L.E.	Methionine	172-182	transglutaminase 1	Homo sapiens	158-162
33768716-0	2021	A Novel Perovskite Electron-Ion Conductive Coating to Simultaneously Enhance Cycling Stability and Rate Capability of Li1.2 Ni0.13 Co0.13 Mn0.54 O2 Cathode Material for Lithium-Ion Batteries.	perovskite	8-18	transglutaminase 1	Homo sapiens	118-121
33944567-0	2021	Energetic Stability and Its Role in the Mechanism of Ionic Transport in NASICON-Type Solid-State Electrolyte Li1+xAlxTi2-x(PO4)3.	po4	123-126	transglutaminase 1	Homo sapiens	109-112
33944567-1	2021	We apply high-temperature oxide melt solution calorimetry to assess the thermodynamic properties of the material Li1+xAlxTi2-x(PO4)3, which has been broadly recognized as one of the best Li-ion-conducting solid electrolytes of the NASICON family.	Oxides	26-31	transglutaminase 1	Homo sapiens	113-116
33765599-0	2021	Dual role (promotion and inhibition) of transglutaminase in mediating myofibrillar protein gelation under malondialdehyde-induced oxidative stress.	Malondialdehyde	106-121	transglutaminase 1	Homo sapiens	40-56
33765599-4	2021	Under varying degrees of MDA oxidation, the addition of TGase always led to changes in the tertiary structure, loss of free amine and thiol groups, crosslinking of the myosin heavy chain, and decreasing solubility.	Malondialdehyde	25-28	transglutaminase 1	Homo sapiens	56-61
33765599-4	2021	Under varying degrees of MDA oxidation, the addition of TGase always led to changes in the tertiary structure, loss of free amine and thiol groups, crosslinking of the myosin heavy chain, and decreasing solubility.	Amines	124-129	transglutaminase 1	Homo sapiens	56-61
33765599-4	2021	Under varying degrees of MDA oxidation, the addition of TGase always led to changes in the tertiary structure, loss of free amine and thiol groups, crosslinking of the myosin heavy chain, and decreasing solubility.	Sulfhydryl Compounds	134-139	transglutaminase 1	Homo sapiens	56-61
33768716-0	2021	A Novel Perovskite Electron-Ion Conductive Coating to Simultaneously Enhance Cycling Stability and Rate Capability of Li1.2 Ni0.13 Co0.13 Mn0.54 O2 Cathode Material for Lithium-Ion Batteries.	Oxygen	145-147	transglutaminase 1	Homo sapiens	118-121
33768716-0	2021	A Novel Perovskite Electron-Ion Conductive Coating to Simultaneously Enhance Cycling Stability and Rate Capability of Li1.2 Ni0.13 Co0.13 Mn0.54 O2 Cathode Material for Lithium-Ion Batteries.	Lithium	169-176	transglutaminase 1	Homo sapiens	118-121
33768716-2	2021	Herein, a novel perovskite electron-ion mixed conductor Nd0.6 Sr0.4 CoO3 (NSCO) is used as the coating layer on Li1.2 Ni0.13 Co0.13 Mn0.54 O2 (LNCMO) to simultaneously enhance its cycling stability and rate capability.	coo3	68-72	transglutaminase 1	Homo sapiens	112-115
33768716-2	2021	Herein, a novel perovskite electron-ion mixed conductor Nd0.6 Sr0.4 CoO3 (NSCO) is used as the coating layer on Li1.2 Ni0.13 Co0.13 Mn0.54 O2 (LNCMO) to simultaneously enhance its cycling stability and rate capability.	nsco	74-78	transglutaminase 1	Homo sapiens	112-115
33768716-2	2021	Herein, a novel perovskite electron-ion mixed conductor Nd0.6 Sr0.4 CoO3 (NSCO) is used as the coating layer on Li1.2 Ni0.13 Co0.13 Mn0.54 O2 (LNCMO) to simultaneously enhance its cycling stability and rate capability.	Oxygen	139-141	transglutaminase 1	Homo sapiens	112-115
34658075-2	2021	Herein, a unique electron and ion co-conductive catalyst of carbon-coated Li1.4 Al0.4 Ti1.6 (PO4 )3 (C@LATP) is developed, which not only possesses strong adsorption to LiPSs, but, more importantly, also promotes the instantaneous conversion reaction of LiPSs to Li2 S. The C@LATP nanoparticles as catalytic active sites can synchronously and efficiently provide both Li ions and electrons to facilitate the conversion reaction of LiPSs.	Carbon	60-66	transglutaminase 1	Homo sapiens	74-77
33350083-0	2018	New Trends in the Microencapsulation of Functional Fatty Acid-Rich Oils Using Transglutaminase Catalyzed Crosslinking.	Fatty Acids	51-61	transglutaminase 1	Homo sapiens	78-94
33350083-2	2018	However, recent advances with transglutaminase (TGase) enzyme as an effective protein cross-linker could provide workable solutions for the encapsulation of omega-3 and omega-6 fatty acids without compromising their targeted release and their biological and physicochemical characteristics.	omega-3	157-164	transglutaminase 1	Homo sapiens	30-46
33350083-2	2018	However, recent advances with transglutaminase (TGase) enzyme as an effective protein cross-linker could provide workable solutions for the encapsulation of omega-3 and omega-6 fatty acids without compromising their targeted release and their biological and physicochemical characteristics.	omega-3	157-164	transglutaminase 1	Homo sapiens	48-53
33350083-2	2018	However, recent advances with transglutaminase (TGase) enzyme as an effective protein cross-linker could provide workable solutions for the encapsulation of omega-3 and omega-6 fatty acids without compromising their targeted release and their biological and physicochemical characteristics.	Fatty Acids, Omega-6	169-188	transglutaminase 1	Homo sapiens	30-46
33350083-2	2018	However, recent advances with transglutaminase (TGase) enzyme as an effective protein cross-linker could provide workable solutions for the encapsulation of omega-3 and omega-6 fatty acids without compromising their targeted release and their biological and physicochemical characteristics.	Fatty Acids, Omega-6	169-188	transglutaminase 1	Homo sapiens	48-53
33350083-9	2018	A significant structural, thermal and oxidative stability for edible oils-loaded microcapsules in the presence of TGase can be also obtained.	edible oils	62-73	transglutaminase 1	Homo sapiens	114-119
34932356-0	2022	Developing Atomically Thin Li1.81H0.19Ti2O5 2H2O Nanosheets for Selective Photocatalytic CO2 Reduction to CO.	Carbon Dioxide	89-92	transglutaminase 1	Homo sapiens	27-30
34932356-0	2022	Developing Atomically Thin Li1.81H0.19Ti2O5 2H2O Nanosheets for Selective Photocatalytic CO2 Reduction to CO.	Carbon Monoxide	106-108	transglutaminase 1	Homo sapiens	27-30
34932356-3	2022	Herein, layered Li1.81H0.19Ti2O5 2H2O (LHTO) nanosheets were explored as the photocatalyst for photocatalytic CO2 reduction, and atomically thin LHTO nanosheets with one-unit-cell thickness were successfully constructed for photocatalytic CO2 reduction.	lhto	39-43	transglutaminase 1	Homo sapiens	16-19
34932356-3	2022	Herein, layered Li1.81H0.19Ti2O5 2H2O (LHTO) nanosheets were explored as the photocatalyst for photocatalytic CO2 reduction, and atomically thin LHTO nanosheets with one-unit-cell thickness were successfully constructed for photocatalytic CO2 reduction.	Carbon Dioxide	110-113	transglutaminase 1	Homo sapiens	16-19
34932356-3	2022	Herein, layered Li1.81H0.19Ti2O5 2H2O (LHTO) nanosheets were explored as the photocatalyst for photocatalytic CO2 reduction, and atomically thin LHTO nanosheets with one-unit-cell thickness were successfully constructed for photocatalytic CO2 reduction.	Carbon Dioxide	239-242	transglutaminase 1	Homo sapiens	16-19
34889915-0	2021	Preparation and characterization of the Li1.12K0.05Mn0.57Ni0.24Nb0.02O2 cathode material with highly improved rate cycling performance for lithium ion batteries.	Lithium	139-146	transglutaminase 1	Homo sapiens	40-43
34889915-1	2021	In this work, Li1.12K0.05Mn0.57Ni0.24Nb0.02O2 (LMN-K/Nb) as a novel and high energy density cathode material is successfully synthesized and applied in lithium ion batteries.	Lithium	152-159	transglutaminase 1	Homo sapiens	14-17
34583038-3	2022	Herein, a promising class of Ti-Mn based cathode materials Li1.25Mn0.25Nb0.25Ti0.25O2 and Li1.25Mn0.25Ti0.5O1.75F0.25 were designed and successfully synthesized to construct high energy density DRX and investigate the effect of fluorination on cation and anion redox activity.	Titanium	29-31	transglutaminase 1	Homo sapiens	59-62
34583038-3	2022	Herein, a promising class of Ti-Mn based cathode materials Li1.25Mn0.25Nb0.25Ti0.25O2 and Li1.25Mn0.25Ti0.5O1.75F0.25 were designed and successfully synthesized to construct high energy density DRX and investigate the effect of fluorination on cation and anion redox activity.	Titanium	29-31	transglutaminase 1	Homo sapiens	90-93
34583038-6	2022	Combining relevant spectroscopic results and HRTEM images, we revealed that the excellent cyclability of Li1.25Mn0.25Ti0.5O1.75F0.25 is rooted in the weakened adverse effects of moderated oxygen redox and the reduced Jahn-Teller distortion effect resulting from Mn3+, endowing the fluoridized DRX with better structural stability and larger Mn2+/Mn4+ reservoir.	Oxygen	188-194	transglutaminase 1	Homo sapiens	105-108
34583038-6	2022	Combining relevant spectroscopic results and HRTEM images, we revealed that the excellent cyclability of Li1.25Mn0.25Ti0.5O1.75F0.25 is rooted in the weakened adverse effects of moderated oxygen redox and the reduced Jahn-Teller distortion effect resulting from Mn3+, endowing the fluoridized DRX with better structural stability and larger Mn2+/Mn4+ reservoir.	manganese(III) acetate dihydrate	262-266	transglutaminase 1	Homo sapiens	105-108
34583038-6	2022	Combining relevant spectroscopic results and HRTEM images, we revealed that the excellent cyclability of Li1.25Mn0.25Ti0.5O1.75F0.25 is rooted in the weakened adverse effects of moderated oxygen redox and the reduced Jahn-Teller distortion effect resulting from Mn3+, endowing the fluoridized DRX with better structural stability and larger Mn2+/Mn4+ reservoir.	Manganese(2+)	341-345	transglutaminase 1	Homo sapiens	105-108
34583038-6	2022	Combining relevant spectroscopic results and HRTEM images, we revealed that the excellent cyclability of Li1.25Mn0.25Ti0.5O1.75F0.25 is rooted in the weakened adverse effects of moderated oxygen redox and the reduced Jahn-Teller distortion effect resulting from Mn3+, endowing the fluoridized DRX with better structural stability and larger Mn2+/Mn4+ reservoir.	mn4+	346-350	transglutaminase 1	Homo sapiens	105-108
34874715-3	2021	First, a virtual proline scan was performed based on folding free energy changes to obtain TGm1 variants with enhanced thermostability.	Proline	17-24	transglutaminase 1	Homo sapiens	91-95
34658075-2	2021	Herein, a unique electron and ion co-conductive catalyst of carbon-coated Li1.4 Al0.4 Ti1.6 (PO4 )3 (C@LATP) is developed, which not only possesses strong adsorption to LiPSs, but, more importantly, also promotes the instantaneous conversion reaction of LiPSs to Li2 S. The C@LATP nanoparticles as catalytic active sites can synchronously and efficiently provide both Li ions and electrons to facilitate the conversion reaction of LiPSs.	po4 )	93-98	transglutaminase 1	Homo sapiens	74-77
34832820-0	2021	Exploring the Effect of a MnO2 Coating on the Electrochemical Performance of a Li1.2Mn0.54Ni0.13Co0.13O2 Cathode Material.	manganese dioxide	26-30	transglutaminase 1	Homo sapiens	79-82
34832820-1	2021	The effect of electrochemically active MnO2 as a coating material on the electrochemical properties of a Li1.2Mn0.54Ni0.13Co0.13O2 (LTMO) cathode material is explored in this article.	manganese dioxide	39-43	transglutaminase 1	Homo sapiens	105-108
34498788-3	2021	The Li1.4Al0.4Ti1.6(PO4)3 nanowires (LNs) can tightly anchor the essential N, N-dimethylformamide (DMF) in poly(vinylidene fluoride) (PVDF), which greatly enhances its electrochemical stability and suppresses the side reactions.	Dimethylformamide	75-97	transglutaminase 1	Homo sapiens	4-7
34739208-0	2021	Quasi-Solid-State Lithium Metal Batteries Using the LiNi0.8Co0.1Mn0.1O2-Li1+xAlxTi2-x(PO4)3 Composite Positive Electrode.	lithium metal	18-31	transglutaminase 1	Homo sapiens	72-75
34739208-1	2021	NASICON-type Li1+xAlxTi2-x(PO4)3 (LATP) is a promising solid electrolyte (SE) candidate for next-generation solid-state batteries.	-x(po4)3	24-32	transglutaminase 1	Homo sapiens	13-16
34739208-1	2021	NASICON-type Li1+xAlxTi2-x(PO4)3 (LATP) is a promising solid electrolyte (SE) candidate for next-generation solid-state batteries.	latp	34-38	transglutaminase 1	Homo sapiens	13-16
34498788-3	2021	The Li1.4Al0.4Ti1.6(PO4)3 nanowires (LNs) can tightly anchor the essential N, N-dimethylformamide (DMF) in poly(vinylidene fluoride) (PVDF), which greatly enhances its electrochemical stability and suppresses the side reactions.	Dimethylformamide	99-102	transglutaminase 1	Homo sapiens	4-7
34498788-3	2021	The Li1.4Al0.4Ti1.6(PO4)3 nanowires (LNs) can tightly anchor the essential N, N-dimethylformamide (DMF) in poly(vinylidene fluoride) (PVDF), which greatly enhances its electrochemical stability and suppresses the side reactions.	polyvinylidene fluoride	107-132	transglutaminase 1	Homo sapiens	4-7
34498788-3	2021	The Li1.4Al0.4Ti1.6(PO4)3 nanowires (LNs) can tightly anchor the essential N, N-dimethylformamide (DMF) in poly(vinylidene fluoride) (PVDF), which greatly enhances its electrochemical stability and suppresses the side reactions.	polyvinylidene fluoride	134-138	transglutaminase 1	Homo sapiens	4-7
34927937-0	2021	Resolving the Structural Defects of Spent Li1- x CoO2 Particles to Directly Reconstruct High Voltage Performance Cathode for Lithium-Ion Batteries.	coo2	49-53	transglutaminase 1	Homo sapiens	42-45
34651436-0	2021	Structural and Chemical Compatibilities of Li1- x Ni0.5 Co0.2 Mn0.3 O2 Cathode Material with Garnet-Type Solid Electrolyte for All-Solid-State Batteries.	Oxygen	68-70	transglutaminase 1	Homo sapiens	43-46
34606719-0	2021	Reaction of Li1.3Al0.3Ti1.7(PO4)3 and LiNi0.6Co0.2Mn0.2O2 in Co-Sintered Composite Cathodes for Solid-State Batteries.	po4	28-31	transglutaminase 1	Homo sapiens	12-15
34927937-0	2021	Resolving the Structural Defects of Spent Li1- x CoO2 Particles to Directly Reconstruct High Voltage Performance Cathode for Lithium-Ion Batteries.	Lithium	125-132	transglutaminase 1	Homo sapiens	42-45
34927937-2	2021	Herein, a practical solution is presented to recover and increase the stability of the layered structure from scrap Li1- x CoO2 via high-temperature supplementation of Li and Mg doping, without an extra synthesis step or cost.	coo2	123-127	transglutaminase 1	Homo sapiens	116-119
34927937-2	2021	Herein, a practical solution is presented to recover and increase the stability of the layered structure from scrap Li1- x CoO2 via high-temperature supplementation of Li and Mg doping, without an extra synthesis step or cost.	Magnesium	175-177	transglutaminase 1	Homo sapiens	116-119
34563021-4	2021	HUS pretreatment and TGase-mediated cross-linking significantly increased the water-holding capacity but decreased the swelling ratios of the gels (p < 0.05).	Water	78-83	transglutaminase 1	Homo sapiens	21-26
34328321-4	2021	The structural comparison between the two crystals and Na3La2(BO3)3 indicates that the various coordination environments of alkali metal cations play an important role in the evolution of the crystal structure from Li3La2(BO3)3 and Li1.75Na1.25La2(BO3)3 to Na3La2(BO3)3.	na3la2	55-61	transglutaminase 1	Homo sapiens	232-235
34500840-10	2021	Pg-EE can enhance the expression of filaggrin (FLG), transglutaminase (TGM)-1, hyaluronic acid synthase (HAS)-1, and HAS-2 in human keratinocytes.	pg-ee	0-5	transglutaminase 1	Homo sapiens	53-77
34445570-9	2021	Moreover, kahweol increased the outcome of HAS1, HAS2, occludin, and TGM-1 from six hours in a dose-dependent manner as well as the activation of STAT1 from six hours.	kahweol	10-17	transglutaminase 1	Homo sapiens	69-74
34328321-4	2021	The structural comparison between the two crystals and Na3La2(BO3)3 indicates that the various coordination environments of alkali metal cations play an important role in the evolution of the crystal structure from Li3La2(BO3)3 and Li1.75Na1.25La2(BO3)3 to Na3La2(BO3)3.	Metals	131-136	transglutaminase 1	Homo sapiens	232-235
34328321-4	2021	The structural comparison between the two crystals and Na3La2(BO3)3 indicates that the various coordination environments of alkali metal cations play an important role in the evolution of the crystal structure from Li3La2(BO3)3 and Li1.75Na1.25La2(BO3)3 to Na3La2(BO3)3.	na3la2	257-263	transglutaminase 1	Homo sapiens	232-235
34129333-5	2021	Au@TAcoGal can retain its stability in blood circulation (pH 7.4) even in the presence of TGase in plasma.	Gold	0-2	transglutaminase 1	Homo sapiens	90-95
34232235-3	2021	Here, we explore the controlled solid-state synthesis of Li-N-H solid-solution anti-fluorite structures ranging from amide-dominated (Li4/3(NH2)2/3(NH)1/3 or Li1.333NH1.667) through lithium imide to majority incorporation of lithium nitride-hydride (Li3.167(NH)0.416N0.584H0.584 or Li3.167NH).	li-n-h	57-63	transglutaminase 1	Homo sapiens	158-161
34064226-1	2021	"Spinel-layered" Li1+xNi0.5Mn1.5O4 (x = 0, 0.5, 1) materials are considered as a cobalt-free alternative to currently used positive electrode (cathode) materials for Li-ion batteries.	Cobalt	81-87	transglutaminase 1	Homo sapiens	17-20
34152120-7	2021	Specifically, the CoAl-LDH coating layer reacts with LiOH during the lithiation-calcination process to form a Li1-x(Co0.75Al0.25)1+xO2 mesophase as the buffer layer, which increases the formation temperature of the layered structure and reduces Li+/Ni2+ cation mixing, making a well-ordered crystal structure.	lithium hydroxide	53-57	transglutaminase 1	Homo sapiens	110-113
34152120-7	2021	Specifically, the CoAl-LDH coating layer reacts with LiOH during the lithiation-calcination process to form a Li1-x(Co0.75Al0.25)1+xO2 mesophase as the buffer layer, which increases the formation temperature of the layered structure and reduces Li+/Ni2+ cation mixing, making a well-ordered crystal structure.	xo2 mesophase	131-144	transglutaminase 1	Homo sapiens	110-113
34152120-7	2021	Specifically, the CoAl-LDH coating layer reacts with LiOH during the lithiation-calcination process to form a Li1-x(Co0.75Al0.25)1+xO2 mesophase as the buffer layer, which increases the formation temperature of the layered structure and reduces Li+/Ni2+ cation mixing, making a well-ordered crystal structure.	Nickel(2+)	249-253	transglutaminase 1	Homo sapiens	110-113
34086448-1	2021	The discovery of the (Li1-xFexOH)FeSe superconductor has aroused significant interest in metal hydroxide-intercalated iron chalcogenides.	iron chalcogenides	118-136	transglutaminase 1	Homo sapiens	22-25
34086448-10	2021	Theoretical calculations suggest that inducing superconductivity in (Na1-xOH)Fe1-ySe is promising due to the similarity of the electronic structures between stoichiometric (NaOH)FeSe and the (Li1-xFexOH)FeSe superconductor.	xoh	73-76	transglutaminase 1	Homo sapiens	192-195
35636191-3	2022	After WG was incubated with TGase, phosphorylation pretreatment significantly increased apparent viscosity of WG dispersant solution, suggesting that phosphorylation treatment promoted the generation of cross-linked polymers.	tryptophylglycine	110-112	transglutaminase 1	Homo sapiens	28-33
35636191-4	2022	In addition, phosphorylation pretreatment enhanced hydrophobic interactions and disulfide bond formation between TGase-induced WG gels, thus leading to a more homogeneous and dense three-dimensional network structure of gel, which was confirmed by SEM micrographs.	Disulfides	80-89	transglutaminase 1	Homo sapiens	113-118
35093648-0	2022	Conjugation of the glutelin hydrolysates-glucosamine by transglutaminase and functional properties and antioxidant activity of the products.	glutelin hydrolysates	19-40	transglutaminase 1	Homo sapiens	56-72
35093648-0	2022	Conjugation of the glutelin hydrolysates-glucosamine by transglutaminase and functional properties and antioxidant activity of the products.	Glucosamine	41-52	transglutaminase 1	Homo sapiens	56-72
35093648-3	2022	Corn glutelin was limited hydrolyzed by Alcalase, and then its hydrolysates were glycosylated with GlcN by transglutaminase (TGase) to modify its main and side chain, respectively.	Glucosamine	99-103	transglutaminase 1	Homo sapiens	107-123
35093648-3	2022	Corn glutelin was limited hydrolyzed by Alcalase, and then its hydrolysates were glycosylated with GlcN by transglutaminase (TGase) to modify its main and side chain, respectively.	Glucosamine	99-103	transglutaminase 1	Homo sapiens	125-130
35093648-5	2022	According to electrospray ionization mass spectrometry (ESI-MS) analysis, there are two types of glycopeptides in the mixture, TGase and non-enzymatic glycated counterparts.	Glycopeptides	97-110	transglutaminase 1	Homo sapiens	127-132
35042110-0	2022	Tetrasodium pyrophosphate ameliorates oxidative damage to the TGase-catalyzed gelation of actomyosins.	sodium pyrophosphate	0-25	transglutaminase 1	Homo sapiens	62-67
35042110-1	2022	The present study attempted to investigate the interactive roles of protein oxidation (0-20 mM H2O2) and tetrasodium pyrophosphate (TSPP) on the crosslinking efficiency of actomyosin mediated by transglutaminase (TGase).	Hydrogen Peroxide	95-99	transglutaminase 1	Homo sapiens	195-211
35042110-1	2022	The present study attempted to investigate the interactive roles of protein oxidation (0-20 mM H2O2) and tetrasodium pyrophosphate (TSPP) on the crosslinking efficiency of actomyosin mediated by transglutaminase (TGase).	sodium pyrophosphate	105-130	transglutaminase 1	Homo sapiens	213-218
35042110-1	2022	The present study attempted to investigate the interactive roles of protein oxidation (0-20 mM H2O2) and tetrasodium pyrophosphate (TSPP) on the crosslinking efficiency of actomyosin mediated by transglutaminase (TGase).	sodium pyrophosphate	132-136	transglutaminase 1	Homo sapiens	195-211
35042110-1	2022	The present study attempted to investigate the interactive roles of protein oxidation (0-20 mM H2O2) and tetrasodium pyrophosphate (TSPP) on the crosslinking efficiency of actomyosin mediated by transglutaminase (TGase).	Hydrogen Peroxide	95-99	transglutaminase 1	Homo sapiens	213-218
35042110-1	2022	The present study attempted to investigate the interactive roles of protein oxidation (0-20 mM H2O2) and tetrasodium pyrophosphate (TSPP) on the crosslinking efficiency of actomyosin mediated by transglutaminase (TGase).	sodium pyrophosphate	132-136	transglutaminase 1	Homo sapiens	213-218
35042110-3	2022	However, the binding of TSPP to myosin alleviated oxidation suppression to TGase-catalyzed crosslinking in varying degrees and retarded the migration of crosslinking site from S1 to S2.	sodium pyrophosphate	24-28	transglutaminase 1	Homo sapiens	75-80
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	Hydrogen Peroxide	38-42	transglutaminase 1	Homo sapiens	124-129
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	Hydrogen Peroxide	38-42	transglutaminase 1	Homo sapiens	301-306
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	Water	98-103	transglutaminase 1	Homo sapiens	124-129
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	sodium pyrophosphate	160-164	transglutaminase 1	Homo sapiens	186-191
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	sodium pyrophosphate	160-164	transglutaminase 1	Homo sapiens	301-306
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	sodium pyrophosphate	234-238	transglutaminase 1	Homo sapiens	124-129
35042110-4	2022	Moreover, oxidation (especially 20 mM H2O2) decreased the final (90  C) elasticity index (EI) and water holding capacity of TGase-treated actomyosin gel, while TSPP intensified those of TGase-catalyzed actomyosin gel, indicating that TSPP had a positive effect on ameliorating the oxidative stress to TGase-catalyzed gelation of actomyosin.	sodium pyrophosphate	234-238	transglutaminase 1	Homo sapiens	186-191
35042110-1	2022	The present study attempted to investigate the interactive roles of protein oxidation (0-20 mM H2O2) and tetrasodium pyrophosphate (TSPP) on the crosslinking efficiency of actomyosin mediated by transglutaminase (TGase).	sodium pyrophosphate	105-130	transglutaminase 1	Homo sapiens	195-211
35188772-3	2022	Apomyoglobin was chosen as a model protein and derivatized via site-specific enzymatic reaction catalyzed by transglutaminase (TGase) with the H-Cys-Gly-Lys-Gly-OH tetrapeptide for the insertion in the protein sequence of a reactive N-terminal Cys for 99mTc chelation.	h-cys-gly-lys-gly-oh tetrapeptide	143-176	transglutaminase 1	Homo sapiens	109-125
35631808-8	2022	Lm-ME upregulated the expression of hyaluronan synthases-2/3 (HAS-2/3) and transglutaminase-1 (TGM-1), as well as secreted levels of hyaluronic acid (HA) via p38 and JNK activation.	lm-me	0-5	transglutaminase 1	Homo sapiens	75-93
35631808-8	2022	Lm-ME upregulated the expression of hyaluronan synthases-2/3 (HAS-2/3) and transglutaminase-1 (TGM-1), as well as secreted levels of hyaluronic acid (HA) via p38 and JNK activation.	lm-me	0-5	transglutaminase 1	Homo sapiens	95-100
35294795-0	2022	Stabilizing the Li1.3Al0.3Ti1.7(PO4)3 Li Interface for High Efficiency and Long Lifespan Quasi-Solid-State Lithium Metal Batteries.	po4	32-35	transglutaminase 1	Homo sapiens	16-19
35294795-0	2022	Stabilizing the Li1.3Al0.3Ti1.7(PO4)3 Li Interface for High Efficiency and Long Lifespan Quasi-Solid-State Lithium Metal Batteries.	Lithium	107-114	transglutaminase 1	Homo sapiens	16-19
35294795-1	2022	To tackle the poor chemical/electrochemical stability of Li1+xAlxTi2-x(PO4)3 (LATP) against Li and poor electrode electrolyte interfacial contact, we apply a thin poly(2,3-bis(2,2,6,6-tetramethylpiperidine-N-oxycarbonyl)-norbornene) (PTNB) protection layer and meanwhile include small amount of ionic liquid electrolyte (ILE).	latp	78-82	transglutaminase 1	Homo sapiens	57-60
35294795-1	2022	To tackle the poor chemical/electrochemical stability of Li1+xAlxTi2-x(PO4)3 (LATP) against Li and poor electrode electrolyte interfacial contact, we apply a thin poly(2,3-bis(2,2,6,6-tetramethylpiperidine-N-oxycarbonyl)-norbornene) (PTNB) protection layer and meanwhile include small amount of ionic liquid electrolyte (ILE).	poly(2,3-bis(2,2,6,6-tetramethylpiperidine-n-oxycarbonyl)-norbornene)	163-232	transglutaminase 1	Homo sapiens	57-60
35294795-1	2022	To tackle the poor chemical/electrochemical stability of Li1+xAlxTi2-x(PO4)3 (LATP) against Li and poor electrode electrolyte interfacial contact, we apply a thin poly(2,3-bis(2,2,6,6-tetramethylpiperidine-N-oxycarbonyl)-norbornene) (PTNB) protection layer and meanwhile include small amount of ionic liquid electrolyte (ILE).	ptnb	234-238	transglutaminase 1	Homo sapiens	57-60
35297444-0	2022	Influence of TiIV substitution on the properties of a Li1.5Al0.5Ge1.5(PO4)3 nanofiber-based solid electrolyte.	po4	70-73	transglutaminase 1	Homo sapiens	54-57
35040212-6	2022	Subsequently, Li-excess Li1+t Co1-t O2-t with intermediate spin Co3+ is developed to mitigate H+ influence and the adverse phase transition in aqueous electrolyte.	cobalt adenosine diphosphate complex	64-68	transglutaminase 1	Homo sapiens	24-27
35407276-4	2022	This study reports the optimization of the synthesis of sodium superionic conductor-type Li1.5Al0.3Si0.2Ti1.7P2.8O12 (LASTP) solid electrolyte.	Sodium	56-62	transglutaminase 1	Homo sapiens	89-92
35392400-0	2022	Transglutaminase-Catalyzed Bottom-Up Synthesis of Polymer Hydrogel.	Polymers	50-57	transglutaminase 1	Homo sapiens	0-16
35392400-4	2022	In this mini-review, TGase-catalyzed synthesis of polymer hydrogels, including fibrin hydrogels, polyethylene glycol hydrogels, soy protein hydrogels, collagen hydrogels, gelatin hydrogels and hyaluronan hydrogels, has been reviewed in detail.	Polymers	50-57	transglutaminase 1	Homo sapiens	21-26
35392400-4	2022	In this mini-review, TGase-catalyzed synthesis of polymer hydrogels, including fibrin hydrogels, polyethylene glycol hydrogels, soy protein hydrogels, collagen hydrogels, gelatin hydrogels and hyaluronan hydrogels, has been reviewed in detail.	Polyethylene Glycols	97-116	transglutaminase 1	Homo sapiens	21-26
35392400-6	2022	Furthermore, future perspectives and challenges in the preparation of polymer hydrogels by TGase are also highlighted.	Polymers	70-77	transglutaminase 1	Homo sapiens	91-96
35188772-3	2022	Apomyoglobin was chosen as a model protein and derivatized via site-specific enzymatic reaction catalyzed by transglutaminase (TGase) with the H-Cys-Gly-Lys-Gly-OH tetrapeptide for the insertion in the protein sequence of a reactive N-terminal Cys for 99mTc chelation.	h-cys-gly-lys-gly-oh tetrapeptide	143-176	transglutaminase 1	Homo sapiens	127-132
35188772-3	2022	Apomyoglobin was chosen as a model protein and derivatized via site-specific enzymatic reaction catalyzed by transglutaminase (TGase) with the H-Cys-Gly-Lys-Gly-OH tetrapeptide for the insertion in the protein sequence of a reactive N-terminal Cys for 99mTc chelation.	n-terminal cys	233-247	transglutaminase 1	Homo sapiens	109-125
35188772-3	2022	Apomyoglobin was chosen as a model protein and derivatized via site-specific enzymatic reaction catalyzed by transglutaminase (TGase) with the H-Cys-Gly-Lys-Gly-OH tetrapeptide for the insertion in the protein sequence of a reactive N-terminal Cys for 99mTc chelation.	n-terminal cys	233-247	transglutaminase 1	Homo sapiens	127-132
35156804-7	2022	Finally, in the range of 0.75 <= x <= 1.0, for Li1-xRu0.5O1.5, the formation of an O(2p)-O(2p)* antibonding state derived from the structural distortion of the RuO6 octahedron leads to the irreversibility of the OR reaction and enhanced voltage hysteresis.	ruo6 octahedron	160-175	transglutaminase 1	Homo sapiens	47-50
35425223-2	2022	Herein, the co-doping of trace non-metal ion (S) and metal ion (Al) into Li1.6Mn1.6O4 (LMO-SAl) is established and shows excellent Li+ adsorption capacity and Mn anti-dissolution properties.	Metals	35-40	transglutaminase 1	Homo sapiens	73-76
34978175-0	2022	Solid Polymer Electrolyte Reinforced with a Li1.3Al0.3Ti1.7(PO4)3-Coated Separator for All-Solid-State Lithium Batteries.	Polymers	6-13	transglutaminase 1	Homo sapiens	44-47
34978175-0	2022	Solid Polymer Electrolyte Reinforced with a Li1.3Al0.3Ti1.7(PO4)3-Coated Separator for All-Solid-State Lithium Batteries.	Lithium	103-110	transglutaminase 1	Homo sapiens	44-47
34978175-4	2022	The porous Li1.3Al0.3Ti1.7(PO4)3 (LATP)-coated polyethylene (PE) separator is filled with PEO/lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) solution, which possesses both a robust mechanical property and processable flexibility.	po4)3 (latp)-coated	27-46	transglutaminase 1	Homo sapiens	11-14
34978175-4	2022	The porous Li1.3Al0.3Ti1.7(PO4)3 (LATP)-coated polyethylene (PE) separator is filled with PEO/lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) solution, which possesses both a robust mechanical property and processable flexibility.	Polyethylene	47-59	transglutaminase 1	Homo sapiens	11-14
34978175-4	2022	The porous Li1.3Al0.3Ti1.7(PO4)3 (LATP)-coated polyethylene (PE) separator is filled with PEO/lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) solution, which possesses both a robust mechanical property and processable flexibility.	Polyethylene	61-63	transglutaminase 1	Homo sapiens	11-14
34978175-4	2022	The porous Li1.3Al0.3Ti1.7(PO4)3 (LATP)-coated polyethylene (PE) separator is filled with PEO/lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) solution, which possesses both a robust mechanical property and processable flexibility.	Polyethylene Glycols	90-93	transglutaminase 1	Homo sapiens	11-14
35113112-2	2022	We combined ReaxFF and experiments to investigate the dissolution at the Li1+xAlxTi2-x(PO4)3-water interface.	Water	93-98	transglutaminase 1	Homo sapiens	73-76
35425223-2	2022	Herein, the co-doping of trace non-metal ion (S) and metal ion (Al) into Li1.6Mn1.6O4 (LMO-SAl) is established and shows excellent Li+ adsorption capacity and Mn anti-dissolution properties.	Metals	53-58	transglutaminase 1	Homo sapiens	73-76
35425223-2	2022	Herein, the co-doping of trace non-metal ion (S) and metal ion (Al) into Li1.6Mn1.6O4 (LMO-SAl) is established and shows excellent Li+ adsorption capacity and Mn anti-dissolution properties.	Aluminum	64-66	transglutaminase 1	Homo sapiens	73-76
2571332-3	1989	Classical amine substrates for TGase, such as dansylcadaverine and putrescine, were also incorporated stoichiometrically into lipocortin I. Cross-linking or amine incorporation was not observed with lipocortin II.	Amines	10-15	transglutaminase 1	Homo sapiens	31-36
2571332-3	1989	Classical amine substrates for TGase, such as dansylcadaverine and putrescine, were also incorporated stoichiometrically into lipocortin I. Cross-linking or amine incorporation was not observed with lipocortin II.	monodansylcadaverine	46-62	transglutaminase 1	Homo sapiens	31-36
2571332-5	1989	The cross-linking of lipocortin I by TGase resulted in a remarkable enhancement of calcium sensitivity for phospholipid binding; i.e., the free calcium concentration required for the cross-linked lipocortin I to attain 50% maximal binding to phosphatidylserine vesicles was as little as 3 microM, while that required for intact monomeric lipocortin I was 20 microM.	Calcium	83-90	transglutaminase 1	Homo sapiens	37-42
2571332-5	1989	The cross-linking of lipocortin I by TGase resulted in a remarkable enhancement of calcium sensitivity for phospholipid binding; i.e., the free calcium concentration required for the cross-linked lipocortin I to attain 50% maximal binding to phosphatidylserine vesicles was as little as 3 microM, while that required for intact monomeric lipocortin I was 20 microM.	Phospholipids	107-119	transglutaminase 1	Homo sapiens	37-42
2571332-3	1989	Classical amine substrates for TGase, such as dansylcadaverine and putrescine, were also incorporated stoichiometrically into lipocortin I. Cross-linking or amine incorporation was not observed with lipocortin II.	Putrescine	67-77	transglutaminase 1	Homo sapiens	31-36
2571332-5	1989	The cross-linking of lipocortin I by TGase resulted in a remarkable enhancement of calcium sensitivity for phospholipid binding; i.e., the free calcium concentration required for the cross-linked lipocortin I to attain 50% maximal binding to phosphatidylserine vesicles was as little as 3 microM, while that required for intact monomeric lipocortin I was 20 microM.	Calcium	144-151	transglutaminase 1	Homo sapiens	37-42
2890619-2	1987	Following cell membrane perturbation by Triton X-100 treatment, TGase was bound to the extracellular matrix and was found to coexist with fibronectin as visualized by immunofluorescence microscopy.	Octoxynol	40-52	transglutaminase 1	Homo sapiens	64-69
2565284-1	1989	The effects of transglutaminase (TGase) substrates putrescine, dansylcadaverine, spermine, etc., and the TGase inhibitor cystamine were tested on the motility of demembranated mammalian spermatozoa.	Cystamine	121-130	transglutaminase 1	Homo sapiens	105-110
2565284-3	1989	These minimal inhibitory concentrations could be decreased 5-150-fold when TGase substrates and inhibitor were incubated with demembranated spermatozoa for 15 min prior to the addition of Mg.ATP.	Adenosine Triphosphate	191-194	transglutaminase 1	Homo sapiens	75-80
2565284-5	1989	TGase activities, as measured by the incorporation of 3H-putrescine into TCA-precipitable proteins, were present in both sperm Triton-soluble and -insoluble fractions.	3h-putrescine	54-67	transglutaminase 1	Homo sapiens	0-5
2565284-5	1989	TGase activities, as measured by the incorporation of 3H-putrescine into TCA-precipitable proteins, were present in both sperm Triton-soluble and -insoluble fractions.	Trichloroacetic Acid	73-76	transglutaminase 1	Homo sapiens	0-5
2565284-6	1989	On the other hand, amine acceptor protein substrates for the TGase-catalyzed reaction were present only in the insoluble fraction.	Amines	19-24	transglutaminase 1	Homo sapiens	61-66
2883247-5	1987	The retinoid-induced expression of tissue TGase was the result of increased accumulation of the enzyme peptide and not activation of preexisting enzyme.	Retinoids	4-12	transglutaminase 1	Homo sapiens	42-47
2903078-0	1988	Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells.	Cyclic AMP	19-29	transglutaminase 1	Homo sapiens	82-98
2903078-0	1988	Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells.	Tretinoin	45-58	transglutaminase 1	Homo sapiens	82-98
2903078-1	1988	When the human myeloid leukemia cell line (HL60) is induced to differentiate with retinoic acid (RA), there is a concentration-dependent increase in transglutaminase (TGase) activity which peaks on day 5.	Tretinoin	82-95	transglutaminase 1	Homo sapiens	149-165
2903078-1	1988	When the human myeloid leukemia cell line (HL60) is induced to differentiate with retinoic acid (RA), there is a concentration-dependent increase in transglutaminase (TGase) activity which peaks on day 5.	Tretinoin	82-95	transglutaminase 1	Homo sapiens	167-172
2903078-1	1988	When the human myeloid leukemia cell line (HL60) is induced to differentiate with retinoic acid (RA), there is a concentration-dependent increase in transglutaminase (TGase) activity which peaks on day 5.	Tretinoin	97-99	transglutaminase 1	Homo sapiens	149-165
2903078-1	1988	When the human myeloid leukemia cell line (HL60) is induced to differentiate with retinoic acid (RA), there is a concentration-dependent increase in transglutaminase (TGase) activity which peaks on day 5.	Tretinoin	97-99	transglutaminase 1	Homo sapiens	167-172
2903078-2	1988	While dibutyryl 3",5"-cyclic adenosine monophosphate (db-cAMP) alone produced only a slight increase in TGase activity in HL60 cells, the concomitant addition of db-cAMP (100 microM) with RA (10(-12)-10(-4) M) potentiates RA induction of TGase activity.	Bucladesine	54-61	transglutaminase 1	Homo sapiens	104-109
2903078-2	1988	While dibutyryl 3",5"-cyclic adenosine monophosphate (db-cAMP) alone produced only a slight increase in TGase activity in HL60 cells, the concomitant addition of db-cAMP (100 microM) with RA (10(-12)-10(-4) M) potentiates RA induction of TGase activity.	Bucladesine	162-169	transglutaminase 1	Homo sapiens	238-243
2903078-3	1988	Maximal increases in TGase activity (2- to 10-fold) were observed with 10(-4)-10(-7) M RA and when db-cAMP was present from 24 to 48 h after the addition of RA.	Tretinoin	87-89	transglutaminase 1	Homo sapiens	21-26
2903078-3	1988	Maximal increases in TGase activity (2- to 10-fold) were observed with 10(-4)-10(-7) M RA and when db-cAMP was present from 24 to 48 h after the addition of RA.	Bucladesine	99-106	transglutaminase 1	Homo sapiens	21-26
2903078-3	1988	Maximal increases in TGase activity (2- to 10-fold) were observed with 10(-4)-10(-7) M RA and when db-cAMP was present from 24 to 48 h after the addition of RA.	Tretinoin	157-159	transglutaminase 1	Homo sapiens	21-26
2903078-6	1988	Although the simultaneous addition of PGE1 or PGE2 (10(-8)-10(-6) M) produced no enhancement of RA-induced TGase activity, adding PGE1 or PGE2 24 or 48 h following RA treatments produced an enhancement of TGase activity.	Alprostadil	130-134	transglutaminase 1	Homo sapiens	205-210
2903078-6	1988	Although the simultaneous addition of PGE1 or PGE2 (10(-8)-10(-6) M) produced no enhancement of RA-induced TGase activity, adding PGE1 or PGE2 24 or 48 h following RA treatments produced an enhancement of TGase activity.	Dinoprostone	138-142	transglutaminase 1	Homo sapiens	205-210
2903078-9	1988	cAMP potentiates RA-induced TGase activity in HL60 cells and the combination appears to be associated with enhanced RA-induced differentiation.	Cyclic AMP	0-4	transglutaminase 1	Homo sapiens	28-33
2903078-9	1988	cAMP potentiates RA-induced TGase activity in HL60 cells and the combination appears to be associated with enhanced RA-induced differentiation.	Tretinoin	17-19	transglutaminase 1	Homo sapiens	28-33
2890619-4	1987	Exogenous sources of soluble TGase were transferred to the extracellular matrix of an untreated or methanol fixed cell.	Methanol	99-107	transglutaminase 1	Homo sapiens	29-34
6141568-0	1984	Dexamethasone inhibition of DMSO-induced transglutaminase activity and differentiation of leukemic cells.	Dexamethasone	0-13	transglutaminase 1	Homo sapiens	41-57
2879848-6	1987	Cycloheximide completely inhibited the increase in the quantity of TGase antigen in the insoluble fraction, 8 h post-stimulation, while actinomycin D caused a partial inhibition.	Cycloheximide	0-13	transglutaminase 1	Homo sapiens	67-72
2880343-2	1986	The purified TGase was catalytically active and exhibited a single band of apparent Mr = 85,000 on SDS-PAGE and Western blotting.	Sodium Dodecyl Sulfate	99-102	transglutaminase 1	Homo sapiens	13-18
2413053-1	1985	The activity of transglutaminase (TGase) was measured in cultured C6 glioma cells after their stimulation by either isoproterenol and isobutyl-methylxanthine or by a serum-containing medium.	Isoproterenol	116-129	transglutaminase 1	Homo sapiens	16-32
2413053-1	1985	The activity of transglutaminase (TGase) was measured in cultured C6 glioma cells after their stimulation by either isoproterenol and isobutyl-methylxanthine or by a serum-containing medium.	Isoproterenol	116-129	transglutaminase 1	Homo sapiens	34-39
2413053-1	1985	The activity of transglutaminase (TGase) was measured in cultured C6 glioma cells after their stimulation by either isoproterenol and isobutyl-methylxanthine or by a serum-containing medium.	1-Methyl-3-isobutylxanthine	134-157	transglutaminase 1	Homo sapiens	16-32
2413053-1	1985	The activity of transglutaminase (TGase) was measured in cultured C6 glioma cells after their stimulation by either isoproterenol and isobutyl-methylxanthine or by a serum-containing medium.	1-Methyl-3-isobutylxanthine	134-157	transglutaminase 1	Homo sapiens	34-39
2413053-3	1985	The first peak of TGase activity was affected neither by cycloheximide nor by actinomycin D, which inhibited protein synthesis.	Cycloheximide	57-70	transglutaminase 1	Homo sapiens	18-23
2874845-1	1986	Transglutaminase (TGase) substrates monodansyl cadaverine (MDC, monodansyl-1,5 diaminopentane) and methylamine (MA) and polyamines (PA) were tested for their effects on the cellular processing of radioiodinated human follicle-stimulating hormone (125I-hFSH).	monodansylcadaverine	36-57	transglutaminase 1	Homo sapiens	0-16
2874845-1	1986	Transglutaminase (TGase) substrates monodansyl cadaverine (MDC, monodansyl-1,5 diaminopentane) and methylamine (MA) and polyamines (PA) were tested for their effects on the cellular processing of radioiodinated human follicle-stimulating hormone (125I-hFSH).	monodansylcadaverine	59-62	transglutaminase 1	Homo sapiens	0-16
2874845-1	1986	Transglutaminase (TGase) substrates monodansyl cadaverine (MDC, monodansyl-1,5 diaminopentane) and methylamine (MA) and polyamines (PA) were tested for their effects on the cellular processing of radioiodinated human follicle-stimulating hormone (125I-hFSH).	monodansylcadaverine	59-62	transglutaminase 1	Homo sapiens	18-23
2874845-1	1986	Transglutaminase (TGase) substrates monodansyl cadaverine (MDC, monodansyl-1,5 diaminopentane) and methylamine (MA) and polyamines (PA) were tested for their effects on the cellular processing of radioiodinated human follicle-stimulating hormone (125I-hFSH).	monodansyl-1,5 diaminopentane	64-93	transglutaminase 1	Homo sapiens	0-16
2874845-1	1986	Transglutaminase (TGase) substrates monodansyl cadaverine (MDC, monodansyl-1,5 diaminopentane) and methylamine (MA) and polyamines (PA) were tested for their effects on the cellular processing of radioiodinated human follicle-stimulating hormone (125I-hFSH).	monodansyl-1,5 diaminopentane	64-93	transglutaminase 1	Homo sapiens	18-23
2874845-11	1986	TGase substrates (MDC, MA, PA) prevented entry of sequestered 125I-hFSH into the degradative pathways of Sertoli cells.	125i-hfsh	62-71	transglutaminase 1	Homo sapiens	0-5
9937012-0	1985	Decay process of Li 1s core exciton in lithium halides studied by photoelectron spectroscopy.	lithium halides	39-54	transglutaminase 1	Homo sapiens	17-21
2861155-4	1985	The levels of TGase in the virus-transformed cells increased significantly when the cells were grown in the presence of sodium butyrate to induce enzyme activity.	Butyric Acid	120-135	transglutaminase 1	Homo sapiens	14-19
2857744-1	1985	The culture of HPBM in serum-containing medium induced a large accumulation of the protein cross-linking enzyme, tissue TGase.	hpbm	15-19	transglutaminase 1	Homo sapiens	120-125
2857744-5	1985	Thus, serum retinoids seem to play an important regulatory role in the expression of tissue TGase gene in differentiating human monocytes.	Retinoids	12-21	transglutaminase 1	Homo sapiens	92-97
2864293-0	1985	Transglutaminase activity increases in HL60 cells induced to differentiate with retinoic acid and TPA but not with DMSO.	Tretinoin	80-93	transglutaminase 1	Homo sapiens	0-16
2864293-0	1985	Transglutaminase activity increases in HL60 cells induced to differentiate with retinoic acid and TPA but not with DMSO.	Tetradecanoylphorbol Acetate	98-101	transglutaminase 1	Homo sapiens	0-16
2864293-1	1985	HL60 cells induced to differentiate into myeloid cells by retinoic acid exhibited a 300-fold increase in transglutaminase (TGase) activity which peaked on day 5.	Tretinoin	58-71	transglutaminase 1	Homo sapiens	105-121
2864293-1	1985	HL60 cells induced to differentiate into myeloid cells by retinoic acid exhibited a 300-fold increase in transglutaminase (TGase) activity which peaked on day 5.	Tretinoin	58-71	transglutaminase 1	Homo sapiens	123-128
2864293-2	1985	HL60 cells induced to differentiate into monocytes by a phorbol ester tetradecanoylphorbol-12-myristate-13-acetate (TPA) had a greater than 840-fold increase in TGase activity on day 7.	phorbol ester tetradecanoylphorbol-12-myristate-13-acetate	56-114	transglutaminase 1	Homo sapiens	161-166
2864293-2	1985	HL60 cells induced to differentiate into monocytes by a phorbol ester tetradecanoylphorbol-12-myristate-13-acetate (TPA) had a greater than 840-fold increase in TGase activity on day 7.	Tetradecanoylphorbol Acetate	116-119	transglutaminase 1	Homo sapiens	161-166
2864293-4	1985	Elevation of TGase activity appears to be characteristic of monocyte differentiation and retinoic acid-induced myeloid differentiation but not of myeloid differentiation in response to DMSO.	Tretinoin	89-102	transglutaminase 1	Homo sapiens	13-18
2868061-1	1985	Isoniazid (INH) and hydralazine (HYD) are transglutaminase (TGase, E.C.2.3.2.13.)	Isoniazid	0-9	transglutaminase 1	Homo sapiens	42-58
2868061-1	1985	Isoniazid (INH) and hydralazine (HYD) are transglutaminase (TGase, E.C.2.3.2.13.)	Isoniazid	0-9	transglutaminase 1	Homo sapiens	60-65
2868061-1	1985	Isoniazid (INH) and hydralazine (HYD) are transglutaminase (TGase, E.C.2.3.2.13.)	Hydralazine	20-31	transglutaminase 1	Homo sapiens	42-58
2868061-1	1985	Isoniazid (INH) and hydralazine (HYD) are transglutaminase (TGase, E.C.2.3.2.13.)	Hydralazine	20-31	transglutaminase 1	Homo sapiens	60-65
2868061-3	1985	Since they can be expected to inhibit TGase-mediated cell functions by competing with physiological substrates, their effect upon allogeneically and lectin-induced proliferation of mononucleocytes and upon zymosan-induced chemiluminescence of phagocytes was studied.	Zymosan	206-213	transglutaminase 1	Homo sapiens	38-43
6141568-0	1984	Dexamethasone inhibition of DMSO-induced transglutaminase activity and differentiation of leukemic cells.	Dimethyl Sulfoxide	28-32	transglutaminase 1	Homo sapiens	41-57
6141568-4	1984	Similarly, these steroids inhibited DMSO-increased TGase activity but not n-butyric acid-increased TGase activity in intact FL cells.	Steroids	17-25	transglutaminase 1	Homo sapiens	51-56
6141568-4	1984	Similarly, these steroids inhibited DMSO-increased TGase activity but not n-butyric acid-increased TGase activity in intact FL cells.	Dimethyl Sulfoxide	36-40	transglutaminase 1	Homo sapiens	51-56
6125941-3	1982	Retinoid analogs altered the expression of the initial TGase peak in both CHO and melanoma cells.	Retinoids	0-8	transglutaminase 1	Homo sapiens	55-60
6414528-3	1983	Cholesterol specific radioactivity (SRA) peaked 1 h after, and leveled off afterwards in the OL1, LI1 and AR1 groups.	Cholesterol	0-11	transglutaminase 1	Homo sapiens	98-101
6085823-2	1983	Both transamidation of glutamine residues in the enzyme catalyzed by TGase and phosphorylation of serine and threonine residues catalyzed by a polyamine-stimulated protein kinase have been demonstrated.	Glutamine	23-32	transglutaminase 1	Homo sapiens	69-74
6085823-4	1983	Transamidation of specific proteins with primary amines catalyzed by intracellular TGase may be an important posttranslational modification, capable of altering genetic transcription.	Amines	49-55	transglutaminase 1	Homo sapiens	83-88
7141606-2	1982	We have investigated the relationship between these two systems by performing simultaneous measurements of the maximal rates of lithium-sodium (Li1-Na0) countertransport and outward sodium-potassium (Na-K) cotransport in red cells from normotensive and hypertensive subjects.	lithium-sodium	128-142	transglutaminase 1	Homo sapiens	144-147
7141606-3	1982	Li1-Na0 countertransport was assayed by measuring the Na0-stimulated Li efflux from cells loaded to contain 10 mmoles Li per liter of cells by incubation in isotonic LiCl.	3-acetylpyridine-adenine dinucleotide phosphate	4-7	transglutaminase 1	Homo sapiens	0-3
7141606-3	1982	Li1-Na0 countertransport was assayed by measuring the Na0-stimulated Li efflux from cells loaded to contain 10 mmoles Li per liter of cells by incubation in isotonic LiCl.	3-acetylpyridine-adenine dinucleotide phosphate	54-57	transglutaminase 1	Homo sapiens	0-3
7141606-3	1982	Li1-Na0 countertransport was assayed by measuring the Na0-stimulated Li efflux from cells loaded to contain 10 mmoles Li per liter of cells by incubation in isotonic LiCl.	Lithium Chloride	166-170	transglutaminase 1	Homo sapiens	0-3
6125941-4	1982	Retinol increased the activity of TGase 1 hr after release in CHO cells, and the activity remained elevated until hr 4.	Vitamin A	0-7	transglutaminase 1	Homo sapiens	34-39
6125941-5	1982	A broad peak of TGase activity also occurred after the addition of alpha-difluoromethylornithine, an irreversible inhibitor of ODCase, and after addition of alpha-difluoromethylornithine plus retinol.	Eflornithine	67-96	transglutaminase 1	Homo sapiens	16-21
6125941-5	1982	A broad peak of TGase activity also occurred after the addition of alpha-difluoromethylornithine, an irreversible inhibitor of ODCase, and after addition of alpha-difluoromethylornithine plus retinol.	Eflornithine	157-186	transglutaminase 1	Homo sapiens	16-21
6125941-5	1982	A broad peak of TGase activity also occurred after the addition of alpha-difluoromethylornithine, an irreversible inhibitor of ODCase, and after addition of alpha-difluoromethylornithine plus retinol.	Vitamin A	192-199	transglutaminase 1	Homo sapiens	16-21
6125941-6	1982	In mouse melanoma cells, retinoic acid plus MSH markedly enhanced the activity of the initial TGase peak compared to MSH alone.	Tretinoin	25-38	transglutaminase 1	Homo sapiens	94-99
6125941-7	1982	Retinoic acid alone also increased TGase activity biphasically in these cells without the addition of MSH.	Tretinoin	0-13	transglutaminase 1	Homo sapiens	35-40
6125941-8	1982	These studies suggest that retinoid effects that increase TGase activity may alter the ODCase expression in proliferation and differentiation.	Retinoids	27-35	transglutaminase 1	Homo sapiens	58-63
6109309-4	1980	Indirect immunofluorescence studies with antibody to cellular transglutaminase demonstrated the presence of transglutaminase in Triton X-100-insoluble material.	Octoxynol	128-140	transglutaminase 1	Homo sapiens	62-78
6109309-4	1980	Indirect immunofluorescence studies with antibody to cellular transglutaminase demonstrated the presence of transglutaminase in Triton X-100-insoluble material.	Octoxynol	128-140	transglutaminase 1	Homo sapiens	108-124
6109309-6	1980	Normal human and mouse cells that elicited contact inhibition of growth and had the high TGase activity also had more epsilon-(gamma-glutamyl) lysine isopeptide bonds than transformed counterparts.	epsilon-(gamma-glutamyl)-lysine	118-149	transglutaminase 1	Homo sapiens	89-94
33460961-0	2021	Tetrasodium pyrophosphate promotes light meromyosin crosslinking by microbial transglutaminase.	sodium pyrophosphate	0-25	transglutaminase 1	Homo sapiens	78-94
4325079-0	1971	Thyroid secretion in vitro: inhibition of TSH and dibutyryl cyclic-AMP stimulated 131-I release by Li+1.	Cyclic AMP	60-70	transglutaminase 1	Homo sapiens	99-103
33460961-0	2021	Tetrasodium pyrophosphate promotes light meromyosin crosslinking by microbial transglutaminase.	meromyosin	41-51	transglutaminase 1	Homo sapiens	78-94
33429299-0	2021	Phosvitin-wheat gluten complex catalyzed by transglutaminase in the presence of Na2SO3: Formation, cross-link behavior and emulsifying properties.	sodium sulfite	80-86	transglutaminase 1	Homo sapiens	44-60
33460961-2	2021	This present study attempted to reveal the interactive roles of protein oxidation and tetrasodium pyrophosphate (TSPP) on the crosslinking pattern of myosin mediated by transglutaminase (TGase).	sodium pyrophosphate	86-111	transglutaminase 1	Homo sapiens	169-185
33460961-2	2021	This present study attempted to reveal the interactive roles of protein oxidation and tetrasodium pyrophosphate (TSPP) on the crosslinking pattern of myosin mediated by transglutaminase (TGase).	sodium pyrophosphate	86-111	transglutaminase 1	Homo sapiens	187-192
33460961-2	2021	This present study attempted to reveal the interactive roles of protein oxidation and tetrasodium pyrophosphate (TSPP) on the crosslinking pattern of myosin mediated by transglutaminase (TGase).	sodium pyrophosphate	113-117	transglutaminase 1	Homo sapiens	169-185
33460961-2	2021	This present study attempted to reveal the interactive roles of protein oxidation and tetrasodium pyrophosphate (TSPP) on the crosslinking pattern of myosin mediated by transglutaminase (TGase).	sodium pyrophosphate	113-117	transglutaminase 1	Homo sapiens	187-192
33460961-3	2021	Mild oxidation at 1 mM H2O2 facilitated the TGase-initiated crosslinking, with the dominate crosslinking site shifted from S1 (in nonoxidized myosin) to Rod.	Hydrogen Peroxide	23-27	transglutaminase 1	Homo sapiens	44-49
34018189-8	2021	The gel structure and water holding capacity of MP/WG were improved by the cross-linking of TGase.	Water	22-27	transglutaminase 1	Homo sapiens	92-97
33932733-0	2021	Manganese Migration in Li1-xMn2O4 Cathode Materials.	Manganese	0-9	transglutaminase 1	Homo sapiens	23-26
33892260-2	2021	Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) results showed that HUS increased the amounts of high-molecular-weight polymers/aggregates in WPISA after incubation with TGase.	Sodium Dodecyl Sulfate	0-22	transglutaminase 1	Homo sapiens	191-196
33892260-6	2021	HUS significantly increased (P < 0.05) the water holding capacity and gel strength of glucono-delta-lactone (GDL)-induced TGase cross-linked WPISA gels.	beta-glucono-1,5-lactone	86-107	transglutaminase 1	Homo sapiens	122-127
32976879-6	2021	Here, we investigated the ability of KB105, a gene therapy vector encoding full-length human TGM1, to deliver functional human TGM1 to keratinocytes.	kb105	37-42	transglutaminase 1	Homo sapiens	127-131
33974999-0	2022	Correction of the pathogenic mutation in TGM1 gene by adenine base editing in mutant embryos.	Adenine	54-61	transglutaminase 1	Homo sapiens	41-45
33783055-3	2021	To solve this material dilemma, herein, a novel morphological and structural design is introduced to Li1.11 Mn0.49 Ni0.29 Co0.11 O2 , reporting a sub-micrometer-level LMR with a relatively delocalized, excess-Li system.	CO0	122-125	transglutaminase 1	Homo sapiens	101-104
33783055-3	2021	To solve this material dilemma, herein, a novel morphological and structural design is introduced to Li1.11 Mn0.49 Ni0.29 Co0.11 O2 , reporting a sub-micrometer-level LMR with a relatively delocalized, excess-Li system.	Oxygen	129-131	transglutaminase 1	Homo sapiens	101-104
33871956-3	2021	Here, the thermal stability of a NASICON-type Li1.4Al0.4Ti1.6(PO4)3 (LATP) SE pellet against metallic lithium is quantified in a quasi-practical situation.	po4)3 (latp)	62-74	transglutaminase 1	Homo sapiens	46-49
33871956-3	2021	Here, the thermal stability of a NASICON-type Li1.4Al0.4Ti1.6(PO4)3 (LATP) SE pellet against metallic lithium is quantified in a quasi-practical situation.	Lithium	102-109	transglutaminase 1	Homo sapiens	46-49
33733754-0	2021	Terahertz Magneto-Optical Excitations of the sd-Hybrid States of Lithium Nitridocobaltate Li2(Li1-xCox)N. We report the results of the experimental and theoretical study of the magnetic anisotropy of single crystals of the Co-doped lithium nitride Li2(Li1-xCox)N with x = 0.005, 0.01, and 0.02.	lithium nitridocobaltate	65-89	transglutaminase 1	Homo sapiens	94-97
33733754-0	2021	Terahertz Magneto-Optical Excitations of the sd-Hybrid States of Lithium Nitridocobaltate Li2(Li1-xCox)N. We report the results of the experimental and theoretical study of the magnetic anisotropy of single crystals of the Co-doped lithium nitride Li2(Li1-xCox)N with x = 0.005, 0.01, and 0.02.	lithium nitridocobaltate	65-89	transglutaminase 1	Homo sapiens	252-255
33733754-2	2021	Our combined electron spin resonance (ESR) and THz spectroscopic investigations of Li2(Li1-xCox)N in a very broad frequency range up to 1.7 THz and in magnetic fields up to 16 T enable an accurate determination of the energies of the spin levels of the ground state multiplet S = 1 of the paramagnetic Co(I) ion.	thz	140-143	transglutaminase 1	Homo sapiens	87-90
33733754-6	2021	Its microscopic origin is the unusual linear coordination of the Co(I) ions in Li2(Li1-xCox)N with two nitrogen ligands.	Nitrogen	103-111	transglutaminase 1	Homo sapiens	83-86
32976879-7	2021	In vitro, KB105 efficiently infected TGM1-deficient human keratinocytes, produced TGM1 protein, and rescued transglutaminase enzyme function.	kb105	10-15	transglutaminase 1	Homo sapiens	37-41
32976879-8	2021	In vivo studies demonstrated that both single and repeated topical KB105 administration induced TGM1 protein expression in the target epidermal layer without triggering fibrosis, necrosis, or acute inflammation.	kb105	67-72	transglutaminase 1	Homo sapiens	96-100
33333173-5	2021	(a) A metalloprotease (alveolin) hydrolyzes the N-terminal proline-glutamine (Pro-Gln) region of zona pellucida (ZP) 1 and (b) triggers intermolecular cross-linking to ZP3 catalyzed by transglutaminase (TGase).	Proline	59-66	transglutaminase 1	Homo sapiens	203-208
33663208-3	2021	In this work, we try to improve the rate performance of a lithium-rich manganese-based material Li1.2Mn0.54Co0.13Ni0.13O2 using a collaborative approach with Co-doping and NaxCoO2-coating methods.	Lithium	58-65	transglutaminase 1	Homo sapiens	96-99
33663208-3	2021	In this work, we try to improve the rate performance of a lithium-rich manganese-based material Li1.2Mn0.54Co0.13Ni0.13O2 using a collaborative approach with Co-doping and NaxCoO2-coating methods.	Manganese	71-80	transglutaminase 1	Homo sapiens	96-99
33663208-3	2021	In this work, we try to improve the rate performance of a lithium-rich manganese-based material Li1.2Mn0.54Co0.13Ni0.13O2 using a collaborative approach with Co-doping and NaxCoO2-coating methods.	13o2	117-121	transglutaminase 1	Homo sapiens	96-99
33663208-5	2021	Under the synergistic effect of these two modification strategies, the surface and internal dynamics of the Li1.2Mn0.54Co0.13Ni0.13O2 material are enhanced and its rate performance is considerably improved without decay of the cycle stability.	13o2	129-133	transglutaminase 1	Homo sapiens	108-111
33977057-3	2021	By in situ polymerizing poly(ethylene glycol) methyl ether acrylate within self-supported three-dimensional porous Li1.3Al0.3Ti1.7(PO4)3 framework, the as-assembled solid-state battery employing 4.5 V LiNi0.8Mn0.1Co0.1O2 cathode and Li metal anode demonstrates a high Coulombic efficiency exceeding 99% at room temperature.	2-METHOXYETHYL ACRYLATE	24-67	transglutaminase 1	Homo sapiens	115-118
33977057-3	2021	By in situ polymerizing poly(ethylene glycol) methyl ether acrylate within self-supported three-dimensional porous Li1.3Al0.3Ti1.7(PO4)3 framework, the as-assembled solid-state battery employing 4.5 V LiNi0.8Mn0.1Co0.1O2 cathode and Li metal anode demonstrates a high Coulombic efficiency exceeding 99% at room temperature.	(po4)	130-135	transglutaminase 1	Homo sapiens	115-118
33977057-3	2021	By in situ polymerizing poly(ethylene glycol) methyl ether acrylate within self-supported three-dimensional porous Li1.3Al0.3Ti1.7(PO4)3 framework, the as-assembled solid-state battery employing 4.5 V LiNi0.8Mn0.1Co0.1O2 cathode and Li metal anode demonstrates a high Coulombic efficiency exceeding 99% at room temperature.	li metal	233-241	transglutaminase 1	Homo sapiens	115-118
33977057-5	2021	Meanwhile, the in situ polymerized poly(ethylene glycol) methyl ether acrylate can not only integrate the loose interfacial contact but also protect Li1.3Al0.3Ti1.7(PO4)3 from being reduced by lithium metal.	2-METHOXYETHYL ACRYLATE	35-78	transglutaminase 1	Homo sapiens	149-152
33977057-5	2021	Meanwhile, the in situ polymerized poly(ethylene glycol) methyl ether acrylate can not only integrate the loose interfacial contact but also protect Li1.3Al0.3Ti1.7(PO4)3 from being reduced by lithium metal.	lithium metal	193-206	transglutaminase 1	Homo sapiens	149-152
33121760-6	2021	Owing to these merits of polyhedral structure and Li-Ni co-doping, the optimized Li1.02Ni0.05Mn1.93O4 exhibits good electrochemical performance with high initial discharge capacity of 119.8, 107.1 and 97.9 mAh g-1 at 1, 5 and 10 C, respectively.	li-ni	50-55	transglutaminase 1	Homo sapiens	81-84
33333173-5	2021	(a) A metalloprotease (alveolin) hydrolyzes the N-terminal proline-glutamine (Pro-Gln) region of zona pellucida (ZP) 1 and (b) triggers intermolecular cross-linking to ZP3 catalyzed by transglutaminase (TGase).	Proline	59-66	transglutaminase 1	Homo sapiens	185-201
33333173-5	2021	(a) A metalloprotease (alveolin) hydrolyzes the N-terminal proline-glutamine (Pro-Gln) region of zona pellucida (ZP) 1 and (b) triggers intermolecular cross-linking to ZP3 catalyzed by transglutaminase (TGase).	Glutamine	67-76	transglutaminase 1	Homo sapiens	185-201
33333173-5	2021	(a) A metalloprotease (alveolin) hydrolyzes the N-terminal proline-glutamine (Pro-Gln) region of zona pellucida (ZP) 1 and (b) triggers intermolecular cross-linking to ZP3 catalyzed by transglutaminase (TGase).	Glutamine	67-76	transglutaminase 1	Homo sapiens	203-208
33333173-5	2021	(a) A metalloprotease (alveolin) hydrolyzes the N-terminal proline-glutamine (Pro-Gln) region of zona pellucida (ZP) 1 and (b) triggers intermolecular cross-linking to ZP3 catalyzed by transglutaminase (TGase).	Prolyl-Glutamine	78-85	transglutaminase 1	Homo sapiens	185-201
33333173-5	2021	(a) A metalloprotease (alveolin) hydrolyzes the N-terminal proline-glutamine (Pro-Gln) region of zona pellucida (ZP) 1 and (b) triggers intermolecular cross-linking to ZP3 catalyzed by transglutaminase (TGase).	Prolyl-Glutamine	78-85	transglutaminase 1	Homo sapiens	203-208
33358097-8	2021	Importantly, blockade of HA production by inhibiting conversion of beta-NAG2 to UDP-NAG abolished beta-NAG2-mediated up-regulation of PCNA, TGM1 and FLG mRNA expression in cultured keratinocytes.	udp-nag	80-87	transglutaminase 1	Homo sapiens	140-144
33448801-1	2021	We investigated the impact of electrolyte difference on lithiation and delithiation properties of a Li1.00Si electrode to improve the Coulombic efficiency (CE) of Si-based electrodes.	Silicon	106-108	transglutaminase 1	Homo sapiens	100-103
33448801-5	2021	The addition of vinylene carbonate (VC) to the ionic-liquid electrolyte suppressed the phase transition of Li1.00Si to Si.	vinylene carbonate	16-34	transglutaminase 1	Homo sapiens	107-110
33448801-5	2021	The addition of vinylene carbonate (VC) to the ionic-liquid electrolyte suppressed the phase transition of Li1.00Si to Si.	vinylene carbonate	36-38	transglutaminase 1	Homo sapiens	107-110
33448801-5	2021	The addition of vinylene carbonate (VC) to the ionic-liquid electrolyte suppressed the phase transition of Li1.00Si to Si.	Silicon	113-115	transglutaminase 1	Homo sapiens	107-110
33567435-9	2021	The ester-linked fatty acid may be removed by an as yet unidentified esterase, and the resulting omega-hydroxyceramide may become ester linked to the outer surface of the cornified envelope through action of transglutaminase 1.	Esters	4-9	transglutaminase 1	Homo sapiens	208-226
33567435-9	2021	The ester-linked fatty acid may be removed by an as yet unidentified esterase, and the resulting omega-hydroxyceramide may become ester linked to the outer surface of the cornified envelope through action of transglutaminase 1.	Fatty Acids	17-27	transglutaminase 1	Homo sapiens	208-226
33567435-9	2021	The ester-linked fatty acid may be removed by an as yet unidentified esterase, and the resulting omega-hydroxyceramide may become ester linked to the outer surface of the cornified envelope through action of transglutaminase 1.	omega-hydroxyceramide	97-118	transglutaminase 1	Homo sapiens	208-226
33567435-9	2021	The ester-linked fatty acid may be removed by an as yet unidentified esterase, and the resulting omega-hydroxyceramide may become ester linked to the outer surface of the cornified envelope through action of transglutaminase 1.	Esters	69-74	transglutaminase 1	Homo sapiens	208-226
32961971-1	2020	The Li1.17Ni0.17Mn0.50Co0.17O2 Li-rich NMC positive electrode (cathode) for lithium-ion batteries has been coated with nanocrystals of the LiMn1.5Co0.5O4 high-voltage spinel cathode material.	Lithium	76-83	transglutaminase 1	Homo sapiens	4-7
33146213-0	2020	Interaction of myofibrillar proteins and epigallocatechin gallate in the presence of transglutaminase in solutions.	epigallocatechin gallate	41-65	transglutaminase 1	Homo sapiens	85-101
33146213-5	2020	Meanwhile, changes in SDS-PAGE, FT-IR, and sulfhydryl contents showed that TGase increased the disulfide bond contents, whereas it decreased after EGCG was added, suggesting that EGCG could react with MP via non-covalent and covalent interactions.	Sodium Dodecyl Sulfate	22-25	transglutaminase 1	Homo sapiens	75-80
33146213-5	2020	Meanwhile, changes in SDS-PAGE, FT-IR, and sulfhydryl contents showed that TGase increased the disulfide bond contents, whereas it decreased after EGCG was added, suggesting that EGCG could react with MP via non-covalent and covalent interactions.	Disulfides	95-104	transglutaminase 1	Homo sapiens	75-80
33146213-5	2020	Meanwhile, changes in SDS-PAGE, FT-IR, and sulfhydryl contents showed that TGase increased the disulfide bond contents, whereas it decreased after EGCG was added, suggesting that EGCG could react with MP via non-covalent and covalent interactions.	epigallocatechin gallate	179-183	transglutaminase 1	Homo sapiens	75-80
33146213-5	2020	Meanwhile, changes in SDS-PAGE, FT-IR, and sulfhydryl contents showed that TGase increased the disulfide bond contents, whereas it decreased after EGCG was added, suggesting that EGCG could react with MP via non-covalent and covalent interactions.	mp	201-203	transglutaminase 1	Homo sapiens	75-80
33146213-6	2020	Assembly measurements illustrated that TGase increased the turbidity and particle size of MP, while TGase and EGCG treatment accelerated MP aggregation and it was associated with the increase in the EGCG concentration, which was further confirmed by SEM and AFM.	epigallocatechin gallate	199-203	transglutaminase 1	Homo sapiens	100-105
33251494-1	2020	In this work, a spinel single-crystalline Li1.1Mn1.9O4 has been successfully synthesized using beta-MnO2 nanotubes as the self-sacrifice template.	beta-mno2 nanotubes	95-114	transglutaminase 1	Homo sapiens	42-45
33251494-4	2020	Li1.1Mn1.9O4 nanotubes exhibited favorable lithium extraction behavior due to tubular nanostructure, single-crystalline nature, and high crystallinity.	Lithium	43-50	transglutaminase 1	Homo sapiens	0-3
33251494-5	2020	(NH4)2S2O8 eluent ensures the structural stability of Li1.1Mn1.9O4 nanotube, registering a Li+ adsorption capacity of 39.21 mg g-1 (~89.73% of the theoretical capacity) with only 0.08% manganese dissolution after eight adsorption/desorption cycles, compared to that of 1.21% for H2SO4.	(nh4)2s2o8	0-10	transglutaminase 1	Homo sapiens	54-57
33251494-5	2020	(NH4)2S2O8 eluent ensures the structural stability of Li1.1Mn1.9O4 nanotube, registering a Li+ adsorption capacity of 39.21 mg g-1 (~89.73% of the theoretical capacity) with only 0.08% manganese dissolution after eight adsorption/desorption cycles, compared to that of 1.21% for H2SO4.	Manganese	185-194	transglutaminase 1	Homo sapiens	54-57
33251494-5	2020	(NH4)2S2O8 eluent ensures the structural stability of Li1.1Mn1.9O4 nanotube, registering a Li+ adsorption capacity of 39.21 mg g-1 (~89.73% of the theoretical capacity) with only 0.08% manganese dissolution after eight adsorption/desorption cycles, compared to that of 1.21% for H2SO4.	sulfuric acid	279-284	transglutaminase 1	Homo sapiens	54-57
33202123-0	2020	Effects of Structure and Magnetism on the Electrochemistry of the Layered Li1+x(Ni0.5Mn0.5)1-xO2 Cathode Material.	1-xo2 cathode	91-104	transglutaminase 1	Homo sapiens	74-77
33644685-7	2020	First, chemo-enzymatic techniques, namely transglutaminase (TGase)-mediated transamidation of a conserved glutamine residue and glycan remodeling of a conserved asparagine N-glycan (GlyCLICK), both in the Fc region.	Glutamine	106-115	transglutaminase 1	Homo sapiens	42-58
33644685-7	2020	First, chemo-enzymatic techniques, namely transglutaminase (TGase)-mediated transamidation of a conserved glutamine residue and glycan remodeling of a conserved asparagine N-glycan (GlyCLICK), both in the Fc region.	Glutamine	106-115	transglutaminase 1	Homo sapiens	60-65
32724975-1	2020	Lithium-rich spinel lithium manganese oxide (LMO) compounds are one kind of promising adsorbents for lithium recovery from brine due to their high capacity and low Mn dissolution; Li1.6Mn1.6O4 is one of them.	Lithium	0-7	transglutaminase 1	Homo sapiens	180-183
32786252-3	2020	Herein, a new electrolyte additive copper fluoride (CuF2) is used in liquid electrolyte to construct a stable interphase between Li1.5Al0.5Ge1.5(PO4)3 (LAGP) SSE and Li metal for a quasi-solid-state Li-S battery.	copper fluoride	35-50	transglutaminase 1	Homo sapiens	129-132
32786252-3	2020	Herein, a new electrolyte additive copper fluoride (CuF2) is used in liquid electrolyte to construct a stable interphase between Li1.5Al0.5Ge1.5(PO4)3 (LAGP) SSE and Li metal for a quasi-solid-state Li-S battery.	Cupric fluoride	52-56	transglutaminase 1	Homo sapiens	129-132
32786252-3	2020	Herein, a new electrolyte additive copper fluoride (CuF2) is used in liquid electrolyte to construct a stable interphase between Li1.5Al0.5Ge1.5(PO4)3 (LAGP) SSE and Li metal for a quasi-solid-state Li-S battery.	po4	145-148	transglutaminase 1	Homo sapiens	129-132
32061735-1	2020	The transglutaminase (TGase) family consists of eight isozymes that catalyze the Ca2+-dependent crosslink formation between the glutamine and lysine residues of proteins.	Calcium	81-85	transglutaminase 1	Homo sapiens	4-20
32061735-1	2020	The transglutaminase (TGase) family consists of eight isozymes that catalyze the Ca2+-dependent crosslink formation between the glutamine and lysine residues of proteins.	Calcium	81-85	transglutaminase 1	Homo sapiens	22-27
32061735-1	2020	The transglutaminase (TGase) family consists of eight isozymes that catalyze the Ca2+-dependent crosslink formation between the glutamine and lysine residues of proteins.	arginyl-glutamine	128-137	transglutaminase 1	Homo sapiens	4-20
32061735-1	2020	The transglutaminase (TGase) family consists of eight isozymes that catalyze the Ca2+-dependent crosslink formation between the glutamine and lysine residues of proteins.	arginyl-glutamine	128-137	transglutaminase 1	Homo sapiens	22-27
32061735-1	2020	The transglutaminase (TGase) family consists of eight isozymes that catalyze the Ca2+-dependent crosslink formation between the glutamine and lysine residues of proteins.	tyrosyl-lysine	142-148	transglutaminase 1	Homo sapiens	4-20
32061735-1	2020	The transglutaminase (TGase) family consists of eight isozymes that catalyze the Ca2+-dependent crosslink formation between the glutamine and lysine residues of proteins.	tyrosyl-lysine	142-148	transglutaminase 1	Homo sapiens	22-27
32805958-0	2020	Enhanced Cathode Performance: Mixed Al2O3 and LiAlO2 Coating of Li1.2Ni0.13Co0.13Mn0.54O2.	Aluminum Oxide	36-41	transglutaminase 1	Homo sapiens	64-67
32805958-0	2020	Enhanced Cathode Performance: Mixed Al2O3 and LiAlO2 Coating of Li1.2Ni0.13Co0.13Mn0.54O2.	lithium aluminate	46-52	transglutaminase 1	Homo sapiens	64-67
32678403-0	2020	Sulfur doped Li1.3Al0.3Ti1.7(PO4)3 solid electrolytes with enhanced ionic conductivity and a reduced activation energy barrier.	Sulfur	0-6	transglutaminase 1	Homo sapiens	13-16
32678403-0	2020	Sulfur doped Li1.3Al0.3Ti1.7(PO4)3 solid electrolytes with enhanced ionic conductivity and a reduced activation energy barrier.	po4	29-32	transglutaminase 1	Homo sapiens	13-16
32678403-3	2020	Herein, we report the synthesis of a sulfur-doped Li1.3Al0.3Ti1.7(PO4)3 (LATP) solid electrolyte with a NASICON crystal structure that combines elevated ionic conductivity with intrinsic stability against an ambient atmosphere.	Sulfur	37-43	transglutaminase 1	Homo sapiens	50-53
32678403-3	2020	Herein, we report the synthesis of a sulfur-doped Li1.3Al0.3Ti1.7(PO4)3 (LATP) solid electrolyte with a NASICON crystal structure that combines elevated ionic conductivity with intrinsic stability against an ambient atmosphere.	po4)3 (latp)	66-78	transglutaminase 1	Homo sapiens	50-53
32832273-4	2020	Methods: The cytotoxicity of the Ligno TG-K against human breast (MCF7), prostate (PC3) and lung (A549) adenocarcinoma cell lines was evaluated using MTT cytotoxicity assay.	monooxyethylene trimethylolpropane tristearate	150-153	transglutaminase 1	Homo sapiens	39-43
32643372-1	2020	A cold-active transglutaminase (TGase, EC 2.3.2.13) that catalyzes the reaction of protein glutamine + protein lysine   protein with gamma-glutamyl-epsilon-lysine cross-link + NH3 at low temperatures was reported previously.	Glutamine	91-100	transglutaminase 1	Homo sapiens	32-37
32643372-1	2020	A cold-active transglutaminase (TGase, EC 2.3.2.13) that catalyzes the reaction of protein glutamine + protein lysine   protein with gamma-glutamyl-epsilon-lysine cross-link + NH3 at low temperatures was reported previously.	Ammonia	176-179	transglutaminase 1	Homo sapiens	32-37
32594740-4	2020	We first synthesized Li2La2Ti3O10 and showed that its lithium-ion conductivity can be systematically enhanced by incorporation of cation deficiency in interstack sites through synthesis of Li1.9La2Ti2.9Nb0.1O10, Li1.8La2Ti2.8Nb0.2O10, and Li1.75La2Ti2.75Nb0.25O10.	Lithium	54-61	transglutaminase 1	Homo sapiens	189-192
32594740-4	2020	We first synthesized Li2La2Ti3O10 and showed that its lithium-ion conductivity can be systematically enhanced by incorporation of cation deficiency in interstack sites through synthesis of Li1.9La2Ti2.9Nb0.1O10, Li1.8La2Ti2.8Nb0.2O10, and Li1.75La2Ti2.75Nb0.25O10.	Lithium	54-61	transglutaminase 1	Homo sapiens	212-215
32743195-0	2020	Enhanced Li1+x Al x Ge2-x (PO4)3 Anode-Protecting Membranes for Hybrid Lithium-Air Batteries by Spark Plasma Sintering.	Lithium	71-78	transglutaminase 1	Homo sapiens	9-12
32432462-6	2020	Silicon, Li1.5Al0.5Ge1.5(PO4)3 or Li1.4Al0.4Ti1.6(PO4)3 nanoparticles are coated to suppress lithium morphological instabilities and demonstrated ~4 times longer cycle life.	Lithium	93-100	transglutaminase 1	Homo sapiens	9-12
32617520-7	2020	Moreover, LCRF-0006 and bortezomib synergistically induced 5TGM1 MM tumor cell apoptosis in vitro.	lcrf-0006	10-19	transglutaminase 1	Homo sapiens	60-64
32617520-7	2020	Moreover, LCRF-0006 and bortezomib synergistically induced 5TGM1 MM tumor cell apoptosis in vitro.	Bortezomib	24-34	transglutaminase 1	Homo sapiens	60-64
32724975-1	2020	Lithium-rich spinel lithium manganese oxide (LMO) compounds are one kind of promising adsorbents for lithium recovery from brine due to their high capacity and low Mn dissolution; Li1.6Mn1.6O4 is one of them.	lithium manganese oxide	20-43	transglutaminase 1	Homo sapiens	180-183
32724975-1	2020	Lithium-rich spinel lithium manganese oxide (LMO) compounds are one kind of promising adsorbents for lithium recovery from brine due to their high capacity and low Mn dissolution; Li1.6Mn1.6O4 is one of them.	lithium manganese oxide	45-48	transglutaminase 1	Homo sapiens	180-183
32724975-1	2020	Lithium-rich spinel lithium manganese oxide (LMO) compounds are one kind of promising adsorbents for lithium recovery from brine due to their high capacity and low Mn dissolution; Li1.6Mn1.6O4 is one of them.	Lithium	20-27	transglutaminase 1	Homo sapiens	180-183
32724975-2	2020	However, Mn3+ exists in the Li1.6Mn1.6O4 precursor due to incomplete reaction during syntheses, and the disproportionation reaction of Mn3+ inevitably results in Mn dissolution during lithium adsorption and desorption.	manganese(III) acetate dihydrate	9-13	transglutaminase 1	Homo sapiens	28-31
32724975-3	2020	The stable recycling and structural stability of Li1.6Mn1.6O4 were improved in aqueous lithium resources through K-gradient doping (LMO-K).	Lithium	87-94	transglutaminase 1	Homo sapiens	49-52
32383102-5	2020	The obtained outcomes present that the Li1@TNAP and the Li2@TNAP molecules are the lithium-salt.	Lithium	83-90	transglutaminase 1	Homo sapiens	39-47
32390024-2	2020	A lithium extraction method based on a solar-powered electrolysis technique with a solid-state electrolyte, Li1.5Al0.5Ge1.5(PO4)3 (LAGP), as the selective membrane has been reported to obtain metallic lithium from seawater.	Lithium	2-9	transglutaminase 1	Homo sapiens	108-111
32390024-2	2020	A lithium extraction method based on a solar-powered electrolysis technique with a solid-state electrolyte, Li1.5Al0.5Ge1.5(PO4)3 (LAGP), as the selective membrane has been reported to obtain metallic lithium from seawater.	Lithium	201-208	transglutaminase 1	Homo sapiens	108-111
32492773-8	2020	ACR of the coated kobbah with TGase-treated GPF in the presence nanoparticles (MSN or CH-NPs) was reduced by 41.0% and 47.5%, respectively.	kobbah	18-24	transglutaminase 1	Homo sapiens	30-35
32548496-0	2020	Effect of [MnO6] Octahedra to the Coloring Mechanism of (Li1-x Na x )2MnO3.	[mno6] octahedra	10-26	transglutaminase 1	Homo sapiens	57-60
32548496-3	2020	The (Li1-x Na x )2MnO3 (0 <= x <= 0.10) solid solutions absorbed the visible light at wavelengths shorter than 550 nm and around 680 nm.	2mno3	17-22	transglutaminase 1	Homo sapiens	5-8
32548496-8	2020	Among the (Li1-x Na x )2MnO3 (0 <= x <= 0.10) samples synthesized in this study, the highest red color purity was obtained in the (Li0.93Na0.07)2MnO3 (hue angle: h  = 39.1) sample.	2mno3	23-28	transglutaminase 1	Homo sapiens	11-14
32548496-8	2020	Among the (Li1-x Na x )2MnO3 (0 <= x <= 0.10) samples synthesized in this study, the highest red color purity was obtained in the (Li0.93Na0.07)2MnO3 (hue angle: h  = 39.1) sample.	2mno3	144-149	transglutaminase 1	Homo sapiens	11-14
32724637-3	2020	The results showed that the addition of encapsulated TGase significantly (p   .05) increased protein and fat content, dry matter, nitrogen recovery, and pH, as well as the production yield of cheeses.	Nitrogen	130-138	transglutaminase 1	Homo sapiens	53-58
32030866-0	2020	Ultra-Long Life Li-Rich Li1.2Mn0.6Ni0.2O2 Cathode by Three-in-One Surface Modification for Lithium-Ion Batteries.	Superoxides	38-41	transglutaminase 1	Homo sapiens	24-27
32030866-0	2020	Ultra-Long Life Li-Rich Li1.2Mn0.6Ni0.2O2 Cathode by Three-in-One Surface Modification for Lithium-Ion Batteries.	Lithium	91-98	transglutaminase 1	Homo sapiens	24-27
32030866-2	2020	Here, we design a three-in-one surface treatment via the pyrolysis of urea to improve the voltage and capacity stability of Li1.2Mn0.6Ni0.2O2 (LMNO), by which oxygen vacancy, spinel phase integration and N-doped carbon nanolayer are synchronously built on the surface of LMNO microspheres.	Urea	70-74	transglutaminase 1	Homo sapiens	124-127
32030866-2	2020	Here, we design a three-in-one surface treatment via the pyrolysis of urea to improve the voltage and capacity stability of Li1.2Mn0.6Ni0.2O2 (LMNO), by which oxygen vacancy, spinel phase integration and N-doped carbon nanolayer are synchronously built on the surface of LMNO microspheres.	Superoxides	138-141	transglutaminase 1	Homo sapiens	124-127
32030866-2	2020	Here, we design a three-in-one surface treatment via the pyrolysis of urea to improve the voltage and capacity stability of Li1.2Mn0.6Ni0.2O2 (LMNO), by which oxygen vacancy, spinel phase integration and N-doped carbon nanolayer are synchronously built on the surface of LMNO microspheres.	Oxygen	159-165	transglutaminase 1	Homo sapiens	124-127
32030866-2	2020	Here, we design a three-in-one surface treatment via the pyrolysis of urea to improve the voltage and capacity stability of Li1.2Mn0.6Ni0.2O2 (LMNO), by which oxygen vacancy, spinel phase integration and N-doped carbon nanolayer are synchronously built on the surface of LMNO microspheres.	Nitrogen	134-135	transglutaminase 1	Homo sapiens	124-127
32030866-2	2020	Here, we design a three-in-one surface treatment via the pyrolysis of urea to improve the voltage and capacity stability of Li1.2Mn0.6Ni0.2O2 (LMNO), by which oxygen vacancy, spinel phase integration and N-doped carbon nanolayer are synchronously built on the surface of LMNO microspheres.	Carbon	212-218	transglutaminase 1	Homo sapiens	124-127
32383102-5	2020	The obtained outcomes present that the Li1@TNAP and the Li2@TNAP molecules are the lithium-salt.	Salts	91-95	transglutaminase 1	Homo sapiens	39-47
32370047-0	2020	Preparation and Evaluation of New Glycopeptides Obtained by Proteolysis from Corn Gluten Meal Followed by Transglutaminase-Induced Glycosylation with Glucosamine.	Glycopeptides	34-47	transglutaminase 1	Homo sapiens	106-122
32247485-1	2020	Two novel calcium delivery systems with high calcium-binding ability were prepared with desalted duck egg white peptides (DPs) and chitosan oligosaccharide (COS) by Amadori-type linkage and transglutaminase (TGase) induced reaction.	Calcium	10-17	transglutaminase 1	Homo sapiens	190-206
32370047-0	2020	Preparation and Evaluation of New Glycopeptides Obtained by Proteolysis from Corn Gluten Meal Followed by Transglutaminase-Induced Glycosylation with Glucosamine.	Glucosamine	150-161	transglutaminase 1	Homo sapiens	106-122
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glycopeptides	4-17	transglutaminase 1	Homo sapiens	88-104
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glycopeptides	4-17	transglutaminase 1	Homo sapiens	106-111
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glucosamine	140-151	transglutaminase 1	Homo sapiens	88-104
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glucosamine	140-151	transglutaminase 1	Homo sapiens	106-111
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glucosamine	153-157	transglutaminase 1	Homo sapiens	88-104
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glucosamine	153-157	transglutaminase 1	Homo sapiens	106-111
32167273-5	2020	Herein, we present the performance of a Li-rich layered sulfide of formula Li1.13Ti0.57Fe0.3S2 (LTFS) in room temperature operating all-solid-state batteries, using beta-Li3PS4 as SE and both InLi and Li anode materials.	Sulfides	56-63	transglutaminase 1	Homo sapiens	75-78
32080860-6	2020	First, an antibody is conjugated to a clickable handle via site-specific modification of glutamine (Gln) residues catalyzed by transglutaminase (TGase, EC 2.3.2.13).	Glutamine	89-98	transglutaminase 1	Homo sapiens	127-143
32080860-6	2020	First, an antibody is conjugated to a clickable handle via site-specific modification of glutamine (Gln) residues catalyzed by transglutaminase (TGase, EC 2.3.2.13).	Glutamine	89-98	transglutaminase 1	Homo sapiens	145-150
32080860-6	2020	First, an antibody is conjugated to a clickable handle via site-specific modification of glutamine (Gln) residues catalyzed by transglutaminase (TGase, EC 2.3.2.13).	Glutamine	100-103	transglutaminase 1	Homo sapiens	127-143
32080860-6	2020	First, an antibody is conjugated to a clickable handle via site-specific modification of glutamine (Gln) residues catalyzed by transglutaminase (TGase, EC 2.3.2.13).	Glutamine	100-103	transglutaminase 1	Homo sapiens	145-150
32167273-5	2020	Herein, we present the performance of a Li-rich layered sulfide of formula Li1.13Ti0.57Fe0.3S2 (LTFS) in room temperature operating all-solid-state batteries, using beta-Li3PS4 as SE and both InLi and Li anode materials.	beta-li3ps4	165-176	transglutaminase 1	Homo sapiens	75-78
32167273-5	2020	Herein, we present the performance of a Li-rich layered sulfide of formula Li1.13Ti0.57Fe0.3S2 (LTFS) in room temperature operating all-solid-state batteries, using beta-Li3PS4 as SE and both InLi and Li anode materials.	Selenium	180-182	transglutaminase 1	Homo sapiens	75-78
31699562-0	2020	Consequences of superfine grinding treatment on structure, physicochemical and rheological properties of transglutaminase-crosslinked whey protein isolate.	superfine	16-25	transglutaminase 1	Homo sapiens	105-121
32268605-0	2020	Rhombohedral Li1+xYxZr2-x(PO4)3 Solid Electrolyte Prepared by Hot-Pressing for All-Solid-State Li-Metal Batteries.	Metals	98-103	transglutaminase 1	Homo sapiens	13-16
32268605-3	2020	The dense Li1.1Y0.1Zr1.9(PO4)3 pellet prepared by hot-pressing shows a high Li-ion conductivity of 9 x 10-5 S cm-1, which is two orders of magnitude higher than that of LiZr2(PO4)3.	po4	25-28	transglutaminase 1	Homo sapiens	10-13
32268605-4	2020	The in-situ formed Li3P layer on the surface of Li1.1Y0.1Zr1.9(PO4)3 after contact with the lithium metal increases the wettability of the pellet by the metallic lithium anode.	li3p	19-23	transglutaminase 1	Homo sapiens	48-51
32268605-4	2020	The in-situ formed Li3P layer on the surface of Li1.1Y0.1Zr1.9(PO4)3 after contact with the lithium metal increases the wettability of the pellet by the metallic lithium anode.	Lithium	92-99	transglutaminase 1	Homo sapiens	48-51
32268605-4	2020	The in-situ formed Li3P layer on the surface of Li1.1Y0.1Zr1.9(PO4)3 after contact with the lithium metal increases the wettability of the pellet by the metallic lithium anode.	Metals	100-105	transglutaminase 1	Homo sapiens	48-51
32268605-4	2020	The in-situ formed Li3P layer on the surface of Li1.1Y0.1Zr1.9(PO4)3 after contact with the lithium metal increases the wettability of the pellet by the metallic lithium anode.	Lithium	162-169	transglutaminase 1	Homo sapiens	48-51
31699562-1	2020	Impacts of superfine grinding treatment (0, 2, 4, 6, 8 or 10 h) on structure, physicochemical and rheological properties of transglutaminase (TGase)-crosslinked whey protein isolate (WPI) were investigated.	superfine	11-20	transglutaminase 1	Homo sapiens	124-140
31699562-1	2020	Impacts of superfine grinding treatment (0, 2, 4, 6, 8 or 10 h) on structure, physicochemical and rheological properties of transglutaminase (TGase)-crosslinked whey protein isolate (WPI) were investigated.	superfine	11-20	transglutaminase 1	Homo sapiens	142-147
31699562-2	2020	Size exclusion chromatography showed that high molecular weight polymers were formed in TGase-treated sWPI (WPI treated with superfine grinding), whereas its consumption of free amino groups reached the maximum at grinding 8 h and 10 h. With the milling time extended from 0 to 10 h, particle size of the TGase-crosslinked sWPI gradually increased.	superfine	125-134	transglutaminase 1	Homo sapiens	88-93
31699562-2	2020	Size exclusion chromatography showed that high molecular weight polymers were formed in TGase-treated sWPI (WPI treated with superfine grinding), whereas its consumption of free amino groups reached the maximum at grinding 8 h and 10 h. With the milling time extended from 0 to 10 h, particle size of the TGase-crosslinked sWPI gradually increased.	Amino Acids	178-183	transglutaminase 1	Homo sapiens	88-93
31699562-6	2020	These findings indicated that superfine grinding treatment could enhance the TGase cross-linking degree, and improve rheological properties in TGase-crosslinked WPI.	superfine	30-39	transglutaminase 1	Homo sapiens	77-82
31699562-6	2020	These findings indicated that superfine grinding treatment could enhance the TGase cross-linking degree, and improve rheological properties in TGase-crosslinked WPI.	superfine	30-39	transglutaminase 1	Homo sapiens	143-148
32350151-0	2020	The influence of retinol concentration in liquid crystal formula on epidermal growth factor, interleukin-6 and transglutaminase-1 mRNA expression in the epidermis.	Vitamin A	17-24	transglutaminase 1	Homo sapiens	111-129
32168369-0	2020	Ethylene carbonate adsorption on the major surfaces of lithium manganese oxide Li1-xMn2O4 spinel (0.000 < x < 0.375): a DFT+U-D3 study.	ethylene carbonate	0-18	transglutaminase 1	Homo sapiens	79-82
32168369-0	2020	Ethylene carbonate adsorption on the major surfaces of lithium manganese oxide Li1-xMn2O4 spinel (0.000 < x < 0.375): a DFT+U-D3 study.	Lithium	55-62	transglutaminase 1	Homo sapiens	79-82
31951131-4	2020	Spe-cifically, the two characteristic features observed in both 27Al and 71Ga NMR spectra result from both the deviations in the poly-hedral coordination/site-symmetry within the 4-fold coordinated Li1/24d sites (rather than the doping of the other Li2/96h or La sites) and with the number of occupied adjacent Li2 sites that share oxygen atoms with these dopant sites.	Aluminum	66-68	transglutaminase 1	Homo sapiens	198-201
31951131-4	2020	Spe-cifically, the two characteristic features observed in both 27Al and 71Ga NMR spectra result from both the deviations in the poly-hedral coordination/site-symmetry within the 4-fold coordinated Li1/24d sites (rather than the doping of the other Li2/96h or La sites) and with the number of occupied adjacent Li2 sites that share oxygen atoms with these dopant sites.	gallium arsenide	73-77	transglutaminase 1	Homo sapiens	198-201
31951131-4	2020	Spe-cifically, the two characteristic features observed in both 27Al and 71Ga NMR spectra result from both the deviations in the poly-hedral coordination/site-symmetry within the 4-fold coordinated Li1/24d sites (rather than the doping of the other Li2/96h or La sites) and with the number of occupied adjacent Li2 sites that share oxygen atoms with these dopant sites.	poly If	129-133	transglutaminase 1	Homo sapiens	198-201
31951131-4	2020	Spe-cifically, the two characteristic features observed in both 27Al and 71Ga NMR spectra result from both the deviations in the poly-hedral coordination/site-symmetry within the 4-fold coordinated Li1/24d sites (rather than the doping of the other Li2/96h or La sites) and with the number of occupied adjacent Li2 sites that share oxygen atoms with these dopant sites.	Oxygen	332-338	transglutaminase 1	Homo sapiens	198-201
32350151-13	2020	Interestingly, TGM1 expression was found to increase together with increasing retinol concentration (0.15%, 0.3%, 0.5%).	Vitamin A	78-85	transglutaminase 1	Homo sapiens	15-19
31654744-9	2019	Furthermore, Vitamin E preconditioned cells exposed to thermal stress showed significant down-regulated expression of BAX and up-regulated expression of PCNA, BCL-XL, vascular endothelial growth factor; VEGF, involucrin, transglutaminase 1 (TGM1) and filaggrin (FLG) escorted by increased paracrine release of VEGF, basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF).	Vitamin E	13-22	transglutaminase 1	Homo sapiens	221-239
31847353-5	2019	DTA also upregulated the mRNA expression of various keratinocyte differentiation markers, including TGM-1, involucrin, and caspase-14.	dehydrotrametenolic acid	0-3	transglutaminase 1	Homo sapiens	100-105
31654744-9	2019	Furthermore, Vitamin E preconditioned cells exposed to thermal stress showed significant down-regulated expression of BAX and up-regulated expression of PCNA, BCL-XL, vascular endothelial growth factor; VEGF, involucrin, transglutaminase 1 (TGM1) and filaggrin (FLG) escorted by increased paracrine release of VEGF, basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF).	Vitamin E	13-22	transglutaminase 1	Homo sapiens	241-245
31186660-5	2019	Mc-ME also showed antidehydration properties by inducing the expression of natural moisturizing factors such as filaggrin (FLG), transglutaminase-1 (TGM-1), and hyaluronic acid synthase (HAS)-1, -2, and -3 in HaCaT cells.	mc-me	0-5	transglutaminase 1	Homo sapiens	129-147
31479092-2	2019	Here, we evaluate the industrially-applied chemoenzymatic "Q-tag" strategy based on transglutaminase-mediated (TGase) amide-bond formation in the generation of 89Zr-radiolabelled antibody conjugates.	Amides	118-123	transglutaminase 1	Homo sapiens	84-109
31479092-2	2019	Here, we evaluate the industrially-applied chemoenzymatic "Q-tag" strategy based on transglutaminase-mediated (TGase) amide-bond formation in the generation of 89Zr-radiolabelled antibody conjugates.	Amides	118-123	transglutaminase 1	Homo sapiens	111-116
30955600-3	2019	Current results showed that microbial transglutaminase (TGase) remarkably enhanced the gel strength, water holding capacity and viscoelasticity of HFT.	Water	101-106	transglutaminase 1	Homo sapiens	38-54
30955600-3	2019	Current results showed that microbial transglutaminase (TGase) remarkably enhanced the gel strength, water holding capacity and viscoelasticity of HFT.	Water	101-106	transglutaminase 1	Homo sapiens	56-61
30955600-5	2019	TGase-induced intermolecular epsilon-(gamma-glutamyl) lysine strengthened protein network and contributed the most to HFT structure.	(gamma-glutamyl) lysine	37-60	transglutaminase 1	Homo sapiens	0-5
31124653-3	2019	Here, fully ordered Li1.2Mn0.54Ni0.13Co0.13O2 spheres of shortened primary particle size were synthesized via the coprecipitation method for use as cathodes.	13o2	41-45	transglutaminase 1	Homo sapiens	20-23
31199108-3	2019	In contrast, NASICON-type phosphates such as Li1+ xAl xTi2- x(PO4)3 and Li1+ xAl xGe2- x(PO4)3 are stable at high potentials, but their mechanical rigidity and high grain boundary resistance are thought to impede their application in bulk-type solid-state batteries.	Phosphates	26-36	transglutaminase 1	Homo sapiens	45-48
31199108-3	2019	In contrast, NASICON-type phosphates such as Li1+ xAl xTi2- x(PO4)3 and Li1+ xAl xGe2- x(PO4)3 are stable at high potentials, but their mechanical rigidity and high grain boundary resistance are thought to impede their application in bulk-type solid-state batteries.	Phosphates	26-36	transglutaminase 1	Homo sapiens	72-75
30744866-6	2019	MW enhanced intermolecular forces by engendering more disulfide bonds, which hindered the catalysis by TGase.	Disulfides	54-63	transglutaminase 1	Homo sapiens	103-108
31687798-2	2019	Herein, cation-disordered rocksalt-type Li-Fe-Ti oxides of Li0.89Fe0.44Ti0.45O2, Li1.18Fe0.34Ti0.45O2, and Li1.24Fe0.38Ti0.38O2 with different Li-to-transition metal ratios (Li/TM = 1, 1.49, or 1.63) are investigated to understand the effect of a Li excess on the electrochemical Li-ion storage properties.	Iron	43-45	transglutaminase 1	Homo sapiens	81-84
31815231-0	2019	Temperature-Controlled Synthesis of Li- and Mn-Rich Li1.2Mn0.54Ni0.13Co0.13O2 Hollow Nano/Sub-Microsphere Electrodes for High-Performance Lithium-Ion Battery.	13o2	73-77	transglutaminase 1	Homo sapiens	52-55
31815231-0	2019	Temperature-Controlled Synthesis of Li- and Mn-Rich Li1.2Mn0.54Ni0.13Co0.13O2 Hollow Nano/Sub-Microsphere Electrodes for High-Performance Lithium-Ion Battery.	Lithium	138-145	transglutaminase 1	Homo sapiens	52-55
31815231-2	2019	Here, we report the formation of well-crystallized homogeneously dispersed Li1.2Mn0.54Ni0.13Co0.13O2 hollow nano/sub-microsphere architectures through a simple cost-effective coprecipitation and chemical mixing route without surface modification for improving the efficiency of energy storage devices.	13o2	96-100	transglutaminase 1	Homo sapiens	75-78
31815231-3	2019	The synthesized Li1.2Mn0.54Ni0.13Co0.13O2 hollow nano/sub-microsphere cathode materials are calcined at 800, 900, 950, and 1000  C. Among them, Li1.2Mn0.54Ni0.13Co0.13O2 calcined at 950  C exhibits a high discharge capacity (277 mAh g-1 at 0.1C rate) and excellent capacity retention (88%) after 50 cycles and also delivers an excellent discharge capacity of >172 mAh g-1 at 5C rate.	13o2	37-41	transglutaminase 1	Homo sapiens	16-19
31815231-3	2019	The synthesized Li1.2Mn0.54Ni0.13Co0.13O2 hollow nano/sub-microsphere cathode materials are calcined at 800, 900, 950, and 1000  C. Among them, Li1.2Mn0.54Ni0.13Co0.13O2 calcined at 950  C exhibits a high discharge capacity (277 mAh g-1 at 0.1C rate) and excellent capacity retention (88%) after 50 cycles and also delivers an excellent discharge capacity of >172 mAh g-1 at 5C rate.	13o2	37-41	transglutaminase 1	Homo sapiens	144-147
31815231-5	2019	Higher calcination temperature (>=950  C) leads to an increase of the primary particle size, poor cycling stability, and inferior rate capacity of Li1.2Mn0.54Ni0.13Co0.13O2 due to smashing of quasi-hollow spheres upon repeated lithium ion intercalations/deintercalations.	Lithium	227-234	transglutaminase 1	Homo sapiens	147-150
31432823-1	2019	Solid-state Li1+xAlxGe2-x(PO4)3 electrolytes with high ionic conductivity were prepared and successfully applied in lithium-oxygen batteries (LOBs).	xalxge2-x(po4)3	16-31	transglutaminase 1	Homo sapiens	12-15
31432823-1	2019	Solid-state Li1+xAlxGe2-x(PO4)3 electrolytes with high ionic conductivity were prepared and successfully applied in lithium-oxygen batteries (LOBs).	Lithium	116-123	transglutaminase 1	Homo sapiens	12-15
31432823-1	2019	Solid-state Li1+xAlxGe2-x(PO4)3 electrolytes with high ionic conductivity were prepared and successfully applied in lithium-oxygen batteries (LOBs).	Oxygen	124-130	transglutaminase 1	Homo sapiens	12-15
31432823-1	2019	Solid-state Li1+xAlxGe2-x(PO4)3 electrolytes with high ionic conductivity were prepared and successfully applied in lithium-oxygen batteries (LOBs).	lobs	142-146	transglutaminase 1	Homo sapiens	12-15
31438686-5	2019	The significant negative deviation of the real conductivity of (Li1-xCsx)2CO3 from the one estimated by the Nernst-Einstein (NE) relation is clearly explained by the contribution from the cross correlations; specifically, the cross term between Li+and CO3 2-, which is negative at x = 0, significantly shifts to the positive side when x increases, which is dominantly responsible for dampening the conductivity from the NE conductivity.	co3 2	252-257	transglutaminase 1	Homo sapiens	64-67
31339042-4	2019	Here, LZTO is a solid solution of Li[Li1/3Ti5/3]O4 (x = 0) and Li2ZnTi3O8 (x = 0.5), both of which have a spinel-framework structure.	lzto	6-10	transglutaminase 1	Homo sapiens	37-40
31203612-0	2019	Lithium Deficiencies Engineering in Li-Rich Layered Oxide Li1.098Mn0.533Ni0.113Co0.138O2 for High-Stability Cathode.	Lithium	0-7	transglutaminase 1	Homo sapiens	58-61
30968397-0	2019	Congenital lamellar ichthyosis in Tunisia associated with vitamin D rickets caused by a founder nonsense mutation in the TGM1 gene.	Vitamin D	58-67	transglutaminase 1	Homo sapiens	121-125
31097727-1	2019	We report a new diluted ferromagnetic semiconductor Li1+y(Cd,Mn)P, wherein carrier is doped via excess Li while spin is doped by isovalence substitution of Mn2+ into Cd2+.	Manganese(2+)	156-160	transglutaminase 1	Homo sapiens	52-55
31067675-6	2019	Treatment of T-Skin  with retinol decreased the expression of differentiation markers, cytokeratin 10 and transglutaminase 1 and increased the proliferation marker, Ki67, in epidermis basal-layer cells.	Vitamin A	26-33	transglutaminase 1	Homo sapiens	106-124
31186660-5	2019	Mc-ME also showed antidehydration properties by inducing the expression of natural moisturizing factors such as filaggrin (FLG), transglutaminase-1 (TGM-1), and hyaluronic acid synthase (HAS)-1, -2, and -3 in HaCaT cells.	mc-me	0-5	transglutaminase 1	Homo sapiens	149-154
30594623-10	2019	SDS-PAGE confirmed that TGase positively facilitated the formation of the protein polymers.	Sodium Dodecyl Sulfate	0-3	transglutaminase 1	Homo sapiens	24-29
30594623-10	2019	SDS-PAGE confirmed that TGase positively facilitated the formation of the protein polymers.	Polymers	82-90	transglutaminase 1	Homo sapiens	24-29
30730128-0	2019	Constructing Effective Interfaces for Li1.5Al0.5Ge1.5(PO4)3 Pellets To Achieve Room-Temperature Hybrid Solid-State Lithium Metal Batteries.	lithium metal	115-128	transglutaminase 1	Homo sapiens	38-41
30785159-1	2019	We prepare the lithium-rich layered oxide Li1.2Mn0.54Co0.13Ni0.13O2 with a 3.65 V average-discharge voltage by using lithiated homologous spinel Li0.4Mn0.54Ni0.13Co0.13O1.6 in an O2 atmosphere.	Lithium	15-22	transglutaminase 1	Homo sapiens	42-45
30785159-1	2019	We prepare the lithium-rich layered oxide Li1.2Mn0.54Co0.13Ni0.13O2 with a 3.65 V average-discharge voltage by using lithiated homologous spinel Li0.4Mn0.54Ni0.13Co0.13O1.6 in an O2 atmosphere.	Oxygen	65-67	transglutaminase 1	Homo sapiens	42-45
30817128-0	2019	Formation and Effect of Residual Lithium Compounds on Li-Rich Cathode Material Li1.35[Ni0.35Mn0.65]O2.	Lithium	33-40	transglutaminase 1	Homo sapiens	79-82
30817128-0	2019	Formation and Effect of Residual Lithium Compounds on Li-Rich Cathode Material Li1.35[Ni0.35Mn0.65]O2.	li-rich cathode	54-69	transglutaminase 1	Homo sapiens	79-82
30817128-0	2019	Formation and Effect of Residual Lithium Compounds on Li-Rich Cathode Material Li1.35[Ni0.35Mn0.65]O2.	CHEMBL2180945	86-89	transglutaminase 1	Homo sapiens	79-82
30817128-0	2019	Formation and Effect of Residual Lithium Compounds on Li-Rich Cathode Material Li1.35[Ni0.35Mn0.65]O2.	Oxygen	99-101	transglutaminase 1	Homo sapiens	79-82
30817128-5	2019	The formation and effect of residual lithium compounds on Li-rich cathode material Li1.35[Ni0.35Mn0.65]O2 were systematically investigated.	Lithium	37-44	transglutaminase 1	Homo sapiens	83-86
30730128-2	2019	Although Li1.5Al0.5Ge1.5(PO4)3 (LAGP) has satisfied ionic conductivity at room temperature (~10-4 S cm-1), high stability in air, and can be easily sintered, it still suffers from instability of the lithium metal.	lithium metal	199-212	transglutaminase 1	Homo sapiens	9-12
30615410-2	2019	Recently, colloidal chemistry methods have enabled the design of core-shell nanocrystals of Li1+ xMn2- xO4, an important battery cathode, with passivating shells rich in Al3+ through a colloidal synthetic route.	ALUMINUM ION	170-174	transglutaminase 1	Homo sapiens	92-95
30615410-7	2019	Li1+ xMn2- xO4 nanocrystals with Al3+-rich shells of different thicknesses were synthesized.	ALUMINUM ION	33-37	transglutaminase 1	Homo sapiens	0-3
30422620-0	2018	High-Resolution Surface Analysis on Aluminum Oxide-Coated Li1.2Mn0.55Ni0.15Co0.1O2 with Improved Capacity Retention.	Aluminum Oxide	36-50	transglutaminase 1	Homo sapiens	58-61
30236711-1	2019	Transglutaminase (TGase) catalyzing crosslinking between intra- and inter-chain glutamine and lysine peptide residues has been used for modifying protein"s structure.	Glutamine	80-89	transglutaminase 1	Homo sapiens	0-16
30236711-1	2019	Transglutaminase (TGase) catalyzing crosslinking between intra- and inter-chain glutamine and lysine peptide residues has been used for modifying protein"s structure.	Glutamine	80-89	transglutaminase 1	Homo sapiens	18-23
30236711-1	2019	Transglutaminase (TGase) catalyzing crosslinking between intra- and inter-chain glutamine and lysine peptide residues has been used for modifying protein"s structure.	lysine peptide	94-108	transglutaminase 1	Homo sapiens	0-16
30236711-1	2019	Transglutaminase (TGase) catalyzing crosslinking between intra- and inter-chain glutamine and lysine peptide residues has been used for modifying protein"s structure.	lysine peptide	94-108	transglutaminase 1	Homo sapiens	18-23
30267992-3	2019	To this end, human plasma gels were synthesized with the addition of increasing concentrations of transglutaminase (TGase), which catalyses the formation of covalent bonds between Lys and Glu residues.	Lysine	180-183	transglutaminase 1	Homo sapiens	98-114
30267992-3	2019	To this end, human plasma gels were synthesized with the addition of increasing concentrations of transglutaminase (TGase), which catalyses the formation of covalent bonds between Lys and Glu residues.	Lysine	180-183	transglutaminase 1	Homo sapiens	116-121
30267992-3	2019	To this end, human plasma gels were synthesized with the addition of increasing concentrations of transglutaminase (TGase), which catalyses the formation of covalent bonds between Lys and Glu residues.	Glutamic Acid	188-191	transglutaminase 1	Homo sapiens	98-114
30267992-3	2019	To this end, human plasma gels were synthesized with the addition of increasing concentrations of transglutaminase (TGase), which catalyses the formation of covalent bonds between Lys and Glu residues.	Glutamic Acid	188-191	transglutaminase 1	Homo sapiens	116-121
30457600-0	2018	Synthesis and electrochemical properties of Li1.3Nb0.3Cr0.4O2 as a high-capacity cathode material for rechargeable lithium batteries.	Lithium	115-122	transglutaminase 1	Homo sapiens	44-47
29627904-0	2018	Site-specific derivatization of human interferon beta-1a at lysine residues using microbial transglutaminase.	Lysine	60-66	transglutaminase 1	Homo sapiens	92-108
30546993-0	2018	The nanoscaled metal-organic framework ICR-2 as a carrier of porphyrins for photodynamic therapy.	Metals	15-20	transglutaminase 1	Homo sapiens	39-44
30546993-0	2018	The nanoscaled metal-organic framework ICR-2 as a carrier of porphyrins for photodynamic therapy.	Porphyrins	61-71	transglutaminase 1	Homo sapiens	39-44
30028123-0	2018	Investigation on the Electrochemical Properties and Stabilized Surface/Interface of Nano-AlPO4-Coated Li1.15Ni0.17Co0.11Mn0.57O2 as the Cathode for Lithium-Ion Batteries.	alpo4	89-94	transglutaminase 1	Homo sapiens	102-105
30028123-0	2018	Investigation on the Electrochemical Properties and Stabilized Surface/Interface of Nano-AlPO4-Coated Li1.15Ni0.17Co0.11Mn0.57O2 as the Cathode for Lithium-Ion Batteries.	Lithium	148-155	transglutaminase 1	Homo sapiens	102-105
30028123-3	2018	A systematic investigation has been carried out on the nano-AlPO4 coating layer for the Li1.15Ni0.17Co0.11Mn0.57O2 cathode material through a facile in situ dispersion process.	alpo4	60-65	transglutaminase 1	Homo sapiens	88-91
29912547-0	2018	Coprecipitation-Gel Synthesis and Degradation Mechanism of Octahedral Li1.2Mn0.54Ni0.13Co0.13O2 as High-Performance Cathode Materials for Lithium-Ion Batteries.	Lithium	138-145	transglutaminase 1	Homo sapiens	70-73
29912547-1	2018	The octahedral core-shell Li-rich layered cathode material of Li1.2Mn0.54Ni0.13Co0.13O2 can be synthesized via an ingenious coprecipitation-gel method without subsequent annealing.	13o2	83-87	transglutaminase 1	Homo sapiens	62-65
29912547-3	2018	The surface area of Li1.2Mn0.54Ni0.13Co0.13O2 crystals where the spinel phase is located possesses sufficient Li and O vacancies, resulting in the reinsertion of Li into position after the first charge and maintenance of the interface stability via the replenishment of oxygen from the bulk region.	Oxygen	270-276	transglutaminase 1	Homo sapiens	20-23
30148344-0	2018	Multiple Linkage Modification of Lithium-Rich Layered Oxide Li1.2Mn0.54Ni0.13Co0.13O2 for Lithium Ion Battery.	Lithium	33-40	transglutaminase 1	Homo sapiens	60-63
30148344-0	2018	Multiple Linkage Modification of Lithium-Rich Layered Oxide Li1.2Mn0.54Ni0.13Co0.13O2 for Lithium Ion Battery.	Lithium	90-97	transglutaminase 1	Homo sapiens	60-63
30151508-1	2018	At present, the most common type of cathode materials, NCA (Li1-xNi0.80Co0.15Al0.05O2, x = 0 to 1), have a very high concentration of cobalt.	Cobalt	134-140	transglutaminase 1	Homo sapiens	60-63
30009306-0	2018	Role of transition metals in a charge transfer mechanism and oxygen removal in Li1.17Ni0.17Mn0.5Co0.17O2: experimental and first-principles analysis.	Oxygen	61-67	transglutaminase 1	Homo sapiens	79-82
30009306-1	2018	Oxygen removal from high capacity Li-rich layered oxide Li1.17Ni0.17Mn0.5Co0.17O2 affects the charge transfer process during cycling.	Oxygen	0-6	transglutaminase 1	Homo sapiens	56-59
30009306-8	2018	A detailed explanation of oxygen removal and the charge transfer mechanism of Li1.17Ni0.17Mn0.5Co0.17O2 and Li2MnO3 is provided in the current experimental and density functional theory based study.	Oxygen	26-32	transglutaminase 1	Homo sapiens	78-81
30009306-8	2018	A detailed explanation of oxygen removal and the charge transfer mechanism of Li1.17Ni0.17Mn0.5Co0.17O2 and Li2MnO3 is provided in the current experimental and density functional theory based study.	17mn0	88-93	transglutaminase 1	Homo sapiens	78-81
30009306-8	2018	A detailed explanation of oxygen removal and the charge transfer mechanism of Li1.17Ni0.17Mn0.5Co0.17O2 and Li2MnO3 is provided in the current experimental and density functional theory based study.	.17o2	98-103	transglutaminase 1	Homo sapiens	78-81
30009306-8	2018	A detailed explanation of oxygen removal and the charge transfer mechanism of Li1.17Ni0.17Mn0.5Co0.17O2 and Li2MnO3 is provided in the current experimental and density functional theory based study.	li2mno3	108-115	transglutaminase 1	Homo sapiens	78-81
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Glutamine	134-143	transglutaminase 1	Homo sapiens	10-26
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Glutamine	134-143	transglutaminase 1	Homo sapiens	28-33
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Glutamine	145-148	transglutaminase 1	Homo sapiens	10-26
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Glutamine	145-148	transglutaminase 1	Homo sapiens	28-33
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Lysine	153-159	transglutaminase 1	Homo sapiens	10-26
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Lysine	153-159	transglutaminase 1	Homo sapiens	28-33
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Lysine	161-164	transglutaminase 1	Homo sapiens	10-26
29627904-1	2018	Microbial transglutaminase (TGase) has been successfully used to produce site-specific protein conjugates derivatized at the level of glutamine (Gln) or lysine (Lys) residues with diverse applications.	Lysine	161-164	transglutaminase 1	Homo sapiens	28-33
29627904-4	2018	The 166 amino acids polypeptide chain of IFN beta-1a contains 11 Lys and 11 Gln residues potential sites of TGase derivatization.	Glutamine	76-79	transglutaminase 1	Homo sapiens	108-113
29488926-3	2018	Examination of the phase transformations in the Li1-xFe0.5Mn0.5PO4 positive electrode (cathode) material at C/2 and 10C charge and discharge rates, and a study of the valence state of the Ni cations in the Li1-xNi0.5Mn1.5O4 cathode material for Li-ion batteries, revealed the applicability of this novel cell design to diffraction and spectroscopic investigations of high-power/high-voltage electrodes for metal-ion batteries.	5po4	62-66	transglutaminase 1	Homo sapiens	48-51
29728265-6	2018	In the 3% PADB4.91/2% PADB4.06 ATPS, enzyme recovery of 96.51%, partition coefficient of 4.23 and purification factor of 3.73 for TGase were obtained in the presence of 60 mmol/L MgSO4 and at pH 7.00.	atps	31-35	transglutaminase 1	Homo sapiens	130-135
29728265-6	2018	In the 3% PADB4.91/2% PADB4.06 ATPS, enzyme recovery of 96.51%, partition coefficient of 4.23 and purification factor of 3.73 for TGase were obtained in the presence of 60 mmol/L MgSO4 and at pH 7.00.	Magnesium Sulfate	179-184	transglutaminase 1	Homo sapiens	130-135
29728265-7	2018	The result of sodium dodecyl sulfate-polyacrylamide gel electrophoresis shows that TGase can be well separated from crude extract.	Sodium Dodecyl Sulfate	14-36	transglutaminase 1	Homo sapiens	83-88
29728265-7	2018	The result of sodium dodecyl sulfate-polyacrylamide gel electrophoresis shows that TGase can be well separated from crude extract.	polyacrylamide	37-51	transglutaminase 1	Homo sapiens	83-88
29675405-0	2018	Effect of Nb and F Co-doping on Li1.2Mn0.54Ni0.13Co0.13O2 Cathode Material for High-Performance Lithium-Ion Batteries.	Lithium	96-103	transglutaminase 1	Homo sapiens	32-35
29675405-3	2018	The Li1.2Mn0.54-xNbxCo0.13Ni0.13O2-6xF6x shows suppressed voltage fade and higher capacity retention of 98.1% after 200 cycles at rate of 1 C. The replacement of O2- by the strongly electronegative F- is beneficial for suppressed the structure change of Li2MnO3 from the eliminating of oxygen in initial charge process.	Oxygen	32-34	transglutaminase 1	Homo sapiens	4-7
29675405-3	2018	The Li1.2Mn0.54-xNbxCo0.13Ni0.13O2-6xF6x shows suppressed voltage fade and higher capacity retention of 98.1% after 200 cycles at rate of 1 C. The replacement of O2- by the strongly electronegative F- is beneficial for suppressed the structure change of Li2MnO3 from the eliminating of oxygen in initial charge process.	li2mno3	254-261	transglutaminase 1	Homo sapiens	4-7
29675405-3	2018	The Li1.2Mn0.54-xNbxCo0.13Ni0.13O2-6xF6x shows suppressed voltage fade and higher capacity retention of 98.1% after 200 cycles at rate of 1 C. The replacement of O2- by the strongly electronegative F- is beneficial for suppressed the structure change of Li2MnO3 from the eliminating of oxygen in initial charge process.	Oxygen	286-292	transglutaminase 1	Homo sapiens	4-7
29977690-1	2018	Correlative microscopy has been used to investigate the relationship between Li-ion conductivity and the microstructure of lithium aluminum titanium phosphate (Li1.3Al0.3Ti1.7(PO4)3, LATP) with high spatial resolution.	lithium aluminum titanium phosphate	123-158	transglutaminase 1	Homo sapiens	160-163
29569902-1	2018	Owing to high specific capacity of ~250 mA h g-1, lithium-rich layered oxide cathode materials (Li1+ xNi yCo zMn(3- x-2 y-3 z)/4O2) have been considered as one of the most promising candidates for the next-generation cathode materials of lithium ion batteries.	Lithium	50-57	transglutaminase 1	Homo sapiens	96-99
29768813-2	2018	Doping the cathodes with Al3+ and Cl- ions enhanced electrochemical performance at room temperature and at a high working temperature of 55  C. The as-synthesized optimal composition was Li1.2Ni0.37Al0.03Mn0.6O2.17Cl0.03.	ALUMINUM ION	25-29	transglutaminase 1	Homo sapiens	187-190
29445229-0	2018	Enhanced Electrochemical Properties of Zr4+-doped Li1.20[Mn0.52Ni0.20Co0.08]O2 Cathode Material for Lithium-ion Battery at Elevated Temperature.	PRMT5-IN-2	39-42	transglutaminase 1	Homo sapiens	50-53
29445229-0	2018	Enhanced Electrochemical Properties of Zr4+-doped Li1.20[Mn0.52Ni0.20Co0.08]O2 Cathode Material for Lithium-ion Battery at Elevated Temperature.	Lithium	100-107	transglutaminase 1	Homo sapiens	50-53
29445229-3	2018	Besides, after the doping modification with zirconium ions, Li1.20[Mn0.52Ni0.20Co0.08]O2 cathode demonstrated the lower cation mixing, superior cycling performance and higher rate capacities.	Zirconium	44-53	transglutaminase 1	Homo sapiens	60-63
29316635-4	2018	RT-PCR showed that EGCG increased the expression of natural moisturizing factor-related genes filaggrin (FLG), transglutaminase-1, HAS-1, and HAS-2.	epigallocatechin gallate	19-23	transglutaminase 1	Homo sapiens	111-129
28876922-1	2017	Porcine myofibrillar protein (MP) was modified with glucose oxidase (GluOx)-iron that produces hydroxyl radicals then subjected to microbial transglutaminase (TGase) cross-linking in 0.6 M NaCl at 4  C. The resulting aggregation and gel formation of MP were examined.	Iron	76-80	transglutaminase 1	Homo sapiens	159-164
29165462-0	2017	Lithium diffusion study in Li2MnO3 and Li1.17Ni0.17Mn0.67O2: a combined experimental and computational approach.	Lithium	0-7	transglutaminase 1	Homo sapiens	39-42
28959878-1	2017	The degradation mechanism of dimethyl carbonate electrolyte dissociation on the (010) surfaces of LiCoO2 and delithiated Li1/3CoO2 were investigated by periodic density functional theory.	methyl carbonate	29-47	transglutaminase 1	Homo sapiens	121-124
28959878-2	2017	The high-throughput Madelung matrix calculation was employed to screen possible Li1/3CoO2 supercells for models of the charged state at 4.5 V. The result shows that the Li1/3CoO2(010) surface presents much stronger attraction toward dimethyl carbonate molecule with the adsorption energy of -1.98 eV than the LiCoO2(010) surface does.	methyl carbonate	233-251	transglutaminase 1	Homo sapiens	80-83
28959878-2	2017	The high-throughput Madelung matrix calculation was employed to screen possible Li1/3CoO2 supercells for models of the charged state at 4.5 V. The result shows that the Li1/3CoO2(010) surface presents much stronger attraction toward dimethyl carbonate molecule with the adsorption energy of -1.98 eV than the LiCoO2(010) surface does.	methyl carbonate	233-251	transglutaminase 1	Homo sapiens	169-172
28959878-2	2017	The high-throughput Madelung matrix calculation was employed to screen possible Li1/3CoO2 supercells for models of the charged state at 4.5 V. The result shows that the Li1/3CoO2(010) surface presents much stronger attraction toward dimethyl carbonate molecule with the adsorption energy of -1.98 eV than the LiCoO2(010) surface does.	licoo2	309-315	transglutaminase 1	Homo sapiens	80-83
28959878-2	2017	The high-throughput Madelung matrix calculation was employed to screen possible Li1/3CoO2 supercells for models of the charged state at 4.5 V. The result shows that the Li1/3CoO2(010) surface presents much stronger attraction toward dimethyl carbonate molecule with the adsorption energy of -1.98 eV than the LiCoO2(010) surface does.	licoo2	309-315	transglutaminase 1	Homo sapiens	169-172
28805145-7	2017	An increase in extracellular TGase activity on the HPT cell membrane was observed in a dose-dependent manner after treatment with Sunitinib malate.	Sunitinib	130-146	transglutaminase 1	Homo sapiens	29-34
28876922-3	2017	The subsequent TGase treatment converted protein aggregates into highly cross-linked polymers.	Polymers	85-93	transglutaminase 1	Homo sapiens	15-20
28431172-1	2017	The spatial distribution of Li ions in a lithium iron phosphate (Li1-xFePO4) single crystal after chemical delithiation is quantitatively investigated using Fe M2,3-edge and valence electron energy loss (EEL) spectroscopy techniques.	Lithium iron phosphate	41-63	transglutaminase 1	Homo sapiens	65-68
28655072-4	2017	We found that Gly-Leu and Leu-Gly dipeptides induced the expression of transglutaminase 1 in normal human epidermal keratinocytes (NHEKs) whereas Leu-Leu dipeptides did not.	glycylleucine	14-21	transglutaminase 1	Homo sapiens	71-89
28655072-4	2017	We found that Gly-Leu and Leu-Gly dipeptides induced the expression of transglutaminase 1 in normal human epidermal keratinocytes (NHEKs) whereas Leu-Leu dipeptides did not.	H-Leu-Gly-OH	26-33	transglutaminase 1	Homo sapiens	71-89
28655072-4	2017	We found that Gly-Leu and Leu-Gly dipeptides induced the expression of transglutaminase 1 in normal human epidermal keratinocytes (NHEKs) whereas Leu-Leu dipeptides did not.	Dipeptides	34-44	transglutaminase 1	Homo sapiens	71-89
28431172-1	2017	The spatial distribution of Li ions in a lithium iron phosphate (Li1-xFePO4) single crystal after chemical delithiation is quantitatively investigated using Fe M2,3-edge and valence electron energy loss (EEL) spectroscopy techniques.	Iron	70-72	transglutaminase 1	Homo sapiens	65-68
28580110-4	2017	Upon successful intercalation of the FeS layer, the superconducting critical temperature Tc of mackinawite is enhanced from 5 K to 8 K for the (Li1-x Fe x OH) delta+ intercalate.	Iron	37-40	transglutaminase 1	Homo sapiens	144-147
28514852-3	2017	In this paper, a simple and effective strategy was introduced to separately encapsulate incompatible trypsin and transglutaminase (TGase) into different poly(ethylene glycol) (PEG) network layer grafted on low-density polyethylene (LDPE) film via visible light induced living photografting polymerization.	Polyethylene Glycols	153-174	transglutaminase 1	Homo sapiens	113-129
28514852-3	2017	In this paper, a simple and effective strategy was introduced to separately encapsulate incompatible trypsin and transglutaminase (TGase) into different poly(ethylene glycol) (PEG) network layer grafted on low-density polyethylene (LDPE) film via visible light induced living photografting polymerization.	Polyethylene Glycols	153-174	transglutaminase 1	Homo sapiens	131-136
28514852-3	2017	In this paper, a simple and effective strategy was introduced to separately encapsulate incompatible trypsin and transglutaminase (TGase) into different poly(ethylene glycol) (PEG) network layer grafted on low-density polyethylene (LDPE) film via visible light induced living photografting polymerization.	Polyethylene Glycols	176-179	transglutaminase 1	Homo sapiens	113-129
28514852-3	2017	In this paper, a simple and effective strategy was introduced to separately encapsulate incompatible trypsin and transglutaminase (TGase) into different poly(ethylene glycol) (PEG) network layer grafted on low-density polyethylene (LDPE) film via visible light induced living photografting polymerization.	Polyethylene Glycols	176-179	transglutaminase 1	Homo sapiens	131-136
28514852-3	2017	In this paper, a simple and effective strategy was introduced to separately encapsulate incompatible trypsin and transglutaminase (TGase) into different poly(ethylene glycol) (PEG) network layer grafted on low-density polyethylene (LDPE) film via visible light induced living photografting polymerization.	Polyethylene	206-230	transglutaminase 1	Homo sapiens	113-129
28514852-3	2017	In this paper, a simple and effective strategy was introduced to separately encapsulate incompatible trypsin and transglutaminase (TGase) into different poly(ethylene glycol) (PEG) network layer grafted on low-density polyethylene (LDPE) film via visible light induced living photografting polymerization.	Polyethylene	206-230	transglutaminase 1	Homo sapiens	131-136
28403434-14	2017	Seven of 10 probands with a compound heterozygous TGM1 genotype had a mutation at either arginine 307 or 315, providing evidence that mutations at these sites are temperature sensitive and highlighting the importance of these residues in the pathogenesis of BSI.	Arginine	89-97	transglutaminase 1	Homo sapiens	50-54
28463517-0	2017	Low-Temperature Carbon Coating of Nanosized Li1.015Al0.06Mn1.925O4 and High-Density Electrode for High-Power Li-Ion Batteries.	Carbon	16-22	transglutaminase 1	Homo sapiens	44-47
28580110-4	2017	Upon successful intercalation of the FeS layer, the superconducting critical temperature Tc of mackinawite is enhanced from 5 K to 8 K for the (Li1-x Fe x OH) delta+ intercalate.	Technetium	89-91	transglutaminase 1	Homo sapiens	144-147
28580110-4	2017	Upon successful intercalation of the FeS layer, the superconducting critical temperature Tc of mackinawite is enhanced from 5 K to 8 K for the (Li1-x Fe x OH) delta+ intercalate.	ferrous sulfide	95-106	transglutaminase 1	Homo sapiens	144-147
28163130-3	2017	Observed from the SDS- PAGE and particle size distribution, some complexes with higher molecule weight and relative bigger size particle occurred in the protein mixture, especially after TGase crosslinking.	Sodium Dodecyl Sulfate	18-21	transglutaminase 1	Homo sapiens	187-192
28284699-0	2017	Incorporated glucosamine adversely affects the emulsifying properties of whey protein isolate polymerized by transglutaminase.	Glucosamine	13-24	transglutaminase 1	Homo sapiens	109-125
28284699-2	2017	However, little is known about how the emulsifying properties change when GlcN residues are incorporated into WPI cross-linked by Tgase.	Glucosamine	74-78	transglutaminase 1	Homo sapiens	130-135
28284699-3	2017	We used Tgase as a biocatalyst to cross-link WPI in the presence of GlcN in a liquid system for 12 h at a moderate temperature (25 C).	Glucosamine	68-72	transglutaminase 1	Homo sapiens	8-13
28284699-5	2017	Addition of 5 U Tgase/g protein improved the emulsifying properties of moderately cross-linked WPI polymers.	Polymers	99-107	transglutaminase 1	Homo sapiens	16-21
28284699-6	2017	The Tgase-treated WPI polymers had a larger particle size (~2.6-fold) than native WPI, which may have reduced coalescence and flocculation in an oil-in-water emulsion system.	Polymers	22-30	transglutaminase 1	Homo sapiens	4-9
28284699-6	2017	The Tgase-treated WPI polymers had a larger particle size (~2.6-fold) than native WPI, which may have reduced coalescence and flocculation in an oil-in-water emulsion system.	Oils	145-148	transglutaminase 1	Homo sapiens	4-9
28284699-6	2017	The Tgase-treated WPI polymers had a larger particle size (~2.6-fold) than native WPI, which may have reduced coalescence and flocculation in an oil-in-water emulsion system.	Water	152-157	transglutaminase 1	Homo sapiens	4-9
28284699-7	2017	However, the incorporation of GlcN residues into WPI, predominantly via enzymatic glycation, partly inhibited the cross-links between the WPI molecules catalyzed by Tgase, reducing the size of the WPI polymers 0.81- to 0.86-fold).	Glucosamine	30-34	transglutaminase 1	Homo sapiens	165-170
28284699-10	2017	However, the improved emulsifying properties of WPI cross-linked by Tgase may be useful in food processing at higher NaCl concentrations due to the formation of the thicker steric barrier at the oil-water interface.	Sodium Chloride	117-121	transglutaminase 1	Homo sapiens	68-73
28284699-10	2017	However, the improved emulsifying properties of WPI cross-linked by Tgase may be useful in food processing at higher NaCl concentrations due to the formation of the thicker steric barrier at the oil-water interface.	Oils	195-198	transglutaminase 1	Homo sapiens	68-73
28284699-10	2017	However, the improved emulsifying properties of WPI cross-linked by Tgase may be useful in food processing at higher NaCl concentrations due to the formation of the thicker steric barrier at the oil-water interface.	Water	199-204	transglutaminase 1	Homo sapiens	68-73
28161375-2	2017	In the present study, we tested the hypothesis that serotonin (5-HT)2A/2C receptor-induced Rho family transamidation and activation regulates dendritic spine morphology and that activation of multiple types of receptors can induce transglutaminase (TGase)-catalyzed transamidation of small G proteins.	Serotonin	52-61	transglutaminase 1	Homo sapiens	231-247
28161375-2	2017	In the present study, we tested the hypothesis that serotonin (5-HT)2A/2C receptor-induced Rho family transamidation and activation regulates dendritic spine morphology and that activation of multiple types of receptors can induce transglutaminase (TGase)-catalyzed transamidation of small G proteins.	Serotonin	52-61	transglutaminase 1	Homo sapiens	249-254
28161375-6	2017	In primary cortical cultures, stimulation of 5-HT2A/2C receptors by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) caused a transient dendritic spine enlargement, which was blocked by TGase inhibition.	4-iodo-2,5-dimethoxyphenylisopropylamine	68-113	transglutaminase 1	Homo sapiens	189-194
28388026-0	2017	Temperature-Dependent Lithium-Ion Diffusion and Activation Energy of Li1.2Co0.13Ni0.13Mn0.54O2 Thin-Film Cathode at Nanoscale by Using Electrochemical Strain Microscopy.	Lithium	22-29	transglutaminase 1	Homo sapiens	69-72
28388026-1	2017	This paper presents the in situ mapping of temperature-dependent lithium-ion diffusion at the nanometer level in thin film Li1.2Co0.13Ni0.13Mn0.54O2 cathode using electrochemical strain microscopy.	Lithium	65-72	transglutaminase 1	Homo sapiens	123-126
28388026-2	2017	The thin-film Li1.2Co0.13Ni0.13Mn0.54O2 cathode exhibits higher lithium-ion diffusivities with increasing temperature, which explains the higher capacity observed in the lithium-ion batteries with a Li-rich cathode at elevated temperature.	Lithium	64-71	transglutaminase 1	Homo sapiens	14-17
28388026-2	2017	The thin-film Li1.2Co0.13Ni0.13Mn0.54O2 cathode exhibits higher lithium-ion diffusivities with increasing temperature, which explains the higher capacity observed in the lithium-ion batteries with a Li-rich cathode at elevated temperature.	Lithium	170-177	transglutaminase 1	Homo sapiens	14-17
28074612-0	2017	A New CuO-Fe2 O3 -Mesocarbon Microbeads Conversion Anode in a High-Performance Lithium-Ion Battery with a Li1.35 Ni0.48 Fe0.1 Mn1.72 O4 Spinel Cathode.	cuo-fe2 o3 -mesocarbon	6-28	transglutaminase 1	Homo sapiens	106-109
28074612-0	2017	A New CuO-Fe2 O3 -Mesocarbon Microbeads Conversion Anode in a High-Performance Lithium-Ion Battery with a Li1.35 Ni0.48 Fe0.1 Mn1.72 O4 Spinel Cathode.	Lithium	79-86	transglutaminase 1	Homo sapiens	106-109
28074612-1	2017	A ternary CuO-Fe2 O3 -mesocarbon microbeads (MCMB) conversion anode was characterized and combined with a high-voltage Li1.35 Ni0.48 Fe0.1 Mn1.72 O4 spinel cathode in a lithium-ion battery of relevant performance in terms of cycling stability and rate capability.	cuo-	10-14	transglutaminase 1	Homo sapiens	119-122
28074612-1	2017	A ternary CuO-Fe2 O3 -mesocarbon microbeads (MCMB) conversion anode was characterized and combined with a high-voltage Li1.35 Ni0.48 Fe0.1 Mn1.72 O4 spinel cathode in a lithium-ion battery of relevant performance in terms of cycling stability and rate capability.	Carbon	45-49	transglutaminase 1	Homo sapiens	119-122
28074612-5	2017	The remarkable stability of the CuO-Fe2 O3 -MCMB electrode and the suitable characteristics in terms of delivered capacity and voltage-profile retention allowed its use in an efficient full lithium-ion cell with a high-voltage Li1.35 Ni0.48 Fe0.1 Mn1.72 O4 cathode.	Lithium	190-197	transglutaminase 1	Homo sapiens	227-230
28317951-0	2017	Facile synthesis of nanoporous Li1+xV1-xO2@C composites as promising anode materials for lithium-ion batteries.	Lithium	89-96	transglutaminase 1	Homo sapiens	31-34
28317951-1	2017	Recently, a layered material with composition Li1+xV1-xO2 has been discovered as a promising alternative anode material to graphite due to its high volumetric capacity and low operation potential.	Graphite	123-131	transglutaminase 1	Homo sapiens	46-49
27796611-0	2017	Synergy of 2-deoxy-D-glucose combined with berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis.	Deoxyglucose	11-28	transglutaminase 1	Homo sapiens	92-108
28201918-7	2017	As the liquid Li1-xSix alloys are within the composition range between 0.20 and 0.50, the increment of the states at the Fermi level with increasing the Si content is nearly identical to the amount of the Li states decreased, leading to an almost unchanged number of total electronic states at the Fermi level.	xsix	18-22	transglutaminase 1	Homo sapiens	14-17
28201918-8	2017	However, since Ge atoms do not favor forming covalent bonding in the liquid alloys to keep the Fermi level at a minimum of the density of states, the liquid Li1-xGex alloys would have more electronic states at the Fermi level and thereby higher dc conductivities than the liquid Li1-xSix alloys within the same composition range.	xsix	283-287	transglutaminase 1	Homo sapiens	157-160
27796611-0	2017	Synergy of 2-deoxy-D-glucose combined with berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis.	Berberine	43-52	transglutaminase 1	Homo sapiens	92-108
27792340-1	2016	Lithium-rich transition metal oxides, Li1+xTM1-xO2 (TM, transition metal), have attracted much attention as potential candidate cathode materials for next generation lithium ion batteries because their high theoretical capacity.	Lithium	0-7	transglutaminase 1	Homo sapiens	38-41
27999831-0	2017	Effect of the lipid II sugar moiety on bacterial transglycosylase: the 4-hydroxy epimer of lipid II is a TGase inhibitor.	muramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol	14-22	transglutaminase 1	Homo sapiens	105-110
27999831-0	2017	Effect of the lipid II sugar moiety on bacterial transglycosylase: the 4-hydroxy epimer of lipid II is a TGase inhibitor.	Sugars	23-28	transglutaminase 1	Homo sapiens	105-110
27999831-0	2017	Effect of the lipid II sugar moiety on bacterial transglycosylase: the 4-hydroxy epimer of lipid II is a TGase inhibitor.	muramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenol	91-99	transglutaminase 1	Homo sapiens	105-110
27999831-2	2017	Unexpectedly, N-deacetyled lipid II decreased its activity dramatically, and the C4-axial OH lipid II became an inhibitor (IC50 = 8 muM) with an approximately 14-fold increase in binding affinity toward TGase (25 vs. 27).	n-deacetyled lipid	14-32	transglutaminase 1	Homo sapiens	203-208
27792340-1	2016	Lithium-rich transition metal oxides, Li1+xTM1-xO2 (TM, transition metal), have attracted much attention as potential candidate cathode materials for next generation lithium ion batteries because their high theoretical capacity.	metal oxides	24-36	transglutaminase 1	Homo sapiens	38-41
27792340-1	2016	Lithium-rich transition metal oxides, Li1+xTM1-xO2 (TM, transition metal), have attracted much attention as potential candidate cathode materials for next generation lithium ion batteries because their high theoretical capacity.	Metals	24-29	transglutaminase 1	Homo sapiens	38-41
27792340-1	2016	Lithium-rich transition metal oxides, Li1+xTM1-xO2 (TM, transition metal), have attracted much attention as potential candidate cathode materials for next generation lithium ion batteries because their high theoretical capacity.	Lithium	166-173	transglutaminase 1	Homo sapiens	38-41
27561482-4	2016	SDS-PAGE confirmed that TGase catalyzed crosslinking of whey protein.	Sodium Dodecyl Sulfate	0-3	transglutaminase 1	Homo sapiens	24-29
27561482-6	2016	Furthermore, TGase resulted in an improvement in the water vapor barrier properties and mechanical properties of WPC-CMC (75:25 and 50:50, v/v) composite films, and there was no impairment of thermal stability of composite films.	Water	53-58	transglutaminase 1	Homo sapiens	13-18
27656906-1	2016	Lithiation of hydrothermally synthesized Li1-xFex(OH)Fe1-ySe turns on high-temperature superconductivity when iron ions are displaced from the hydroxide layers by reductive lithiation to fill the vacancies in the iron selenide layers.	Iron	110-114	transglutaminase 1	Homo sapiens	41-44
27617481-0	2016	Facile Synthesis of Platelike Hierarchical Li1.2Mn0.54Ni0.13Co0.13O2 with Exposed {010} Planes for High-Rate and Long Cycling-Stable Lithium Ion Batteries.	Lithium	133-140	transglutaminase 1	Homo sapiens	43-46
27101214-2	2016	The best-known TGase activity, namely the transamidation of specific proteins by polyamines (PAs), has been studied in plants to verify if TGase is a mediator of PAs mechanism of action to re-interpret some of PAs effects.	Polyamines	81-91	transglutaminase 1	Homo sapiens	15-20
27101214-2	2016	The best-known TGase activity, namely the transamidation of specific proteins by polyamines (PAs), has been studied in plants to verify if TGase is a mediator of PAs mechanism of action to re-interpret some of PAs effects.	Polyamines	81-91	transglutaminase 1	Homo sapiens	139-144
27656906-1	2016	Lithiation of hydrothermally synthesized Li1-xFex(OH)Fe1-ySe turns on high-temperature superconductivity when iron ions are displaced from the hydroxide layers by reductive lithiation to fill the vacancies in the iron selenide layers.	hydroxide ion	143-152	transglutaminase 1	Homo sapiens	41-44
27656906-1	2016	Lithiation of hydrothermally synthesized Li1-xFex(OH)Fe1-ySe turns on high-temperature superconductivity when iron ions are displaced from the hydroxide layers by reductive lithiation to fill the vacancies in the iron selenide layers.	Iron selenide	213-226	transglutaminase 1	Homo sapiens	41-44
27367435-5	2016	A formation of the oxidized oxygen species upon electrochemical Li extraction coincides with transformation of the layered Li1-xRhO2 structure into the gamma-MnO2-type rutile-ramsdellite intergrowth LiyRh3O6 structure with rutile-like [1 x 1] channels along with bigger ramsdellite-like [2 x 1] tunnels through massive and concerted Rh migration toward the empty positions in the Li layers.	Oxygen	28-34	transglutaminase 1	Homo sapiens	123-126
27541695-1	2016	UNLABELLED: Composites of lithium-rich Li1.2Ni0.2Mn0.6O2 and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) ( PEDOT: PSS) are synthesized through coprecipitation followed by a wet coating method.	Lithium	26-33	transglutaminase 1	Homo sapiens	39-42
27541695-1	2016	UNLABELLED: Composites of lithium-rich Li1.2Ni0.2Mn0.6O2 and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) ( PEDOT: PSS) are synthesized through coprecipitation followed by a wet coating method.	.6o2	52-56	transglutaminase 1	Homo sapiens	39-42
27541695-2	2016	In the resulting samples, the amorphous conductive polymer films on the surface of the Li1.2Ni0.2Mn0.6O2 particles are 5-20 nm thick.	Polymers	51-58	transglutaminase 1	Homo sapiens	87-90
27541695-3	2016	The electrochemical properties of Li1.2Ni0.2Mn0.6O2 are obviously enhanced after PEDOT: PSS coating.	2ni0	38-42	transglutaminase 1	Homo sapiens	34-37
27541695-3	2016	The electrochemical properties of Li1.2Ni0.2Mn0.6O2 are obviously enhanced after PEDOT: PSS coating.	2mn0	43-47	transglutaminase 1	Homo sapiens	34-37
27541695-3	2016	The electrochemical properties of Li1.2Ni0.2Mn0.6O2 are obviously enhanced after PEDOT: PSS coating.	6O2	48-51	transglutaminase 1	Homo sapiens	34-37
28773783-0	2016	Nano-Crystalline Li1.2Mn0.6Ni0.2O2 Prepared via Amorphous Complex Precursor and Its Electrochemical Performances as Cathode Material for Lithium-Ion Batteries.	Lithium	137-144	transglutaminase 1	Homo sapiens	17-20
28773783-1	2016	An amorphous complex precursor with uniform Mn/Ni cation distribution is attempted for preparing a nano-structured layered Li-rich oxide (Li1.2Mn0.6Ni0.2O2)cathode material, using diethylenetriaminepentaacetic acid (DTPA) as a chelating agent.	li-rich oxide	123-136	transglutaminase 1	Homo sapiens	138-141
28773783-1	2016	An amorphous complex precursor with uniform Mn/Ni cation distribution is attempted for preparing a nano-structured layered Li-rich oxide (Li1.2Mn0.6Ni0.2O2)cathode material, using diethylenetriaminepentaacetic acid (DTPA) as a chelating agent.	Pentetic Acid	180-214	transglutaminase 1	Homo sapiens	138-141
27570369-7	2016	The symmetry reduction seems to be initiated by the ordering of Fe3+ onto the tetrahedral Li1 (12a) site of space group I43d.	ferric sulfate	64-68	transglutaminase 1	Homo sapiens	90-93
27320123-0	2016	Lithium-Rich Layered Oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 as the Cathode Material for Hybrid Sodium-Ion Batteries.	Lithium	0-7	transglutaminase 1	Homo sapiens	27-30
27320123-0	2016	Lithium-Rich Layered Oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 as the Cathode Material for Hybrid Sodium-Ion Batteries.	layered oxide	13-26	transglutaminase 1	Homo sapiens	27-30
27320123-0	2016	Lithium-Rich Layered Oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 as the Cathode Material for Hybrid Sodium-Ion Batteries.	CO0	41-44	transglutaminase 1	Homo sapiens	27-30
27320123-0	2016	Lithium-Rich Layered Oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 as the Cathode Material for Hybrid Sodium-Ion Batteries.	Manganese	48-51	transglutaminase 1	Homo sapiens	27-30
27320123-0	2016	Lithium-Rich Layered Oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 as the Cathode Material for Hybrid Sodium-Ion Batteries.	Sodium	93-99	transglutaminase 1	Homo sapiens	27-30
27320123-1	2016	Li-rich layered oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 (LNCM) is, for the first time, examined as the positive electrode for hybrid sodium-ion battery and its Na(+) storage properties are comprehensively studied in terms of galvanostatic charge-discharge curves, cyclic voltammetry and rate capability.	Oxides	16-21	transglutaminase 1	Homo sapiens	22-25
27320123-1	2016	Li-rich layered oxide Li1.18 Ni0.15 Co0.15 Mn0.52 O2 (LNCM) is, for the first time, examined as the positive electrode for hybrid sodium-ion battery and its Na(+) storage properties are comprehensively studied in terms of galvanostatic charge-discharge curves, cyclic voltammetry and rate capability.	Sodium	130-136	transglutaminase 1	Homo sapiens	22-25
27022834-1	2016	The spinel Li[Mn2]O4 is a candidate cathode for a Li-ion battery, but its capacity fades over a charge/discharge cycle of Li1-x[Mn2]O4 (0 &lt; x &lt; 1) that is associated with a loss of Mn to the organic-liquid electrolyte.	mn2]o4	14-20	transglutaminase 1	Homo sapiens	122-125
27127906-1	2016	A lithium ionic conductor, Li1.3Al0.3Ti1.7(PO4)3 (LATP), is introduced as a coating material on the surface of Mg-doped LiCoO2 to improve electrochemical performances for high-voltage (4.5 V) lithium ion batteries.	Lithium	2-9	transglutaminase 1	Homo sapiens	27-30
27127906-1	2016	A lithium ionic conductor, Li1.3Al0.3Ti1.7(PO4)3 (LATP), is introduced as a coating material on the surface of Mg-doped LiCoO2 to improve electrochemical performances for high-voltage (4.5 V) lithium ion batteries.	latp	50-54	transglutaminase 1	Homo sapiens	27-30
27127906-1	2016	A lithium ionic conductor, Li1.3Al0.3Ti1.7(PO4)3 (LATP), is introduced as a coating material on the surface of Mg-doped LiCoO2 to improve electrochemical performances for high-voltage (4.5 V) lithium ion batteries.	Magnesium	111-113	transglutaminase 1	Homo sapiens	27-30
27127906-1	2016	A lithium ionic conductor, Li1.3Al0.3Ti1.7(PO4)3 (LATP), is introduced as a coating material on the surface of Mg-doped LiCoO2 to improve electrochemical performances for high-voltage (4.5 V) lithium ion batteries.	licoo2	120-126	transglutaminase 1	Homo sapiens	27-30
27127906-1	2016	A lithium ionic conductor, Li1.3Al0.3Ti1.7(PO4)3 (LATP), is introduced as a coating material on the surface of Mg-doped LiCoO2 to improve electrochemical performances for high-voltage (4.5 V) lithium ion batteries.	Lithium	192-199	transglutaminase 1	Homo sapiens	27-30
26234923-0	2016	Pre-deamidation of soy protein isolate exerts impacts on transglutaminase-induced glucosamine glycation and cross-linking as well as properties of the products.	Glucosamine	82-93	transglutaminase 1	Homo sapiens	57-73
27217744-9	2016	Compared with nonsensitive micelles, docetaxel (DTX)-loaded TGK micelles showed a fold higher cellular uptake in HT1080 cells.	Docetaxel	37-46	transglutaminase 1	Homo sapiens	60-63
27217744-9	2016	Compared with nonsensitive micelles, docetaxel (DTX)-loaded TGK micelles showed a fold higher cellular uptake in HT1080 cells.	Docetaxel	48-51	transglutaminase 1	Homo sapiens	60-63
26835219-0	2016	Separation of transglutaminase by thermo-responsive affinity precipitation using l-thyroxin as ligand.	Thyroxine	81-91	transglutaminase 1	Homo sapiens	14-30
26585018-8	2016	In conclusion, HIU changed physicochemical and structural properties of SPI, producing better substrates for TGase.	(R)-3-hydroxy-2-methylpropanoic acid	15-18	transglutaminase 1	Homo sapiens	109-114
26835219-2	2016	In this study, TGase was purified by affinity precipitation using l-thyroxin, coupled to a thermo-responsive polymer (PNBN), as an affinity ligand.	Thyroxine	66-76	transglutaminase 1	Homo sapiens	15-20
26835219-2	2016	In this study, TGase was purified by affinity precipitation using l-thyroxin, coupled to a thermo-responsive polymer (PNBN), as an affinity ligand.	pnbn	118-122	transglutaminase 1	Homo sapiens	15-20
26835219-6	2016	Circular dichroism spectroscopy and ForteBio Octet system were used to explore the interactions between l-thyroxin and TGase.	Thyroxine	104-114	transglutaminase 1	Homo sapiens	119-124
26835219-7	2016	The results show that l-thyroxin is suitable for affinity precipitation of TGase.	Thyroxine	22-32	transglutaminase 1	Homo sapiens	75-80